Document:

Exhibit 10.4

AMENDMENT
no. 1 TO

 

SHARE EXCHANGE
AGREEMENT

 

THIS AMENDMENT NO.
1 TO SHARE EXCHANGE AGREEMENT, dated December 18, 2018 (this “Amendment”), is the first amendment to that certain
Share Exchange Agreement entered into as of August 20, 2018 (the “Agreement”), by and among ALLIANCE
MMA, INC., a Delaware corporation (“AMMA”), SCWORX CORP., a Delaware corporation (“SCWorx”),
and the SCWorx stockholders listed on Schedule A thereto. Defined terms used herein and not otherwise defined herein shall
have the meaning ascribed to them in the Agreement.

 

WHEREAS, the
parties to the Agreement desire to amend the Agreement to (i) extend the date for the closing of the transactions contemplated
thereby and (ii) fix the price per share of AMMA’s common stock for the purpose of determining the number of said shares
that will be issued to the SCWorx shareholders in connection with AMMA’s acquisition of SCWorx.

 

NOW, THEREFORE,
the parties hereto, for good and valuable consideration, the receipt and sufficiency of which are hereby confirmed, do agree
as follows:

 

		1.	Amendment of Section 1.1(b) of Share Exchange Agreement. Section 1.1(b) of the Agreement
is hereby amended and restated to read in its entirety as follows:

 

“1.1(b)
In accordance with the Exchange Ratio set forth on Exhibit B, the aggregate purchase price for the SCWorx Shares shall be
100,000,000 AMMA Shares (collectively, the “Acquisition Shares”) . The Acquisition Shares will be issued to
each respective SCWorx Stockholder in proportion to their respective pro rata ownership of the SCWorx Shares. In addition to the
Acquisition Shares, AMMA shall issue to Mark Munro that number of shares of Series A Preferred Stock having a face value equal
to the amount of all indebtedness owing to him by SCWorx as of the Closing Date (including accrued but unpaid interest) (estimated
to be approximately $1.9 million).”

 

		2.	Amendment of Section 9.1(b) of Share Exchange Agreement. The definition of “Outside Date” set forth in Section
9.1(b) of the Share Exchange Agreement is hereby changed to January 30, 2019.

 

		3.	Amendment of Exhibit B of Share Exchange Agreement. Exhibit B of the Share Exchange Agreement
is hereby amended and restated to read in its entirety as follows:

 

EXHIBIT B

 

Calculation of Exchange
Ratio/No Adjustment

 

The 100,000,000
Acquisition Shares to be issued to SCWorx Stockholders pursuant to Section 1.1(b) is based on (i) a fixed price per AMMA Share
on the Closing Date of $.50 and (ii) a valuation of $50 million for the Acquisition Shares. Regardless of the closing price per
AMMA Share on the Closing Date , the number of Acquisition Shares issuable to the SCWorx Stockholders shall not be subject to any
adjustment. The number of Acquisition Shares being issued is fixed at 100,000,000 and is based upon $50 million (the agreed value
of SCWorx) divided by $.50 per share (the agreed value of per AMMA Share on the Closing Date.

 

		4.	Agreement remains in full force and effect.  Except as expressly modified hereby, the Agreement
remains in full force and effect in accordance with the terms and provisions thereof.

 

     

     

    

 

		5.	Successors and Assigns. Except as otherwise provided
herein, the terms and conditions of this Amendment shall inure to the benefit of and be binding upon the respective successors
and assigns of the parties.

 

		6.	Governing Law. This Amendment Agreement shall
be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise
govern under applicable principles of conflicts of laws. In any action or suit between any of the Parties arising out of or relating
to this Amendment or any of the Contemplated Transactions: (a) each of the Parties irrevocably and unconditionally consents and
submits to the exclusive jurisdiction and venue of the state and federal courts located in the State of Delaware; (b) if any such
action or suit is commenced in a state court, then, subject to applicable Legal Requirements, no Party shall object to the removal
of such action or suit to any federal court located in the District of Delaware; and (c) each of the Parties irrevocably waives
the right to trial by jury.

 

		7.	Attorneys’ Fees. In any action at law or suit in equity to enforce this Amendment
or the rights of any of the Parties under this Amendment, the prevailing Party in such action or suit shall be entitled to receive
a reasonable sum for its attorneys’ fees and all other reasonable costs and expenses incurred in such action or suit.

 

		8.	Counterparts. This Amendment may be executed in two
(2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same
instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall
be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

[signature page follows]

 

     

     

    

 

IN WITNESS WHEREOF,
the Parties have caused this Amendment No. 1 to Share Exchange Agreement to be executed as of the date first above written.

 

	 	ALLIANCE MMA, INC.
	 	 	 
	 	By:	/s/ John Price
	 	Name:	John Price

	 	Title:	 
	 	 	 
	 	SCWORX CORP.
	 	 	 
	 	By:	/s/ Mark Schessel
	 	Name:	Mark Schessel

	 	Title:	 

 

[SCWORX STOCKHOLDERS SIGNATURE PAGES
FOLLOWS]

 

     

     

    

 

	 	SCWORX STOCKHOLDERS
	 	 
	 	SCWORX STOCKHOLDERS
	 	 
	 	/s/ Marc S. Schessel
	 	Marc S. Schessel
	 	 
	 	/s/ Mark E. Munro
	 	Mark E. Munro
	 	 
	 	/s/ Double02 LLC
	 	Double02 LLC
	 	 
	 	/s/ Riverside Merchant Partners
	 	Riverside Merchant Partners
	 	 
	 	/s/ Zachary Hirsch
	 	Zachary Hirsch
	 	 
	 	/s/ Dan Sullivan
	 	Dan Sullivan
	 	 
	 	/s/ Osher Capital Partners LLC
	 	Osher Capital Partners LLC
	 	 
	 	/s/ Michael Ference
	 	Michael Ference
	 	 
	 	/s/ Thomas Rose
	 	Thomas Rose
	 	 
	 	/s/ Harry Ioannou
	 	Harry Ioannou
	 	 
	 	/s/ Dominion Capital LLC
	 	Dominion Capital LLC
	 	 
	 	/s/ George Anagnostou
	 	George Anagnostou
	 	 
	 	/s/ M2B Funding Corporation
	 	M2B Funding Corporation
	 	 
	 	/s/ Frank Basile
	 	Frank Basile
	 	 
	 	/s/ MAK, LLC
	 	MAK, LLC
	 	 
	 	/s/ DXI LLC
	 	DXI LLC
	 	 
	 	/s/ Salvatore Giardina
	 	Salvatore Giardina
	 	 
	 	/s/ Lawrence Sands
	 	Lawrence Sands
	 	 
	 	/s/ Alpha Capital Anstalt
	 	Alpha Capital Anstalt

 

    	 	 	 

     

    

 

SHARE EXCHANGE AGREEMENT

 

Alliance
MMA, Inc.

 

SCWorx
Corp.

 

AND

 

THE STOCKHOLDERS PARTY HERETO

 

Dated as of August [Ÿ],
2018

 

     

     

    

 

Table of Contents

 

	 	 	Page
	 	 	 
	ARTICLE 1 DESCRIPTION OF TRANSACTION	1
	 	 	 
	1.1	Structure of the Exchange	1
	1.2	Closing	2
	1.3	Exchange of Securities	2
	1.4	Further Action	3
	1.5	Tax Consequences	3
	1.6	Allocation Certificate	3
	 	 	 
	ARTICLE 2 REPRESENTATIONS AND WARRANTIES OF SCWORX	4
	 	 	 
	2.1	Subsidiaries; Due Organization; Organizational Documents	4
	2.2	Authority; Vote Required	5
	2.3	Non-Contravention; Consents	5
	2.4	Capitalization	5
	2.5	Financial Statements	6
	2.6	Absence of Changes	7
	2.7	Title to Assets	7
	2.8	Real Property; Leaseholds	7
	2.9	Intellectual Property	7
	2.10	Material Contracts	10
	2.11	Undisclosed Liabilities	12
	2.12	Compliance; Permits; Restrictions	12
	2.13	Tax Matters	13
	2.14	Employee and Labor Matters; Benefit Plans	16
	2.15	[Reserved]	19
	2.16	Insurance	20
	2.17	Legal Proceedings; Orders	20
	2.18	[Reserved]	20
	2.19	No Financial Advisor	20
	2.20	Bank Accounts	20
	2.21	Disclosure; Information Statement	21
	2.22	Related Party Transactions	21
	2.23	Exclusivity of Representations; Reliance	21
	 	 	 
	ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF AMMA	22
	 	 	 
	3.1	Subsidiaries; Due Organization; Organizational Documents	22
	3.2	Authority; Vote Required	23
	3.3	Non-Contravention; Consents	23
	3.4	Capitalization	24
	3.5	SEC Filings; Financial Statements	25

 

     

     

    

 

Table of Contents

(continued)

 

	 	 	Page
	 	 	 
	3.6	Absence of Changes	27
	3.7	Title to Assets	28
	3.8	Real Property; Leaseholds	28
	3.9	Intellectual Property	28
	3.10	Material Contracts	31
	3.11	Undisclosed Liabilities	33
	3.12	Compliance; Permits; Restrictions	33
	3.13	Tax Matters.	34
	3.14	Employee and Labor Matters; Benefit Plans	37
	3.15	Environmental Matters	42
	3.16	Insurance	43
	3.17	Legal Proceedings; Orders	43
	3.18	Anti-Corruption	44
	3.19	[Inapplicability of Anti-takeover Statutes	44
	3.20	No Financial Advisor	44
	3.21	Disclosure	44
	3.22	Bank Accounts; Deposits	45
	3.23	Transactions with Affiliates	45
	3.24	Valid Issuance	45
	3.25	Opinion of Financial Advisor	45
	3.26	Shell Company Status	45
	3.27	Exclusivity of Representations; Reliance	45
	 	 	 
	ARTICLE 4 CERTAIN COVENANTS OF THE PARTIES	45
	 	 	 
	4.1	Access and Investigation	45
	4.2	Operation of AMMA’s Business	47
	4.3	Operation of SCWorx’s Business	49
	4.4	Notification of Certain Matters	50
	4.5	No Solicitation	52
	 	 	 
	ARTICLE 5 ADDITIONAL AGREEMENTS OF THE PARTIES	53
	 	 	 
	5.1	AMMA Stockholders’ Meeting and Proxy Statement	53
	5.2	Information Statement; SCWorx Stockholder Written Consent	55
	5.3	AMMA Stockholders’ Meeting	55
	5.4	Regulatory Approvals	56
	5.5	[Reserved.]	57
	5.6	[Reserved.]	57
	5.7	AMMA Employee and Benefits Matters	57
	5.8	Indemnification of Officers and Directors	58
	5.9	Additional Agreements	59
	5.10	Disclosure	60
	5.11	Listing	60
	5.12	Tax Matters	60

 

    	ii	 

     

    

 

Table of Contents

(continued)

 

	 	 	Page
	 	 	 
	5.13	Legends	61
	5.14	Directors and Officers	61
	5.15	Takeover Statutes	62
	5.16	Validity of Private Placement	62
	5.17	Stockholder Litigation	62
	 	 	 
	ARTICLE 6 CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY	62
	 	 	 
	6.1	No Restraints	62
	6.2	Stockholder Approval	62
	6.3	Listing	63
	6.4	No Governmental Proceedings Relating to Contemplated Transactions or Right to Operate Business	63
	 	 	 
	ARTICLE 7 ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF AMMA	63
	 	 	 
	7.1	Accuracy of Representations	63
	7.2	Performance of Covenants	64
	7.3	No SCWorx Material Adverse Effect	64
	7.4	Closing Certificate	64
	7.5	[Reserved]	64
	7.6	SCWorx Allocation Certificate	64
	7.7	Lock-up Agreements	64
	 	 	 
	ARTICLE 8 ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF SCWORX	65
	 	 	 
	8.1	Accuracy of Representations	65
	8.2	Performance of Covenants	65
	8.3	No AMMA Material Adverse Effect	65
	8.4	Termination of Contracts	65
	8.5	Board of Directors and Officers	65
	8.6	Sarbanes-Oxley Certifications	66
	8.7	Satisfaction of Liabilities	66
	8.8	Amendments to Certificate of Incorporation	66
	8.9	Cancellation of AMMA Options	66
	8.10	Documents	66
	8.11	SCWorx Designees	66
	8.12	Fairness Opinion	66
	 	 	 
	ARTICLE 9 TERMINATION	67
	 	 	 
	9.1	Termination	67
	9.2	Effect of Termination	69
	9.3	Expenses; Termination Fees	69

 

    	iii	 

     

    

 

Table of Contents

(continued)

 

	 	 	Page
	 	 	 
	ARTICLE 10 MISCELLANEOUS PROVISIONS	71
	 	 	 
	10.1	Non-Survival of Representations and Warranties	72
	10.2	Amendment	72
	10.3	Waiver.	72
	10.4	Entire Agreement; Counterparts; Exchanges by Facsimile	72
	10.5	Applicable Law; Jurisdiction	72
	10.6	Attorneys’ Fees	72
	10.7	Assignability; No Third Party Beneficiaries	73
	10.8	Notices	73
	10.9	Severability	73
	10.10	Other Remedies; Specific Performance	74
	10.11	Construction.	74

 

Schedules:

AMMA Disclosure Schedule

SCWorx Disclosure Schedule

	Schedule 5.7(c)	Terminated AMMA Associate Payments
	Schedule 5.7(d)	Terminated AMMA Employee Plans
	Schedule 5.14	AMMA Directors and Officers at the Closing Date
	Schedule 8.4	Terminated Contracts
	Schedule 8.7	Liabilities

 

Exhibits:

	Exhibit A	Certain Definitions
	Exhibit B	Calculation of Exchange Ratio and Adjustment 

 

    	iv	 

     

    

 

SHARE EXCHANGE
AGREEMENT

 

THIS SHARE EXCHANGE
AGREEMENT (this “Agreement”) is made and entered into as of August [Ÿ],
2018, by and among ALLIANCE MMA, INC., a Delaware corporation (“AMMA”),
SCWORX CORP., a Delaware corporation (“SCWorx”), and the SCWorx stockholders listed on Schedule A hereto.
AMMA and SCWorx are referred to herein individually as a “Party” and collectively as the “Parties.”
Certain capitalized terms used in this Agreement are defined in Exhibit A. Other terms are defined within the text. All
defined terms are shown in the Index of Defined Terms that follows the table of contents.

 

RECITALS

 

WHEREAS, AMMA is a publicly held
corporation whose shares of common stock, par value $0.001 per share (the “AMMA Shares”), trade on the The NASDAQ
Stock Market LLC (the “NASDAQ”);

 

WHEREAS, AMMA desires to purchase
from each holder of SCWorx shares of common stock, par value $0.01 per share (the “SCWorx Shares”), in exchange
for newly issued AMMA Shares, all on the terms and subject to the conditions set forth in this Agreement;

 

WHEREAS, as a result of the transactions
contemplated herein, AMMA will become the sole stockholder of SCWorx; and

 

WHEREAS, certain capitalized terms
used in this Agreement are defined on Exhibit A hereto.

 

AGREEMENT

 

The Parties to this
Agreement, intending to be legally bound, agree as follows:

 

ARTICLE 1DESCRIPTION
OF TRANSACTION

 

1.1           Structure
of the Exchange.

 

(a)          On
the Closing Date, and subject to the satisfaction or waiver of the conditions set forth in Article 6, Article 7 and
Article 8, all of the holders of SCWorx Shares (the “SCWorx Stockholders”), shall sell, transfer and
assign to AMMA, and AMMA agrees to acquire, all of the SCWorx Shares. As of the Closing Date, the SCWorx Shares shall constitute
all of the issued and outstanding securities of SCWorx.

 

(b)          In
accordance with the Exchange Ratio set forth on Exhibit B, assuming the closing price of AMMA stock is $.67 per share on
the Closing Date, the aggregate purchase price for the SCWorx Shares shall be 3,731.3433 AMMA Shares for each SCWorx Share, or
74,626,866 AMMA Shares (collectively, the “Acquisition Shares”), which shall represent approximately eighty
percent (80%) of the issued and outstanding AMMA Shares on the Closing Date. The Acquisition Shares will be issued to each respective
SCWorx Stockholder in proportion to their respective pro rata ownership of the SCWorx Shares. If, on the Closing Date the closing
price of AMMA Shares on the NASDAQ has decreased below the $.67 trading price used for the calculation of the Exchange Ratio, the
Exchange Ratio shall be adjusted, pursuant to Exhibit B, and the number of Acquisition Shares issuable to SCWorx Stockholders
shall be correspondingly increased to provide the SCWorx Stockholders with the same economic effect as contemplated by this Agreement.

 

     

     

    

 

The sale of the SCWorx
Shares and issuance of the Acquisition Shares contemplated hereunder shall be referred to herein as the “Exchange.”

 

1.2           Closing.
Unless this Agreement is earlier terminated pursuant to the provisions of Section 9.1, and subject to the satisfaction or
waiver of the conditions set forth in Article 6, Article 7 and Article 8, the closing of the Exchange (the
 “Closing”) shall take place at the offices of Zysman, Aharoni, Gayer and Sullivan & Worcester LLP, 1633
Broadway, New York, NY 10019 as promptly as practicable (but in no event later than the second Business Day following the satisfaction
or waiver of the last to be satisfied or waived of the conditions set forth in Article 6, Article 7 and Article
8, other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or
waiver of each of such conditions), or at such other time, date and place as AMMA and SCWorx may mutually agree in writing. The
date on which the Closing actually takes place is referred to as the “Closing Date.”

 

1.3           Exchange
of Securities.

 

(a)          At
the Closing, each SCWorx Stockholder shall surrender the certificate or certificates that immediately prior to the Closing represent
the SCWorx Shares (the “SCWorx Certificates”) to AMMA in exchange for the Acquisition Shares.

 

(b)          Promptly
after the Closing, AMMA or its designated exchange agent shall make available to each SCWorx Stockholder a letter of transmittal
and instructions for use in effecting the surrender of SCWorx Certificates in exchange for the Acquisition Shares. Upon surrender
of a SCWorx Certificate to AMMA or such exchange agent together with the letter of transmittal, duly executed, the SCWorx Stockholder
shall be entitled to receive in exchange therefore such number of Acquisition Shares as such SCWorx Stockholder has the right to
receive in respect of the SCWorx Certificate so surrendered pursuant to the provisions of this Article 1.

 

(c)          No
dividends or other distributions declared or made with respect to AMMA Shares with a record date after the Closing Date shall be
paid to the holder of any unsurrendered SCWorx Stock Certificate with respect to the AMMA Shares that such holder has the right
to receive in the Exchange until such holder surrenders such SCWorx Stock Certificate or delivers an affidavit of loss or destruction
in lieu thereof in accordance with this Section 1.3 (at which time such holder shall be entitled, subject to the effect
of applicable abandoned property, escheat or similar laws, to receive all such dividends and distributions, without interest).

 

(d)          No
Party to this Agreement shall be liable to any holder of any SCWorx Stock Certificate or to any other Person with respect to any
AMMA Shares (or dividends or distributions with respect thereto) or for any cash amounts required to be delivered to any public
official pursuant to any applicable abandoned property law, escheat law or similar Legal Requirement.

 

    	 	2	 

     

    

 

1.4           Further
Action. If, at any time after the Closing Date, any further action is determined by AMMA or SCWorx to be necessary or desirable
to carry out the purposes of this Agreement, then the officers and directors of AMMA shall be fully authorized, and shall use their
commercially reasonable efforts to take such action.

 

1.5           Tax
Consequences. For federal income Tax purposes, the Exchange is intended to constitute a reorganization within the meaning of
Section 368(a) of the Code and the Treasury Regulations promulgated thereunder. The Parties hereby adopt this Agreement as a “plan
of reorganization” within the meaning of Treasury Regulations Section 1.368-2(g).

 

1.6           Allocation
Certificate. SCWorx will prepare and deliver to AMMA at least five (5) Business Days prior to the Closing Date a certificate
signed by the Chief Financial Officer of SCWorx (or if there is no Chief Financial Officer, the principal accounting officer of
SCWorx) in a form reasonably acceptable to AMMA, which sets forth a true and complete list, as of immediately prior to the Closing
Date (giving effect to all applicable conversions into or exercises of securities convertible into or exercisable for SCWorx Shares,
of: (a) the record holders of SCWorx Shares; (b) the number of SCWorx Shares owned and/or underlying such securities and the per
share exercise price, as applicable, for each such security; and (c) the number of Acquisition Shares each such holder is entitled
to receive pursuant to Section 1.1 (the “Allocation Certificate”). The Allocation Certificate shall be
binding and conclusive on all securityholders of SCWorx.

 

ARTICLE 2REPRESENTATIONS
AND WARRANTIES OF SCWORX

 

SCWorx represents and
warrants to AMMA as follows, except as set forth in the written disclosure schedule delivered by SCWorx to AMMA (the “SCWorx
Disclosure Schedule”) (it being understood that the representations and warranties in this Article 2 are qualified
by: (a) any exceptions and disclosures set forth in the section or subsection of the SCWorx Disclosure Schedule corresponding
to the particular section or subsection in this Article 2 in which such representation and warranty appears; (b) any
exceptions or disclosures explicitly cross-referenced in such section or subsection of the SCWorx Disclosure Schedule by reference
to another section or subsection of the SCWorx Disclosure Schedule; and (c) any exceptions or disclosures set forth in any
other section or subsection of the SCWorx Disclosure Schedule to the extent it is reasonably apparent from the wording of such
exception or disclosure that such exception or disclosure qualifies such representation and warranty). The inclusion of any information
in the SCWorx Disclosure Schedule shall not be deemed to be an admission or acknowledgement, in and of itself, that such information
is required by the terms hereof to be disclosed, is material, has resulted in or would result in a SCWorx Material Adverse Effect,
or is outside the Ordinary Course of Business.

 

    	 	3	 

     

    

 

2.1           Subsidiaries;
Due Organization; Organizational Documents.

 

(a)          SCWorx
has one subsidiary consisting of Primrose Solutions, LLC. Neither SCWorx nor its subsidiary has agreed nor is obligated to make,
nor is bound by any Contract under which it may become obligated to make, any future investment in or capital contribution to any
other Entity. Except for its subsidiary, SCWorx has not, at any time, been a general partner or manager of, or has otherwise been
liable for any of the debts or other obligations of, any general partnership, limited partnership, limited liability company or
other Entity.

 

(b)          SCWorx
is a corporation duly organized, validly existing and in good standing under the laws of Delaware and has all necessary power and
authority: (i) to conduct its business in the manner in which its business is currently being conducted; (ii) to own and use its
assets in the manner in which its assets are currently owned and used; and (iii) to perform its obligations under all SCWorx Contracts.

 

(c)          SCWorx
and its subsidiary are each qualified to do business as a foreign corporation and are in good standing under the laws of all jurisdictions
where the nature of their business requires such qualification other than in jurisdictions where the failure to be so qualified
would not constitute a SCWorx Material Adverse Effect.

 

(d)          Each
director and officer of SCWorx as of the date of this Agreement is set forth in Section 2.1(d) of the SCWorx Disclosure
Schedule.

 

(e)          SCWorx
has delivered or made available to AMMA accurate and complete copies of the certificate of incorporation, bylaws and other charter
and organizational documents, including all currently effective amendments thereto for SCWorx. SCWorx has not taken any action
in breach or violation of any of the provisions of its certificate of incorporation, bylaws or other charter or organizational
documents nor is it in breach or violation of any of the material provisions of its certificate of incorporation, bylaws or other
charter or organizational documents, except as would not reasonably be expected to have, individually or in the aggregate, a SCWorx
Material Adverse Effect.

 

2.2           Authority;
Vote Required.

 

(a)          Subject
to obtaining the approval of the stockholders of SCWorx, which approval will be obtained by unanimous written consent promptly
following the date of this Agreement (the “SCWorx Stockholder Written Consent”), SCWorx has all necessary corporate
power and authority to enter into and to perform its obligations under this Agreement. The SCWorx Board of Directors has: (i) determined
that the Exchange is fair to, and in the best interests of SCWorx and the SCWorx Stockholders; (ii) duly authorized and approved
by all necessary corporate action, the execution, delivery and performance of this Agreement and the Contemplated Transactions;
and (iii) recommended the approval of this agreement, the Exchange and the other transactions contemplated by this Agreement
(the “SCWorx Stockholder Matters”) by the SCWorx Stockholders pursuant to the SCWorx Stockholder Written Consent.
This Agreement has been duly executed and delivered by SCWorx and, assuming the due authorization, execution and delivery by AMMA,
constitutes the legal, valid and binding obligation of SCWorx, enforceable against SCWorx in accordance with its terms, subject
to: (A) laws of general application relating to bankruptcy, insolvency and the relief of debtors; and (B) rules of law governing
specific performance, injunctive relief and other equitable remedies.

 

    	 	4	 

     

    

 

(b)          The
affirmative vote of the holders of a majority of the shares of SCWorx Common Stock, voting as a single class, as outstanding on
the date of the SCWorx Stockholder Written Consent approving the SCWorx Stockholder Matters (the “Required SCWorx Stockholder
Vote”), are the only votes (including any veto rights provisions granted to any of the SCWorx Stockholders) of the holders
of any class or series of SCWorx Capital Stock necessary to approve the SCWorx Stockholder Matters.

 

2.3           Non-Contravention;
Consents.

 

(a)          The
execution and delivery of this Agreement by SCWorx does not, and the performance of this Agreement by SCWorx will not, subject
to obtaining the Required SCWorx Stockholder Vote, (i) conflict with or violate the certificate of incorporation or bylaws
of SCWorx; (ii) subject to compliance with the requirements set forth in Section 2.3(b) below, conflict with or violate
any Legal Requirement applicable to SCWorx or by which its properties are bound or affected, except for any such conflicts or violations
that would not constitute a SCWorx Material Adverse Effect; or (iii) except as listed on Section 2.3(a) of the SCWorx
Disclosure Schedule, require SCWorx to make any filing with or give any notice or make any payment to a Person, or obtain any Consent
from a Person, or result in any breach of or constitute a default (or an event that with notice or lapse of time or both would
become a default) under, or impair SCWorx’s rights or alter the rights or obligations of any third party under, or give to
others any rights of termination, amendment, acceleration or cancelation of, or result in the creation of an Encumbrance on any
of the properties or assets of SCWorx pursuant to, in each case, any SCWorx Material Contract.

 

(b)          No
material Consent, order of, or registration, declaration or filing with, any Governmental Body is required by or with respect to
SCWorx in connection with the execution and delivery of this Agreement or the consummation of the Contemplated Transactions, except
for such Consents, orders, registrations, declarations and filings as may be required under applicable federal and state securities
laws.

 

2.4           Capitalization.

 

(a)          The
authorized capital stock of SCWorx as of the date of this Agreement consists of: (i) 20,000 shares of SCWorx Common Stock, of which
20,000 shares are issued and outstanding as of the date of this Agreement. SCWorx does not hold any of its capital stock in treasury.
All of the outstanding shares of SCWorx Common Stock have been duly authorized and validly issued, and are fully paid and nonassessable.

 

(b)          SCWorx
does not have any stock option plan or any other plan, program, agreement or arrangement providing for any equity-based compensation
for any Person.

 

    	 	5	 

     

    

 

(c)          There
is no: (i) outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any shares
of the capital stock or other securities of SCWorx; (ii) outstanding security, instrument or obligation that is or may become convertible
into or exchangeable for any shares of the capital stock or other securities of SCWorx; (iii) stockholder rights plan (or similar
plan commonly referred to as a “poison pill”) or Contract under which SCWorx is or may become obligated to sell or
otherwise issue any shares of its capital stock or any other securities; or (iv) condition or circumstance that may give rise to
or provide a basis for the assertion of a claim by any Person to the effect that such Person is entitled to acquire or receive
any shares of capital stock or other securities of SCWorx. There are no outstanding or authorized stock appreciation, phantom stock,
profit participation, restricted stock units, equity-based awards or other similar rights with respect to SCWorx.

 

(d)          (i) None
of the outstanding SCWorx Shares are entitled or subject to any preemptive right, right of repurchase or forfeiture, right of participation,
right of maintenance or any similar right; (ii) none of the outstanding SCWorx Shares are subject to any right of first refusal
in favor of SCWorx; (iii) there are no outstanding bonds, debentures, notes or other indebtedness of SCWorx having a right
to vote on any matters on which the SCWorx Stockholders have a right to vote; (iv) there is no SCWorx Contract to which SCWorx
is a party relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise
disposing of (or from granting any option or similar right with respect to), any SCWorx Shares. SCWorx is not under any obligation,
or is bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding
SCWorx Shares or other securities, or to register such shares with the SEC.

 

(e)          All
outstanding SCWorx Shares have been issued and granted in material compliance with all applicable securities laws and other applicable
Legal Requirements.

 

2.5           Financial
Statements.

 

(a)          Section
2.5(a) of the SCWorx Disclosure Schedule includes true and complete copies of (i) SCWorx’s unaudited balance sheet at
December 31, 2017 and SCWorx’s unaudited statements of operations, cash flows and stockholders’ equity for the year
ended December 31, 2017, audited versions of which financial statements shall be provided to AMMA within seventy five (75) days
of the date hereof, but at least 5 business days before the Closing Date (the “SCWorx Audited Financials”) and
(ii) the SCWorx Unaudited Financials (collectively, the “SCWorx Financials”). The SCWorx Audited Financials
will be prepared in accordance with United States generally accepted accounting principles (“GAAP”) applied
on a consistent basis unless otherwise noted therein throughout the periods indicated and the SCWorx Audited Financials will and
the Unaudited Financials do fairly present, the financial condition and operating results of SCWorx in all material respects as
of the dates and for the periods indicated therein.

 

(b)          SCWorx
maintains a system of internal accounting controls designed to provide reasonable assurance that: (i) transactions are executed
in accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted
only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. SCWorx
maintains internal control over financial reporting that provides reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with GAAP.

 

    	 	6	 

     

    

 

2.6           Absence
of Changes. Except as set forth in Section 2.6 of the SCWorx Disclosure Schedule, between June 30, 2018 and the date
of this Agreement, SCWorx has conducted its business in the Ordinary Course of Business and there has not been (a) any event that
has had a SCWorx Material Adverse Effect or (b) or any action, event or occurrence that would have required consent of AMMA pursuant
to Section 4.3(b) of this Agreement had such action, event or occurrence taken place after the execution and delivery of
this Agreement.

 

2.7           Title
to Assets. Except with respect to SCWorx IP Rights, which are covered in Section 2.9, SCWorx owns, and has good and
valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or assets
and equipment used or held for use in its business or operations or purported to be owned by it, in each case, free and clear of
any Encumbrances, except for: (i) any lien for current Taxes not yet due and payable or for Taxes that are being contested in good
faith and for which adequate reserves have been made in the SCWorx Unaudited Financials; (ii) minor liens that have arisen in the
Ordinary Course of Business and that do not (in any case or in the aggregate) materially detract from the value of the assets subject
thereto or materially impair the operations of SCWorx; and (iii) liens listed in Section 2.7 of the SCWorx Disclosure
Schedule.

 

2.8           Real
Property; Leaseholds. SCWorx does not currently own and has never owned any real property or any interest in real property,
except for the leaseholds created under the real property leases (including any amendments thereto) identified in Section 2.8
of the SCWorx Disclosure Schedule (the “SCWorx Leases”), which are each in full force and effect.

 

2.9           Intellectual
Property.

 

(a)          SCWorx
owns, or has the right to use all SCWorx IP Rights, except where any failure to own or have the right to use, or have the right
to bring actions, would not constitute a SCWorx Material Adverse Effect. The foregoing representation and warranty is not intended
to be a representation regarding the absence of infringement or misappropriation, which is addressed in Section 2.9(f) below.

 

(b)          Section
2.9(b) of the SCWorx Disclosure Schedule is an accurate, true and complete listing of (i) all patents within the SCWorx
Registered IP that are owned by SCWorx and (ii) all other SCWorx Registered IP.

 

(c)          Section
2.9(c) of the SCWorx Disclosure Schedule accurately identifies (i) all material SCWorx IP Rights licensed to SCWorx (other
than (A) any non-customized software that (1) is so licensed solely in executable or object code form pursuant to a non-exclusive,
internal use software license and other Intellectual Property associated with such software or (2) is not incorporated into, or
material to the development, manufacturing, or distribution of, any of SCWorx’s products or services, (B) any Intellectual
Property licensed ancillary to the purchase or use of equipment, reagents or other materials, (C) non-disclosure agreements, materials
transfer agreements and template agreements entered into in the Ordinary Course of Business and (D) agreements between SCWorx and
its employees and consultants); (ii) the corresponding SCWorx Contracts pursuant to which such SCWorx IP Rights are licensed to
SCWorx; (iii) whether the license or licenses granted to SCWorx are exclusive or non-exclusive; and (iv) whether, to
the Knowledge of SCWorx, any funding, facilities or personnel of any Governmental Body were used, directly or indirectly, to develop
or create, in whole or in part, such SCWorx IP Rights.

 

    	 	7	 

     

    

 

(d)          Section
2.9(d) of the SCWorx Disclosure Schedule accurately identifies each SCWorx Material Contract pursuant to which any Person (other
than SCWorx) has been granted any license or option to obtain a license under, or otherwise has received or acquired any right
(whether or not currently exercisable) or interest in, any SCWorx IP Rights (in each case, other than non-disclosure agreements,
materials transfer agreements or non-exclusive licenses entered into in the Ordinary Course of Business). SCWorx is not bound by,
and no SCWorx IP Rights (and to the Knowledge of SCWorx, no licensed SCWorx IP Rights) are subject to, any Contract containing
any covenant or contractual obligation that in any way limits or restricts the ability of SCWorx to use, exploit, assert or enforce
any SCWorx IP Rights anywhere in the world, in each case in a manner that would materially limit the business of SCWorx as currently
conducted or planned to be conducted.

 

(e)          Except
as identified on Section 2.9(e) of the SCWorx Disclosure Schedule, SCWorx solely owns all right, title, and interest to
and in the SCWorx Registered IP listed on (or required to be listed on) Section 2.9(b) of the SCWorx Disclosure Schedule
free and clear of any Encumbrances. Without limiting the generality of the foregoing:

 

(i)          All
documents and instruments necessary to register or apply for or renew registration of all SCWorx Registered IP that is solely owned
by SCWorx has been validly executed, delivered and filed in a timely manner with the appropriate Governmental Body except for any
such failure, individually or collectively, that would not constitute a SCWorx Material Adverse Effect.

 

(ii)         Each
Person who is or was an employee or contractor of SCWorx and who is or was involved in the creation or development of any SCWorx
IP Rights has signed a written agreement containing an assignment of such Intellectual Property to SCWorx and confidentiality provisions
protecting trade secrets and confidential information of SCWorx; provided, that any such agreement with a third party contractor
for research, development or manufacturing services on behalf of SCWorx may provide that such third party contractor reserves its
rights in improvements to such third party contractor’s Intellectual Property or generally applicable research, development
or manufacturing technology, in either case that is not specific to any product or service of SCWorx. To the Knowledge of SCWorx,
no current or former stockholder, officer, director, employee or contractor of SCWorx has any claim, right (whether or not currently
exercisable), or interest to or in any SCWorx IP Rights. To the Knowledge of SCWorx, no employee or contractor of SCWorx is (1)
bound by or otherwise subject to any Contract restricting him or her from performing his or her duties for SCWorx or (2) in breach
of any Contract with any current or former employer or other Person concerning SCWorx IP Rights or confidentiality provisions protecting
trade secrets and confidential information comprising SCWorx IP Rights.

 

    	 	8	 

     

    

 

(iii)        To
the Knowledge of SCWorx, no funding, facilities or personnel of any Governmental Body were used, directly or indirectly, to develop
or create, in whole or in part, any SCWorx IP Rights in which SCWorx has an ownership interest.

 

(iv)        SCWorx
has taken reasonable steps to maintain the confidentiality of and otherwise protect and enforce its rights in all proprietary information
that SCWorx holds, or purports to hold, as a trade secret.

 

(v)         Except
as set forth on Section 2.9(e)(v) of the SCWorx Disclosure Schedule, SCWorx has not assigned or otherwise transferred ownership
of, or agreed to assign or otherwise transfer ownership of, any SCWorx IP Rights to any other Person.

 

(vi)        The
SCWorx IP Rights constitute all Intellectual Property necessary for SCWorx to conduct its business as currently conducted or planned
to be conducted.

 

(f)          The
manufacture, marketing, license, sale or intended use of any product or service by SCWorx (i) does not violate or constitute
a breach of any license or agreement between SCWorx and any third party, and, (ii) to the Knowledge of SCWorx, does not infringe
or misappropriate any Intellectual Property right of any third party. To the Knowledge of SCWorx, no third party is infringing
upon or misappropriating, or violating any license or agreement with SCWorx relating to, any SCWorx IP Rights. There is no current
or, to the Knowledge of SCWorx, pending challenge, claim or Legal Proceeding (including opposition, interference or other proceeding
in any patent or other government office) contesting the validity, enforceability, ownership or right to use, sell, license or
dispose of any SCWorx IP Rights, nor has SCWorx received any written notice asserting that the manufacture, marketing, license,
sale or intended use of any product or service currently sold by SCWorx infringes or misappropriates or will infringe or misappropriate
the rights of any other Person.

 

(g)          Each
item of SCWorx IP Rights that is SCWorx Registered IP that is solely owned by SCWorx is and at all times has been filed and maintained
in compliance with all applicable Legal Requirements and all filings, payments and other actions required to be made or taken to
maintain such item of SCWorx Registered IP in full force and effect have been made by the applicable deadline, except for any failure
to perform any of the foregoing, individually or collectively, that would not constitute a SCWorx Material Adverse Effect.

 

(h)          No
trademark (whether registered or unregistered) or trade name owned, used, or applied for by SCWorx conflicts or interferes with
any trademark (whether registered or unregistered) or trade name owned, used, or applied for by any other Person. None of the goodwill
associated with or inherent in any trademark (whether registered or unregistered) in which SCWorx has or purports to have an ownership
interest has been impaired as determined by SCWorx in accordance with GAAP.

 

    	 	9	 

     

    

 

(i)          Except
as set forth on Section 2.9(i) of the SCWorx Disclosure Schedule, (i) SCWorx is not bound by any Contract to indemnify,
defend, hold harmless, or reimburse any other Person with respect to any Intellectual Property infringement, misappropriation,
or similar claim, and (ii) SCWorx has not ever assumed, or agreed to discharge or otherwise take responsibility for, any existing
or potential liability of another Person for infringement, misappropriation, or violation of any Intellectual Property right, which
assumption, agreement or responsibility remains in force as of the date of this Agreement.

 

2.10         Material
Contracts.

 

(a)          Section
2.10(a) of the SCWorx Disclosure Schedule lists the following SCWorx Contracts, in effect as of the date of this Agreement
(each, a “SCWorx Material Contract” and collectively, the “SCWorx Material Contracts”):

 

(i)          each
SCWorx Contract constituting a material bonus, deferred compensation, severance, change in control, retention, incentive compensation,
pension, profit-sharing or retirement plans;

 

(ii)         each
SCWorx Contract pursuant to its express terms relating to the employment of, or the performance of employment-related services
by, any Person, including any employee, consultant or independent contractor, or Entity providing employment related, consulting
or independent contractor services other than any employment agreement, employment contract, offer letter, or similar arrangement
that is terminable “at-will” without penalty, Liability or severance (statutory, contractual, or otherwise), or that
can be terminated without penalty, Liability or premium upon notice of thirty (30) days or less;

 

(iii)        each
SCWorx Contract relating to any agreement or plan, including any stock option plan, stock appreciation right plan or stock purchase
plan with any employee or other individual consultant, independent contractor or director, any of the benefits of which will be
increased, or the vesting of benefits of which will be accelerated, by the occurrence of any of the Contemplated Transactions (either
alone or in conjunction with any other event, such as termination of employment), or the value of any of the benefits of which
will be calculated on the basis of any of the Contemplated Transactions;

 

(iv)        each
collective bargaining agreement or other agreement with any union (trade, labor, or otherwise) or similar employee representative
or works council;

 

(v)         each
SCWorx Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course of Business, where
material indemnification is provided by SCWorx to a third party;

 

(vi)        each
SCWorx Contract containing (A) any covenant limiting the freedom of SCWorx to engage in any line of business or compete with any
Person, (B) any most-favored pricing arrangement, (C) any exclusivity provision, or (D) any non-solicitation provision;

 

    	 	10	 

     

    

 

(vii)       each
SCWorx Contract requiring capital expenditures and requiring payments after the date of this Agreement in excess of $50,000 pursuant
to its express terms and not cancelable without penalty, other than purchase orders for the purchase of inventory in the Ordinary
Course of Business;

 

(viii)      each
SCWorx Contract relating to the disposition or acquisition of material assets with a fair market value exceeding $50,000, other
than in the Ordinary Course of Business or listed on Section 2.9(c) or Section 2.9(d) of the SCWorx Disclosure Schedule,
or any ownership interest in any Entity;

 

(ix)         each
SCWorx Contract relating to any mortgages, indentures, loans, notes or credit agreements, security agreements or other agreements
or instruments relating to the borrowing of money or extension of credit in excess of $250,000 or creating any material Encumbrances
with respect to any assets of SCWorx or any loans or debt obligations with officers or directors of SCWorx;

 

(x)          each
SCWorx Contract requiring payment by or to SCWorx after the date of this Agreement in excess of $50,000 pursuant to its express
terms relating to: (A) any distribution agreement (identifying any that contain exclusivity provisions); (B) any dealer, distributor,
joint marketing, alliance, joint venture, cooperation, development or other agreement currently in force under which SCWorx has
continuing obligations to develop or market any product, technology or service, or any agreement pursuant to which SCWorx has continuing
obligations to develop any Intellectual Property that will not be owned, in whole or in part, by SCWorx; or (C) any Contract with
any third party to manufacture or produce any product, service or technology of SCWorx or any Contract to sell, distribute or commercialize
any products or service of SCWorx, in each case, except for SCWorx Contracts entered into in the Ordinary Course of Business;

 

(xi)         each
SCWorx Contract with any Person, including any financial advisor, broker, finder, investment banker or other Person, providing
advisory services to SCWorx in connection with the Contemplated Transactions;

 

(xii)        each
SCWorx IP Rights Agreement other than (A) software license agreements for non-customized software that (1) is so licensed
solely in executable or object code form pursuant to a non-exclusive, internal use software license and other Intellectual Property
associated with such software or (2) is not incorporated into, or material to the development, manufacturing, or distribution
of, any of SCWorx’s products or services, (B) agreements for the purchase or use of equipment, reagents or other materials
that include licenses to Intellectual Property ancillary to such purchase or use, (C) non-disclosure agreements, materials
transfer agreements and template agreements entered into in the Ordinary Course of Business, (D) agreements between SCWorx
and its employees and consultants, and (E) those that are otherwise immaterial;

 

(xiii)       each
SCWorx Lease; and

 

    	 	11	 

     

    

 

(xiv)      any
other SCWorx Contract that is not terminable at will (with no penalty or payment) by SCWorx requiring payment or receipt by SCWorx
after the date of this Agreement under any such agreement, Contract or commitment of more than $50,000 in the aggregate.

 

(b)          SCWorx
has delivered or made available to AMMA accurate and complete (except for applicable redactions thereto) copies of all SCWorx Material
Contracts, including all amendments thereto. There are no SCWorx Material Contracts that are not in written form. SCWorx has not,
and to the Knowledge of SCWorx, as of the date of this Agreement no other party to a SCWorx Material Contract has, breached, violated
or defaulted under, or received notice that it has breached, violated or defaulted under, any of the terms or conditions of any
SCWorx Material Contract in such manner as would permit any other party to cancel or terminate any such SCWorx Material Contract,
or would permit any other party to seek damages that constitutes a SCWorx Material Adverse Effect. As to SCWorx, as of the date
of this Agreement, each SCWorx Material Contract is valid, binding, enforceable and in full force and effect, subject to: (i) laws
of general application relating to bankruptcy, insolvency and the relief of debtors; and (ii) rules of law governing specific performance,
injunctive relief and other equitable remedies.

 

2.11         Undisclosed
Liabilities. As of the date of this Agreement, SCWorx has no material liability, indebtedness, obligation, expense, claim,
deficiency, guaranty or endorsement of any kind, whether accrued, absolute, contingent, matured, or unmatured (whether or not required
to be reflected in the financial statements in accordance with GAAP) (each a “Liability”), except for: (a) Liabilities
identified as such in the “liabilities” column of the SCWorx Unaudited Financials; (b) normal and recurring current
Liabilities that have been incurred by SCWorx since the date of the SCWorx Unaudited Financials in the Ordinary Course of Business;
(c) Liabilities for performance in the Ordinary Course of Business of obligations of SCWorx under SCWorx Contracts, including the
reasonably expected performance of such SCWorx Contracts in accordance with their terms (which would not include, for example,
any instances of breach or indemnification); (d) Liabilities incurred in connection with the Contemplated Transactions; and (e) Liabilities
listed in Section 2.11 of the SCWorx Disclosure Schedule.

 

2.12         Compliance;
Permits; Restrictions.

 

(a)          SCWorx
is, and since the date of its incorporation has been, in compliance with all applicable Legal Requirements except for any non-compliance
that would not constitute a SCWorx Material Adverse Effect. No investigation, claim, suit, proceeding, audit or other action by
any Governmental Body or authority is pending or, to the Knowledge of SCWorx, threatened against SCWorx. There is no Contract,
judgment, injunction, order or decree binding upon SCWorx which (i) has or would reasonably be expected to have the effect of prohibiting
or materially impairing any business practice of SCWorx, any acquisition of material property by SCWorx or the conduct of business
by SCWorx as currently conducted, (ii) would reasonably be expected to have an adverse effect on SCWorx’s ability to comply
with or perform any covenant or obligation under this Agreement, or (iii) would reasonably be expected to have the effect of preventing,
delaying, making illegal or otherwise interfering with the Exchange or any of the other Contemplated Transactions.

 

    	 	12	 

     

    

 

(b)          SCWorx
holds all required Governmental Authorizations which are material to the operation of the business of SCWorx (the “SCWorx
Permits”) as currently conducted. Section 2.12(b) of the SCWorx Disclosure Schedule identifies each SCWorx Permit.
As of the date of this Agreement, SCWorx is in material compliance with the terms of the SCWorx Permits. No action, proceeding,
revocation proceeding, amendment procedure, writ, injunction or claim is pending or, to the Knowledge of SCWorx, threatened, which
seeks to revoke, limit, suspend, or materially modify any SCWorx Permit.

 

2.13         Tax
Matters.

 

(a)          SCWorx
has timely filed all income Tax Returns and other material Tax Returns that it was required to file under applicable Legal Requirements.
All such Tax Returns were correct and complete in all material respects and have been prepared in material compliance with all
applicable Legal Requirements. SCWorx is not currently the beneficiary of any extension of time within which to file any Tax Return.
No claim has ever been made by an authority in a jurisdiction where SCWorx does not file Tax Returns that it is subject to taxation
by that jurisdiction.

 

(b)          All
material Taxes due and owing by SCWorx on or before the date hereof (whether or not shown on any Tax Return) have been paid. The
unpaid Taxes of SCWorx through the date of the SCWorx Unaudited Financials have been reserved for in the SCWorx Unaudited Financials.
Since the date of the SCWorx Unaudited Financials, SCWorx has not incurred any Liability for Taxes outside the Ordinary Course
of Business or otherwise inconsistent with past custom and practice.

 

(c)          SCWorx
has withheld and paid all Taxes required to have been withheld and paid in connection with any amounts paid or owing to any employee,
independent contractor, creditor, stockholder or other third party.

 

(d)          There
are no Encumbrances for Taxes (other than Taxes not yet due and payable or Taxes that are being contested in good faith and for
which adequate reserves have been made on the SCWorx Unaudited Financials) upon any of the assets of SCWorx.

 

(e)          No
material deficiencies for Taxes with respect to SCWorx have been claimed, proposed or assessed by any Governmental Body in writing.
There are no pending (or, based on written notice, threatened) audits, assessments or other actions for or relating to any Liability
in respect of Taxes of SCWorx. No issues relating to Taxes of SCWorx were raised by the relevant Tax authority in any completed
audit or examination that would reasonably be expected to result in a material amount of Taxes in a later taxable period. SCWorx
(and its predecessors) has not waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect
to a Tax assessment or deficiency, nor has any request been made in writing for any such extension or waiver.

 

    	 	13	 

     

    

 

(f)          SCWorx
has not (i) agreed, nor is it required to make, any adjustment under Section 481(a) of the Code by reason of a change
in accounting method or otherwise; nor (ii) elected at any time to be treated as an S corporation within the meaning of Sections
1361 or 1362 of the Code.

 

(g)          SCWorx
has not been a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code during the applicable
period specified in Section 897(c)(1)(A)(ii) of the Code.

 

(h)          SCWorx
is not a party to any Tax allocation, Tax sharing or similar agreement (including indemnity arrangements), other than commercial
contracts entered into in the Ordinary Course of Business with vendors, customers and landlords, the primary purpose of which does
not relate to Taxes.

 

(i)          SCWorx
has never been a member of an affiliated group filing a consolidated, combined or unitary Tax Return (other than a group the common
parent of which is SCWorx) for federal, state, local or foreign Tax purposes. SCWorx does not have any Liability for the Taxes
of any Person (other than SCWorx) under Treasury Regulations Section 1.1502-6 (or any similar provision of state, local, or foreign
law), as a transferee or successor, or otherwise by operation of applicable Legal Requirements.

 

(j)          SCWorx
has not distributed stock of another Person, or has had its stock distributed by another Person, in a transaction that was purported
or intended to be governed in whole or in part by Section 355 of the Code or Section 361 of the Code.

 

(k)          SCWorx
will not be required to include any item of income in, or exclude any item of deduction from, taxable income for any period (or
any portion thereof) beginning after the Closing Date as a result of any (i) installment sale or other open transaction disposition
made on or prior to Closing, (ii) agreement with any Tax authority (including any closing agreement described in Section 7121 of
the Code or any similar provision of state, local or foreign law) made or entered into on or prior to Closing, (iii) deposit or
prepaid amount received outside the Ordinary Course of Business on or prior to Closing, (iv) election under Section 108(i) of the
Code made on or prior to Closing, or (v) use of an improper method of accounting on or prior to the Closing.

 

(l)          SCWorx
is not a partner for Tax purposes with respect to any joint venture, partnership, or, to the Knowledge of SCWorx, other arrangement
or Contract which is treated as a partnership for Tax purposes.

 

(m)          SCWorx
has not entered into any transaction identified as a “listed transaction” for purposes of Treasury Regulations Sections
1.6011-4(b)(2) or 301.6111-2(b)(2).

 

(n)          SCWorx
has not taken any action, nor to the Knowledge of SCWorx, is there any fact or circumstance, that would reasonably be expected
to prevent the Exchange from qualifying as a reorganization within the meaning of Section 368(a) of the Code.

 

    	 	14	 

     

    

 

(o)          SCWorx
has made available to AMMA for inspection at SCWorx’s office (i) complete and correct copies of all income and other material
Tax Returns of SCWorx filed with respect to taxable periods ended on or after December 31, 2017, and (ii) complete and correct
copies of all private letter rulings, examination reports, revenue agent reports, material information document requests, notices
of proposed deficiencies, deficiency notices, protests, petitions, closing agreements, settlement agreements, pending ruling requests,
gain recognition agreements and any similar documents, submitted by, received by or agreed to by or on behalf of SCWorx, in each
case relating to Taxes for all taxable periods for which the statute of limitations has not yet expired.

 

(p)          SCWorx
has disclosed on its income Tax Returns all positions that could give rise to the imposition on it of a substantial understatement
penalty under Section 6662 of the Code (or any corresponding or similar provision of state, local or foreign income Tax law).

 

(q)          All
related party transactions involving SCWorx and its subsidiaries have been conducted at arm’s length in compliance with Code
Section 482 of the Code and the Treasury Regulations promulgated thereunder and any comparable provisions of any other state, local
and non-U.S. Tax Law.

 

(r)          SCWorx
(i) has not been required to make a basis reduction pursuant to former Treasury Regulation Section 1.1502-20(b) or Treasury Regulation
Section 1.337(d)-2(b); (ii) is or has been required to redetermine or reduce basis pursuant to Treasury Regulation Section 1.1502-36(b)
or (c) or to reduce any attributes under Treasury Regulation Section 1.1502-36(d); and (iii) has incurred (or been allocated) any
dual consolidated loss within the meaning of Section 1503 of the Code.

 

(s)          SCWorx
is not subject to Tax in any jurisdiction outside the United States of America by virtue of (i) having a permanent establishment
(within the meaning of an applicable Tax treaty) or other place of business or (ii) otherwise having a taxable presence in that
jurisdiction.

 

(t)          SCWorx
is not a shareholder of a “controlled foreign corporation” as defined in Section 957 of the Code (or any similar provision
of state, local or foreign law) or a shareholder in a “passive foreign investment company” within the meaning of Section
1297 of the Code.

 

(u)          Nothing
in this Section 2.13 or otherwise in this Agreement shall be construed as a representation or warranty with respect to (i) the
amount or availability of any net operating loss, capital loss, Tax credits, Tax basis or other Tax asset or attribute of SCWorx
in any taxable period (or portion thereof) beginning after the Closing Date, or (ii) except with respect to the Tax Treatment
(as defined in Section 5.12 hereof), any Tax position that AMMA or its Affiliates (including the Surviving Corporation)
may take in respect of any taxable period (or portion thereof) beginning after the Closing Date.

 

    	 	15	 

     

    

 

2.14         Employee
and Labor Matters; Benefit Plans.

 

(a)          Section
2.14(a) of the SCWorx Disclosure Schedule lists, as of the date of this Agreement, all written and describes all non-written
employee benefit plans (as defined in Section 3(3) of ERISA) and all bonus, equity-based, retention, incentive, deferred compensation,
retirement or supplemental retirement, profit sharing, severance, change in control, golden parachute, disability, life or accident
insurance, paid time off, vacation, cafeteria, dependent care, medical care, employee assistance program, education or tuition
assistance programs, fringe or employee benefit, and all other compensation, plans, programs, agreements or arrangements, including
but not limited to any employment, consulting, independent contractor, severance or executive compensation agreements or arrangements
(other than regular salary or wages), written or otherwise, which are currently in effect relating to any present or former employee,
independent contractor or director of SCWorx or any SCWorx Affiliate, or which is maintained by, administered or contributed to
by, or required to be contributed to by, SCWorx or any SCWorx Affiliate, or under which SCWorx or any SCWorx Affiliate has any
current or may incur any future Liability (each, a “SCWorx Employee Plan”) (other than offer letters with non-officer
employees which are materially consistent with forms delivered or made available by the SCWorx prior to the execution of this Agreement;
equity grant notices, and related documentation, with respect to the employees of SCWorx; and agreements with consultants entered
into in the Ordinary Course of Business and which are materially consistent with forms delivered or made available by SCWorx prior
to the execution of this Agreement).

 

(b)          With
respect to each SCWorx Employee Plan, SCWorx has made available to AMMA a true and complete copy of, to the extent applicable:
(i) such SCWorx Employee Plan including any amendments thereto; (ii) all annual reports (Form 5500) as filed with the United States
Department of Labor, including any financial statements and actuarial reports; (iii) each currently effective trust agreement related
to such SCWorx Employee Plan; (iv) the most recent summary plan description, with any summary of material modifications, prospectus
or other summary for each SCWorx Employee Plan; (v) the most recent United States Internal Revenue Service determination or opinion
letter or analogous ruling under foreign law issued with respect to any SCWorx Employee Plan; (vi) all material notices, letters
or other correspondence to or from any Governmental Body or agency thereof; (vii) all non-discrimination and compliance tests;
and (viii) all material written agreements and Contracts currently in effect, including (without limitation) administrative service
agreements, group annuity contracts, and group insurance contracts.

 

(c)          Each
SCWorx Employee Plan that is intended to be qualified under Section 401(a) of the Code has received a favorable determination or
may rely on a favorable opinion letter with respect to such qualified status from the United States Internal Revenue Service. To
the Knowledge of SCWorx, nothing has occurred that would reasonably be expected to adversely affect the qualified status of any
such SCWorx Employee Plan or the exempt status of any related trust.

 

    	 	16	 

     

    

 

(d)          Each
SCWorx Employee Plan has been operated and maintained in compliance, in all material respects, with its terms and, both as to form
and operations, with all applicable Legal Requirements, including the Code and ERISA. Neither SCWorx nor any SCWorx Affiliate is
subject to any Liability or penalty under Sections 4976 through 4980 of the Code or Title I of ERISA with respect to
any of the SCWorx Employee Plans. All contributions required to be made by SCWorx or any SCWorx Affiliate to any SCWorx Employee
Plan have been made on or before their due dates (and no further contributions will be due or will have accrued thereunder as of
the Closing Date, other than contributions accrued in the Ordinary Course of Business consistent with past practice).

 

(e)          Neither
SCWorx nor any SCWorx Affiliate has engaged in any transaction in violation of Sections 404 or 406 of ERISA or any “prohibited
transaction,” as defined in Section 4975(c)(1) of the Code, for which no exemption exists under Section 408 of ERISA or Section
4975(c)(2) or (d) of the Code, or has otherwise violated the provisions of Part 4 of Title I, Subtitle B of ERISA. Neither SCWorx,
nor any SCWorx Affiliate has knowingly participated in a violation of Part 4 of Title I, Subtitle B of ERISA by any plan fiduciary
of any SCWorx Employee Plan subject to ERISA, and neither SCWorx nor any SCWorx Affiliate has been assessed any civil penalty under
Section 502(l) of ERISA.

 

(f)          No
suit, administrative proceeding, action or other litigation has been initiated against, or to the Knowledge of SCWorx, is threatened,
against or with respect to any SCWorx Employee Plan, including any audit or inquiry by the United States Internal Revenue Service,
United States Department of Labor or other Governmental Body.

 

(g)          No
SCWorx Employee Plan is subject to Title IV or Section 302 of ERISA or Section 412 of the Code, and neither SCWorx nor any SCWorx
Affiliate has ever maintained, contributed to or partially or completely withdrawn from, or incurred any obligation or Liability
with respect to, any such plan. No SCWorx Employee Plan is a Multiemployer Plan, and neither SCWorx nor any SCWorx Affiliate has
ever contributed to or had an obligation to contribute, or incurred any Liability in respect of a contribution, to any Multiemployer
Plan. No SCWorx Employee Plan is a Multiple Employer Plan.

 

(h)          No
SCWorx Employee Plan provides for medical, welfare, retirement or death benefits beyond termination of service or retirement, other
than (i) pursuant to COBRA or an analogous state law requirement or (ii) death or retirement benefits under a SCWorx Employee Plan
qualified under Section 401(a) of the Code. Except as provided in Section 2.14(a) of the SCWorx Disclosure Schedule and identified
as a self-funded plan, neither SCWorx nor any SCWorx Affiliate sponsors or maintains any self-funded employee welfare benefit plan.
No SCWorx Employee Plan is subject to any Legal Requirement of any jurisdiction outside of the United States.

 

(i)          To
the Knowledge of SCWorx, no payment pursuant to any SCWorx Employee Plan or other arrangement to any “service provider”
(as such term is defined in Section 409A of the Code and the regulations and guidance thereunder) from SCWorx, including the grant,
vesting or exercise of any stock option, would subject any Person to Tax pursuant to Section 409A of the Code, whether pursuant
to the Contemplated Transactions or otherwise.

 

    	 	17	 

     

    

 

(j)          SCWorx
is in material compliance with all applicable foreign, federal, state and local laws, rules, regulations, orders, rulings, judgments,
decrees or arbitration awards respecting employment, employment practices, terms and conditions of employment, worker classification,
tax withholding, prohibited discrimination, equal employment, fair employment practices, meal and rest periods, immigration status,
employee safety and health, wages (including overtime wages), compensation, hours of work, labor relations, leave of absence requirements,
occupational health and safety, privacy, harassment, retaliation, immigration and wrongful discharge and in each case, with respect
to employees: (i) has withheld and reported all amounts required by law or by agreement to be withheld and reported with respect
to wages, salaries and other payments to employees, (ii) is not liable for any arrears of wages, severance pay or any Taxes or
any penalty of any material amount for failure to comply with any of the foregoing, and (iii) is not liable for any payment to
any trust or other fund governed by or maintained by or on behalf of any Governmental Body, with respect to unemployment compensation
benefits, social security or other benefits or obligations for employees (other than routine payments to be made in the normal
course of business and consistent with past practice). There are no actions, suits, claims or administrative matters pending, or
to the Knowledge of SCWorx, threatened or reasonably anticipated against SCWorx relating to any employee, employment agreement,
independent contractor, independent contractor agreement or SCWorx Employee Plan. There are no pending or, to the Knowledge of
SCWorx, threatened or reasonably anticipated claims or actions against SCWorx or any trustee of SCWorx under any worker’s
compensation policy or long term disability policy. SCWorx is not a party to a conciliation agreement, consent decree or other
agreement or order with any federal, state, or local agency or Governmental Body with respect to employment practices. SCWorx has
good labor relations.

 

(k)          No
current or former consultant or independent contractor of SCWorx would reasonably be deemed to be a misclassified employee. Except
as set forth on Section 2.14(k) of the SCWorx Disclosure Schedule, no independent contractor or contractor is eligible to
participate in any SCWorx Employee Plan. SCWorx does not have any material Liability with respect to any misclassification of:
(A) any Person as an independent contractor rather than as an employee, (B) any employee leased from another employer, or (C) any
employee currently or formerly classified as exempt from overtime wages. SCWorx has not taken any action which would constitute
a “plant closing” or “mass layoff” within the meaning of the WARN Act or similar state or local law, issued
any notification of a plant closing or mass layoff required by the WARN Act or similar state or local law, or incurred any Liability
or obligation under WARN or any similar state or local law that remains unsatisfied. No terminations of employees of SCWorx prior
to the Closing would trigger any notice or other obligations under the WARN Act or similar state or local law.

 

(l)          No
SCWorx employee is covered by an effective or pending collective bargaining agreement or similar labor agreement, and there has
never been any threat of, any strike, slowdown, work stoppage, lockout, job action, union organizing activity, or any similar activity
or dispute, affecting SCWorx. No event has occurred, and no condition or circumstance exists, that might directly or indirectly
be likely to give rise to or provide a basis for the commencement of any such strike, slowdown, work stoppage, lockout, job action,
union organizing activity, question concerning representation or any similar activity or dispute.

 

    	 	18	 

     

    

 

(m)          SCWorx
is not, and has not been engaged in, any unfair labor practice within the meaning of the National Labor Relations Act. There is
no Legal Proceeding, claim, labor dispute or grievance pending or, to the Knowledge of SCWorx, threatened or reasonably anticipated
relating to any employment contract, privacy right, labor dispute, wages and hours, leave of absence, plant closing notification,
workers’ compensation policy or long term disability policy, harassment, retaliation, immigration, employment statute or
regulation, safety or discrimination matter involving any SCWorx Associate, including charges of unfair labor practices or discrimination
complaints.

 

(n)          There
is no Contract or arrangement to which SCWorx or any SCWorx Affiliate is a party or by which it is bound to compensate any of its
current or former employees, independent contractors or directors for additional income or excise Taxes paid pursuant to Sections
409A or 4999 of the Code.

 

(o)          Except
as set forth in Section 2.14(o) of the SCWorx Disclosure Schedule, none of the execution and delivery of this Agreement,
or the consummation of the Contemplated Transactions or any termination of employment or service or any other event in connection
therewith or subsequent thereto will, individually or together or with the occurrence of some other event, (i) result in any
payment (including severance, golden parachute, bonus or otherwise) becoming due to any employee, independent contractor or director
of SCWorx, (ii) materially increase or otherwise enhance any benefits otherwise payable by SCWorx, (iii) result in the
acceleration of the time of payment or vesting of any such benefits, except as required under Section 411(d)(3) of the Code,
(iv) increase the amount of compensation due to any Person by SCWorx, or (v) result in the forgiveness in whole or in
part of any outstanding loans made by SCWorx to any Person.

 

(p)          Except
as noted on Section 2.14(r) of the SCWorx Disclosure Schedule, all individuals employed by SCWorx are employed at-will and
SCWorx has no employment or other agreements that contain any severance, change in control, termination pay liabilities, or advance
notice requirements, and all agreements with independent contractors or consultants may be terminated by SCWorx without penalty
or Liability with thirty (30) days or less notice.

 

(q)          SCWorx
has paid all wages, bonuses, commissions, severance and other benefits and sums due (and all required Taxes, insurance, social
security and withholding thereon), including all accrued vacation, accrued sick leave, accrued benefits and accrued payments to
its employees and former employees and individuals performing services as independent contractors or consultants, other than accrued
amounts representing wages, bonuses, or commission entitlements due for the current pay period or for the reimbursement of legitimate
expenses.

 

2.15         [Reserved.]

 

    	 	19	 

     

    

 

2.16         Insurance.

 

(a)          SCWorx
has delivered or made available to AMMA accurate and complete copies of all material insurance policies and all material self-insurance
programs and arrangements relating to the business, assets, liabilities and operations of SCWorx, as of the date of this Agreement
(other than relating to any SCWorx Employee Plan). Each of such insurance policies is in full force and effect and SCWorx is in
compliance with the terms thereof. As of the date of this Agreement, other than customary end of policy notifications from insurance
carriers, SCWorx has not received any notice or other communication regarding any actual or possible: (a) cancelation or invalidation
of any insurance policy; (b) refusal or denial of any coverage, reservation of rights or rejection of any material claim under
any insurance policy; or (c) material adjustment in the amount of the premiums payable with respect to any insurance policy. There
is no pending workers’ compensation or other claim under or based upon any insurance policy of SCWorx. To the Knowledge of
SCWorx, SCWorx has provided timely written notice to the appropriate insurance carrier(s) of each Legal Proceeding pending or threatened
against SCWorx, and no such carrier has issued a denial of coverage or a reservation of rights with respect to any such Legal Proceeding,
or informed SCWorx of its intent to do so.

 

2.17         Legal
Proceedings; Orders.

 

(a)          There
is no pending Legal Proceeding, and, to the Knowledge of SCWorx, no Person has threatened in writing to commence any Legal Proceeding:
(i) that involves SCWorx, or to the Knowledge of SCWorx, any director or officer of SCWorx (in his or her capacity as such) or
any of the material assets owned or used by SCWorx; or (ii) that challenges, or that would reasonably be expected to have the effect
of preventing, delaying, making illegal or otherwise interfering with, the Contemplated Transactions. To the Knowledge of SCWorx,
no event has occurred, and no claim, dispute or other condition or circumstance exists, that will, or that would reasonably be
expected to, give rise to or serve as a basis for the commencement of any such Legal Proceeding.

 

(b)          There
is no material outstanding order, writ, injunction, judgment or decree to which SCWorx, or any of the material assets owned or
used by SCWorx, is subject. To the Knowledge of SCWorx, no officer of SCWorx is subject to any order, writ, injunction, judgment
or decree that prohibits such officer of SCWorx from engaging in or continuing any conduct, activity or practice relating to the
business of SCWorx or to any material assets owned or used by SCWorx.

 

2.18         [Reserved].

 

2.19         No
Financial Advisor. Except as set forth on Section 2.19 of the SCWorx Disclosure Schedule, no broker, finder or investment
banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission
in connection with the Contemplated Transactions based upon arrangements made by or on behalf of SCWorx.

 

2.20         Bank
Accounts. Section 2.20 of the SCWorx Disclosure Schedule provides accurate information with respect to each account
maintained by or for the benefit of SCWorx at any bank or other financial institution, including the name of the bank or financial
institution, the account number, the balance as of July 30, 2018 and the names of all individuals authorized to draw on or make
withdrawals from such accounts.

 

    	 	20	 

     

    

 

2.21         Disclosure.
The information relating to SCWorx to be supplied by or on behalf of SCWorx for inclusion or incorporation by reference in the
Proxy Statement will not, on the date the Proxy Statement, as applicable, is first filed with the SEC or mailed to the AMMA Stockholders
or at the time of the AMMA Stockholders’ Meeting, contain any untrue statement of any material fact, or omit to state any
material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances
under which they are made, not false or misleading at the time and in the light of the circumstances under which such statement
is made.

 

2.22         Related
Party Transactions. Except as set forth in Section 2.22 of the SCWorx Disclosure Schedule, there are no obligations
of SCWorx to, or Contracts with, current or former Affiliates, officers, directors, stockholders or employees of SCWorx or their
respective Affiliates or family members other than (a) for payment of ordinary course salaries and bonuses for services rendered,
(b) reimbursement of customary and reasonable expenses incurred on behalf of SCWorx and (c) benefits due under a SCWorx Employee
Plan and ordinary course fringe benefits listed in Section 2.14(a) of the SCWorx Disclosure Schedule. To SCWorx’s
Knowledge, no officer, director or employee of SCWorx or SCWorx Stockholder is directly interested in any SCWorx Material Contract.
Except as set forth in Section 2.22 of the SCWorx Disclosure Schedule, neither SCWorx nor any of its Affiliates, directors,
officers or employees (x) possess, directly or indirectly, any financial interest in, or is a director, officer or employee of,
any entity that is a material supplier, contractor lessor, lessee or competitor of SCWorx or (y) has any claim or cause of action
against SCWorx.

 

2.23         Exclusivity
of Representations; Reliance.

 

(a)          Except
as expressly set forth in this Article 2, neither SCWorx nor any Person on behalf of SCWorx has made, nor are any of them
making, any representation or warranty, written or oral, express or implied, at law or in equity, including with respect to merchantability
or fitness for any particular purpose, in respect of SCWorx or its business in connection with the transactions contemplated hereby,
including any representations or warranties about the accuracy or completeness of any information or documents previously provided
(including with respect to any financial or other projections therein), and any other such representations and warranties are hereby
expressly disclaimed.

 

(b)          SCWorx
acknowledges and agrees that, except for the representations and warranties of AMMA set forth in Article 3, neither SCWorx
nor its Representatives is relying on any other representation or warranty of AMMA or any other Person made outside of Article
3 of this Agreement, including regarding the accuracy or completeness of any such other representations or warranties or the
omission of any material information, whether express or implied, in each case with respect to the Contemplated Transactions.

 

    	 	21	 

     

    

 

ARTICLE 3REPRESENTATIONS
AND WARRANTIES OF AMMA

 

AMMA represents and
warrants to SCWorx and the SCWorx Stockholders as follows, except as set forth in the written disclosure schedule delivered by
AMMA to SCWorx and the SCWorx Stockholders (the “AMMA Disclosure Schedule”) (it being understood that the representations
and warranties in this Article 3 are qualified by: (a) any exceptions and disclosures set forth in the section or subsection
of the AMMA Disclosure Schedule corresponding to the particular section or subsection in this Article 3 in which such representation
and warranty appears; (b) any exceptions or disclosures explicitly cross-referenced in such section or subsection of the AMMA
Disclosure Schedule by reference to another section or subsection of the AMMA Disclosure Schedule; and (c) any exceptions
or disclosures set forth in any other section or subsection of the AMMA Disclosure Schedule to the extent it is reasonably apparent
from the wording of such exception or disclosure that such exception or disclosure qualifies such representation and warranty).
The inclusion of any information in the AMMA Disclosure Schedule shall not be deemed to be an admission or acknowledgement, in
and of itself, that such information is required by the terms hereof to be disclosed, is material, has resulted in or would result
in a AMMA Material Adverse Effect, or is outside the Ordinary Course of Business.

 

3.1           Subsidiaries;
Due Organization; Organizational Documents.

 

(a)          Section
3.1(a) of the AMMA Disclosure Schedule identifies each Subsidiary of AMMA (the “AMMA Subsidiaries”). Neither
AMMA nor any AMMA Subsidiary owns any capital stock of, or any equity interest of any nature in, any other Entity. AMMA has not
agreed nor is it obligated to make, nor is it bound by any Contract under which it may become obligated to make, any future investment
in or capital contribution to any other Entity. AMMA has not, at any time, been a general partner or manager of, or has otherwise
been liable for any of the debts or other obligations of, any general partnership, limited partnership, limited liability company
or other Entity.

 

(b)          Each
of AMMA and any AMMA Subsidiary is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction
of its incorporation (where such concept is applicable) and has all necessary power and authority: (i) to conduct its business
in the manner in which its business is currently being conducted; (ii) to own and use its assets in the manner in which its assets
are currently owned and used; and (iii) to perform its obligations under all AMMA Contracts.

 

(c)          Each
of AMMA and any AMMA Subsidiary is qualified to do business as a foreign corporation, and is in good standing, under the laws of
all jurisdictions where the nature of its business requires such qualification other than in jurisdictions where the failure to
be so qualified would not constitute a AMMA Material Adverse Effect.

 

(d)          Each
director and officer of AMMA and any AMMA Subsidiary as of the date of this Agreement is set forth in Section 3.1(d) of
the AMMA Disclosure Schedule.

 

(e)          AMMA
has delivered or made available to SCWorx accurate and complete copies of (i) the charter and organizational documents, including
all currently effective amendments thereto, for AMMA and each AMMA Subsidiary (as applicable); and (ii) any code of conduct or
similar policy adopted by AMMA or by the AMMA Board of Directors or any committee thereof. Neither AMMA nor any AMMA Subsidiary
has taken any action in breach or violation of any of the provisions of its charter or organizational documents (as applicable),
except as would not reasonably be expected to have, individually or in the aggregate, a AMMA Material Adverse Effect.

 

    	 	22	 

     

    

 

3.2           Authority;
Vote Required.

 

(a)          AMMA
has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and, subject
to obtaining the Required AMMA Stockholder Vote, to consummate the Contemplated Transactions. The AMMA Board of Directors has:
(i) determined that the Exchange is fair to, and in the best interests of, AMMA and AMMA Stockholders; (ii) duly authorized
and approved by all necessary corporate action, the execution, delivery and performance of this Agreement and the Contemplated
Transactions; and (iii) recommended the approval of the AMMA Stockholder Matters by the AMMA Stockholders and directed that
the AMMA Stockholder Matters be submitted for consideration by AMMA Stockholders in connection with the solicitation of the Required
AMMA Stockholder Vote, as applicable. This Agreement has been duly executed and delivered by AMMA and, assuming the due authorization,
execution and delivery by SCWorx and each SCWorx Stockholder, constitutes the legal, valid and binding obligation of AMMA, enforceable
against AMMA in accordance with its terms, subject to: (1) laws of general application relating to bankruptcy, insolvency and the
relief of debtors; and (2) rules of law governing specific performance, injunctive relief and other equitable remedies.

 

(b)          With
respect to the items indicated in Section 4.3(a), the affirmative vote of such majority of the holders of the AMMA Shares
required by and voted in accordance with applicable Law (in person or by proxy) on the proposed matters at the AMMA Stockholders’
Meeting is the only vote of the holders of any class or series of AMMA Capital Stock necessary to approve such AMMA Stockholder
Matters (the “Required AMMA Stockholder Vote”).

 

3.3           Non-Contravention;
Consents.

 

(a)          The
execution and delivery of this Agreement by AMMA does not, and the performance of this Agreement by AMMA, subject to obtaining
the Required AMMA Stockholder Vote, will not, (i) conflict with or violate the organizational documents of AMMA or any AMMA
Subsidiary; (ii) subject to compliance with the requirements set forth in Section 3.3(b) below, conflict with or violate
any Legal Requirement applicable to AMMA or the AMMA Subsidiaries or by which it or any of their respective properties is bound
or affected, except for any such conflicts or violations that would not constitute a AMMA Material Adverse Effect; or (iii) except
as listed on Section 3.3(a) of the AMMA Disclosure Schedule, require AMMA or any AMMA Subsidiary to make any filing with
or give any notice to a Person or make any payment, or obtain any Consent from a Person, or result in any breach of or constitute
a default (or an event that with notice or lapse of time or both would become a default) under, or impair AMMA’s rights or
alter the rights or obligations of any third party under, or give to others any rights of termination, amendment, acceleration
or cancelation of, or result in the creation of an Encumbrance on any of the properties or assets of AMMA or any AMMA Subsidiary
pursuant to, any AMMA Material Contract.

 

(b)          No
material Consent, order of, or registration, declaration or filing with any Governmental Body is required by or with respect to
AMMA or any AMMA Subsidiary in connection with the execution and delivery of this Agreement or the consummation of the Contemplated
Transactions, except for (i) such Consents, orders, registrations, declarations and filings as may be required under applicable
federal and state securities laws or the rules of NASDAQ, and (ii) any filings and registrations as may be required under applicable
federal and state securities laws.

 

    	 	23	 

     

    

 

3.4           Capitalization.

 

(a)          The
authorized capital stock of AMMA as of the date of this Agreement consists of: (i) 45,000,000 AMMA Shares, of which 14,862,974
AMMA Shares are issued and outstanding as of the date of this Agreement. AMMA does not hold any of its capital stock in treasury.
All of the outstanding AMMA Shares have been duly authorized and validly issued, and are fully paid and nonassessable.

 

(b)          Except
for the AMMA 2016 Equity Incentive Plan (the “2016 Plan”), AMMA does not have any stock option plan or any other
plan, program, agreement or arrangement providing for any equity-based compensation for any Person. AMMA has reserved 2,000,000
AMMA Shares for issuance under the 2016 Plan. As of the date of this Agreement, of such reserved AMMA Shares, (i) no AMMA Shares
have been issued pursuant to the exercise of outstanding options and options to purchase 1,216,072 AMMA Shares have been granted
and are currently outstanding (including such options that are subject to the approval of the AMMA Stockholders), and (ii) 508,928
AMMA Shares remain available for future issuance pursuant to the 2016 Plan. Section 3.4(b) of the AMMA Disclosure Schedule
sets forth the following information with respect to each AMMA Option outstanding, as of the date of this Agreement: (1) the
name of the optionee, (2) whether the holder is or was at any point during the life of the AMMA Option an AMMA Employee or any
of AMMA Subsidiary, and whether such holder is no longer a service provider to any of AMMA or any of AMMA Subsidiary, (3) the number
of AMMA Shares subject to such AMMA Option as of the date of this Agreement, (4) the exercise price of such AMMA Option, (5) the
date on which such AMMA Option was granted, (6) the date on which such AMMA Option expires, and (7) the vesting schedule applicable
to such AMMA Option, including the extent vested to date and whether by its terms the vesting of such AMMA Option would be accelerated
by the Contemplated Transactions.

 

(c)          Except
as set forth in the AMMA SEC Documents or on Section 3.4(c) of the AMMA Disclosure Schedule, there is no: (i) outstanding subscription,
option, call, warrant or right (whether or not currently exercisable) to acquire any shares of the capital stock or other securities
of AMMA or any AMMA Subsidiary; (ii) outstanding security, instrument or obligation that is or may become convertible into or exchangeable
for any shares of the capital stock or other securities of AMMA or any AMMA Subsidiary; (iii) shareholder rights plan (or similar
plan commonly referred to as a “poison pill”) or Contract under which AMMA or any AMMA Subsidiary is or may become
obligated to sell or otherwise issue any shares of its capital stock or any other securities; or (iv) condition or circumstance
that may give rise to or provide a basis for the assertion of a claim by any Person to the effect that such Person is entitled
to acquire or receive any shares of capital stock or other securities of AMMA or any AMMA Subsidiary. There are no outstanding
or authorized stock appreciation, phantom stock, profit participation, restricted stock units, equity-based awards or other similar
rights with respect to AMMA or any AMMA Subsidiary.

 

    	 	24	 

     

    

 

(d)          Except
as set forth in Section 3.4(d) of the AMMA Disclosure Schedule, (i) none of the outstanding AMMA Shares are entitled
or subject to any preemptive right, right of repurchase or forfeiture, right of participation, right of maintenance or any similar
right; (ii) none of the outstanding AMMA Shares are subject to any right of first refusal in favor of AMMA; (iii) there
are no outstanding bonds, debentures, notes or other indebtedness of AMMA or any AMMA Subsidiary having a right to vote on any
matters on which the AMMA Stockholders have a right to vote; (iv) there is no AMMA Contract to which AMMA or any AMMA Subsidiary
is a party relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise
disposing of (or from granting any option or similar right with respect to), any AMMA Shares or capital stock of any AMMA Subsidiary.
Neither AMMA nor any AMMA Subsidiary are under any obligation, nor is bound by any Contract pursuant to which it may become obligated,
to repurchase, redeem or otherwise acquire any outstanding AMMA Shares, capital stock of an of the AMMA Subsidiaries or other securities.

 

(e)          All
outstanding AMMA Shares, as well as all AMMA Options, have been issued and granted, as applicable, in material compliance with
all applicable securities laws and other applicable Legal Requirements.

 

3.5           SEC
Filings; Financial Statements.

 

(a)          All
of AMMA’s registration statements, proxy statements, Certifications (as defined below) and other statements, reports, schedules,
forms and other documents filed by AMMA with the SEC since AMMA’s initial public offering (the “AMMA SEC Documents”)
can be obtained on the SEC’s website at www.sec.gov. All statements, reports, schedules, forms and other documents
required to have been filed by AMMA with the SEC have been so filed on a timely basis or within permissible extension periods.
As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to the date of this Agreement, then on
the date of such filing), each of the AMMA SEC Documents complied in all material respects with the applicable requirements of
the Securities Act or the Exchange Act (as the case may be) and, as of the time they were filed, none of the AMMA SEC Documents
contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Since AMMA’s
inception, the certifications and statements required by (A) Rule 13a-14 or 15d-14 promulgated under the Exchange Act and (B) 18
U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act) relating to the AMMA SEC Documents (collectively, the “Certifications”)
were accurate and complete and complied as to form and content with all applicable Legal Requirements as of the date they were
filed and no current or former principal executive officer or principal financial officer of AMMA has failed to make the Certifications
required of him or her. As used in this Article 3, the term “file” and variations thereof shall be broadly construed
to include any manner in which a document or information is furnished, supplied or otherwise made available to the SEC. AMMA has
made available to SCWorx true and complete copies of all correspondence, other than transmittal correspondence, between the SEC,
on the one hand, and AMMA, on the other, since AMMA’s inception, including all SEC comment letter and responses to such comment
letters and responses to such comment letters by or on behalf of AMMA other than such documents that can be obtained on the SEC’s
website at www.sec.gov. As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters
received from the SEC or NASDAQ with respect to AMMA SEC Documents. To the Knowledge of AMMA, none of AMMA SEC Documents are the
subject of ongoing SEC review and there are no inquiries or investigations by the SEC or any internal investigations pending or
threatened, including with regards to any accounting practices of AMMA.

 

    	 	25	 

     

    

 

(b)          The
financial statements (including any related notes) contained or incorporated by reference in the AMMA SEC Documents: (i) complied
as to form in all material respects with the published rules and regulations of the SEC applicable thereto; (ii) were prepared
in accordance with GAAP (except as may be indicated in the notes to such financial statements, and except that the unaudited financial
statements may not contain footnotes and are subject to normal and recurring year-end adjustments that are not reasonably expected
to be material in amount) applied on a consistent basis unless otherwise noted therein throughout the periods indicated; and (iii)
fairly present the consolidated financial position of AMMA and any AMMA Subsidiary as of the respective dates thereof and the results
of operations and cash flows of AMMA for the periods covered thereby. Other than as expressly disclosed in the AMMA SEC Documents
filed prior to the date hereof, there has been no material change in AMMA’s accounting methods or principles that would be
required to be disclosed in AMMA’s financial statements in accordance with GAAP. The books of account and other financial
records of AMMA and any AMMA Subsidiary are true and complete in all material respects.

 

(c)          AMMA’s
auditor has at all times since its retention by AMMA been: (i) to the Knowledge of AMMA, a registered public accounting firm (as
defined in Section 2(a)(12) of the Sarbanes-Oxley Act); (ii) to the Knowledge of AMMA, “independent” with respect to
AMMA within the meaning of Regulation S-X under the Exchange Act; and (iii) to the Knowledge of AMMA, in compliance with subsections
(g) through (l) of Section 10A of the Exchange Act and the rules and regulations promulgated by the SEC and the Public Company
Accounting Oversight Board thereunder with respect to services provided to AMMA.

 

(d)          Except
as set forth in the AMMA SEC Documents, from its initial listing on the NASDAQ through the date hereof, AMMA has not received any
correspondence from NASDAQ or the staff thereof relating to the delisting or maintenance of listing of the AMMA Shares on NASDAQ.

 

(e)          Since
AMMA’s inception, there have been no formal internal investigations regarding financial reporting or accounting policies
and practices discussed with, reviewed by or initiated at the direction of the chief executive officer or chief financial officer
of AMMA, the AMMA Board of Directors or any committee thereof, other than ordinary course audits or reviews of accounting policies
and practices or internal controls required by the Sarbanes-Oxley Act.

 

(f)          AMMA
is in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act and, except as disclosed in
Section 3.5(f) of the AMMA Disclosure Schedules, the applicable listing and governance rules and regulations of NASDAQ and the
DGCL.

 

    	 	26	 

     

    

 

(g)          AMMA
maintains a system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act)
that is sufficient to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with GAAP, including policies and procedures sufficient to provide reasonable assurance
(i) that AMMA maintains records that in reasonable detail accurately and fairly reflect AMMA’s transactions and dispositions
of assets, (ii) that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP,
(iii) that receipts and expenditures are made only in accordance with authorizations of management and the AMMA Board of Directors,
and (iv) regarding prevention or timely detection of the unauthorized acquisition, use or disposition of AMMA’s assets that
could have a material effect on AMMA’s financial statements. AMMA has evaluated the effectiveness of AMMA’s internal
control over financial reporting and, to the extent required by applicable Legal Requirements, presented in any applicable AMMA
SEC Document that is a report on Form 10-K (or any amendment thereto) its conclusions about the effectiveness of the internal control
over financial reporting as of the end of the period covered by such report or amendment based on such evaluation. AMMA has disclosed
to AMMA’s auditors and the audit committee of the AMMA Board of Directors (and made available to SCWorx a summary of the
significant aspects of such disclosure) (A) all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting that are reasonably likely to adversely affect AMMA’s ability to record, process,
summarize and report financial information and (B) any fraud, whether or not material, that involves management or other employees
who have a significant role in AMMA’s internal control over financial reporting. Except as disclosed in the AMMA SEC Documents
filed prior to the date hereof, AMMA has not identified any material weaknesses in the design or operation of AMMA’s internal
control over financial reporting. Since AMMA’s inception, there have been no material changes in AMMA’s internal control
over financial reporting.

 

(h)          AMMA’s
 “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) are reasonably
designed to ensure that all information (both financial and non-financial) required to be disclosed by AMMA in the reports that
it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in
the rules and forms of the SEC, and that all such information is accumulated and communicated to AMMA’s management as appropriate
to allow timely decisions regarding required disclosure and to make the Certifications.

 

3.6           Absence
of Changes. Except as set forth in Section 3.6 of the AMMA Disclosure Schedule, between June 30, 2018 and the date of
this Agreement, each of AMMA and any AMMA Subsidiary have conducted its business in the Ordinary Course of Business and there has
not been (a) any event that has had a AMMA Material Adverse Effect or (b) or any action, event or occurrence that would have required
consent of SCWorx pursuant to Section 4.2(b) of this Agreement had such action, event or occurrence taken place after the
execution and delivery of this Agreement.

 

    	 	27	 

     

    

 

3.7           Title
to Assets. Except with respect to AMMA IP Rights, which are covered in Section 3.9, each of AMMA and any AMMA Subsidiary
owns, and has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible
properties or assets and equipment used or held for use in its business or operations or purported to be owned by it, in each case,
free and clear of any Encumbrances, except for: (i) any lien for current Taxes not yet due and payable or for Taxes that are being
contested in good faith and for which adequate reserves have been made on the AMMA Unaudited Interim Balance Sheet; (ii) minor
liens that have arisen in the Ordinary Course of Business and that do not (in any case or in the aggregate) materially detract
from the value of the assets subject thereto or materially impair the operations of AMMA or any AMMA Subsidiary; and (iii) liens
listed in Section 3.7 of the AMMA Disclosure Schedule.

 

3.8           Real
Property; Leaseholds. Neither AMMA nor any AMMA Subsidiary currently owns or has ever owned any real property or any interest
in real property, except for the leaseholds created under the real property leases (including any amendments thereto) identified
in Section 3.8 of the AMMA Disclosure Schedule (the “AMMA Leases”), which are each in full force and
effective, with no existing material default thereunder except as disclosed in Section 3.8 of the AMMA Disclosure Schedule.

 

3.9           Intellectual
Property.

 

(a)          AMMA,
directly or through any of its Subsidiaries, owns, or has the right to use all AMMA IP Rights, except where any failure to own,
or have the right to use, would not constitute a AMMA Material Adverse Effect. The foregoing representation and warranty is not
intended to be a representation regarding the absence of infringement or misappropriation, which is addressed in Section 3.9(g)
below.

 

(b)          Section
3.9(b) of the AMMA Disclosure Schedule is an accurate, true and complete listing of (i) all patents within the AMMA Registered
IP that are owned by AMMA and (ii) all other AMMA Registered IP.

 

(c)          Section
3.9(c) of the AMMA Disclosure Schedule accurately identifies (i) all material AMMA IP Rights licensed to AMMA or any AMMA Subsidiary
(other than (A) any non-customized software that (1) is so licensed solely in executable or object code form pursuant to a non-exclusive,
internal use software license and other Intellectual Property associated with such software and (2) is not incorporated into, or
material to the development, manufacturing, or distribution of, any of AMMA’s or any AMMA Subsidiary’s products or
services, (B) any Intellectual Property licensed ancillary to the purchase or use of equipment, reagents or other materials, (C)
non-disclosure agreements, materials transfer agreements and template agreements entered into in the Ordinary Course of Business
and (D) agreements between AMMA and its employees and consultants); (ii) the corresponding AMMA Contracts pursuant to which such
AMMA IP Rights are licensed to AMMA or any AMMA Subsidiary; (iii) whether the license or licenses granted to AMMA or any AMMA Subsidiary
are exclusive or non-exclusive; and (iv) whether, to AMMA’s Knowledge, any funding, facilities or personnel of any Governmental
Body were used, directly or indirectly, to develop or create, in whole or in part, such AMMA IP Rights.

 

    	 	28	 

     

    

 

(d)          Section
3.9(d) of the AMMA Disclosure Schedule accurately identifies each AMMA Material Contract pursuant to which any Person (other
than AMMA or any AMMA Subsidiary) has been granted any license or option to obtain a license under, or otherwise has received or
acquired any right (whether or not currently exercisable) or interest in, any AMMA IP Rights. AMMA is not bound by, and no AMMA
IP Rights are subject to, any Contract containing any covenant or other contractual obligation that in any way limits or restricts
the ability of AMMA or any AMMA Subsidiary to use, exploit, assert or enforce any AMMA IP Rights anywhere in the world, in each
case as would materially limit the business of AMMA as currently conducted or planned to be conducted.

 

(e)          Except
as identified on Section 3.9(e) of the AMMA Disclosure Schedule, AMMA or one of its Subsidiaries solely owns all right,
title, and interest to and in the AMMA Registered IP listed on (or required to be listed on) Section 3.9(b) of the AMMA
Disclosure Schedule free and clear of any Encumbrances. Without limiting the generality of the foregoing:

 

(i)          All
documents and instruments necessary to register or apply for or renew registration of all AMMA Registered IP that is solely owned
by AMMA or one of its Subsidiaries have been validly executed, delivered and filed in a timely manner with the appropriate Governmental
Body except for any such failure, individually or collectively, that would not constitute a AMMA Material Adverse Effect.

 

(ii)         Each
Person who is or was an employee or contractor of AMMA or any AMMA Subsidiary and who is or was involved in the creation or development
of any AMMA IP Rights has signed a written agreement containing an assignment of such Intellectual Property to AMMA or such Subsidiary
and confidentiality provisions protecting trade secrets and confidential information of AMMA and its Subsidiaries; provided, that
any such agreement with a third party contractor for research, development or manufacturing services on behalf of AMMA or any AMMA
Subsidiary may provide that such third party contractor reserves its rights in improvements to such third party contractor’s
Intellectual Property or generally applicable research, development or manufacturing technology, in either case that is not specific
to any product or service of AMMA or any AMMA Subsidiary. To the Knowledge of AMMA and its Subsidiaries, no current or former shareholder,
officer, director, employee or contractor of AMMA or any AMMA Subsidiary has any claim, right (whether or not currently exercisable),
or interest to or in any AMMA IP Rights. To the Knowledge of AMMA and its Subsidiaries, no employee or contractor of AMMA or any
or any of its Subsidiaries is (a) bound by or otherwise subject to any Contract restricting him or her from performing his or her
duties for AMMA or such Subsidiary or (b) in breach of any Contract with any current or former employer or other Person concerning
AMMA IP Rights or confidentiality provisions protecting trade secrets and confidential information comprising AMMA IP Rights.

 

(iii)        To
the Knowledge of AMMA, no funding, facilities or personnel of any Governmental Body were used, directly or indirectly, to develop
or create, in whole or in part, any AMMA IP Rights in which AMMA or any AMMA Subsidiary has an ownership interest.

 

(iv)        AMMA
and each of its Subsidiaries has taken reasonable steps to maintain the confidentiality of and otherwise protect and enforce its
rights in all proprietary information that AMMA or such Subsidiary holds, or purports to hold, as a trade secret.

 

    	 	29	 

     

    

 

(v)         Except
as set forth on Section 3.9(e)(v) of the AMMA Disclosure Schedule, neither AMMA nor any AMMA Subsidiary has assigned or
otherwise transferred ownership of, or agreed to assign or otherwise transfer ownership of, any AMMA IP Rights to any other Person.

 

(vi)        To
the Knowledge of AMMA and any AMMA Subsidiary, the AMMA IP Rights constitute all Intellectual Property necessary for AMMA and its
Subsidiaries to conduct its business as currently conducted or planned to be conducted.

 

(f)          The
manufacture, marketing, license, sale or intended use of any product or service currently sold by AMMA or any AMMA Subsidiary (i)
does not violate or constitute a breach of any license or agreement between AMMA or its Subsidiaries and any third party, and,
(ii) to the Knowledge of AMMA and its Subsidiaries, does not infringe or misappropriate any Intellectual Property right of any
third party. To the Knowledge of AMMA and its Subsidiaries, no third party is infringing upon or misappropriating, or violating
any license or agreement with AMMA or its Subsidiaries relating to, any AMMA IP Rights. There is no current or, to the Knowledge
of AMMA, pending challenge, claim or Legal Proceeding (including opposition, interference or other proceeding in any patent or
other government office) contesting the validity, enforceability, ownership or right to use, sell, license or dispose of any AMMA
IP Rights, nor has AMMA or any AMMA Subsidiary received any written notice asserting that the manufacture, marketing, license,
sale or intended use of any product or service currently approved or sold or under preclinical or clinical development by AMMA
or any AMMA Subsidiary infringes or misappropriates or will infringe or misappropriate the rights of any other Person.

 

(g)          Each
item of AMMA IP Rights that is AMMA Registered IP that is solely owned by AMMA or one of its Subsidiaries is and at all times has
been filed and maintained in compliance with all applicable Legal Requirements and all filings, payments and other actions required
to be made or taken to maintain such item of AMMA Registered IP in full force and effect have been made by the applicable deadline,
except for any failure to perform any of the foregoing, individually or collectively, that would not constitute a AMMA Material
Adverse Effect.

 

(h)          No
trademark (whether registered or unregistered) or trade name owned, used, or applied for by AMMA or any AMMA Subsidiary conflicts
or interferes with any trademark (whether registered or unregistered) or trade name owned, used, or applied for by any other Person.
None of the goodwill associated with or inherent in any trademark (whether registered or unregistered) in which AMMA or any AMMA
Subsidiary has or purports to have an ownership interest has been impaired as determined by AMMA or any AMMA Subsidiary in accordance
with GAAP.

 

(i)           Except
as set forth on Section 3.9(i) of the AMMA Disclosure Schedule, all databases, data compilations, and any collection deemed
a database or regulated collection of data under applicable laws that are owned, controlled, held or used by AMMA and by any AMMA
Subsidiary and that are required to be registered have been properly registered, and the data therein has been used by AMMA or
any AMMA Subsidiary solely as permitted pursuant to such registrations.

 

    	 	30	 

     

    

 

(j)          Except
as set forth on Section 3.9(j) of the AMMA Disclosure Schedule, all amounts payable by AMMA and any AMMA Subsidiary to all
Persons involved in the research, development, conception or reduction to practice of any AMMA IP Rights have been paid in full.
All AMMA Employees, contractors and consultants who were or are engaged in the development or invention of any AMMA IP Rights have
entered into written agreements with AMMA or with any AMMA Subsidiary by which they validly and irrevocably assigned to AMMA or
its Subsidiaries all rights, title and interests in and to such AMMA IP Rights (or all such rights, title and interests vested
in AMMA or its Subsidiaries as a matter of law), and, with respect to employees, have explicitly waived all rights to receive royalties
or compensation in connection therewith and any applicable non-transferable rights, including moral rights.

 

3.10         Material
Contracts.

 

(a)          Section
3.10(a) of the AMMA Disclosure Schedule lists the following AMMA Contracts, in effect as of the date of this Agreement (each,
a “AMMA Material Contract” and collectively, the “AMMA Material Contracts”):

 

(i)          each
AMMA Contract constituting a material bonus, deferred compensation, severance, change in control, retention, incentive compensation,
pension, profit-sharing or retirement plans, or any other employee benefit plans or arrangements;

 

(ii)         each
AMMA Contract pursuant to its express terms relating to the employment of, or the performance of employment-related services by,
any Person, including any employee, consultant or independent contractor, or Entity providing employment related, consulting or
independent contractor services, other than any employment agreement, employment contract, offer letter, or similar arrangement
that is terminable “at-will” without penalty, Liability or severance (statutory, contractual, or otherwise), or that
can be terminated without penalty, Liability or premium upon notice of thirty (30) days less;

 

(iii)        each
AMMA Contract relating to any agreement or plan, including any stock option plan, stock appreciation right plan or stock purchase
plan with any employee or other individual consultant, independent contractor or director, any of the benefits of which will be
increased, or the vesting of benefits of which will be accelerated, by the occurrence of any of the Contemplated Transactions (either
alone or in conjunction with any other event, such as termination of employment) or the value of any of the benefits of which will
be calculated on the basis of any of the Contemplated Transactions;

 

(iv)        each
collective bargaining agreement or other agreement with any union (trade, labor, or otherwise) or similar employee representative
or works council;

 

(v)         each
AMMA Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course of Business, where
material indemnification is provided by AMMA or AMMA Subsidiary to a third party;

 

    	 	31	 

     

    

 

(vi)        each
AMMA Contract containing (A) any covenant limiting the freedom of AMMA, any AMMA Subsidiary to engage in any line of business or
compete with any Person, (B) any most-favored pricing arrangement, (C) any exclusivity provision, or (D) any non-solicitation provision;

 

(vii)       each
AMMA Contract requiring capital expenditures and requiring payments after the date of this Agreement in excess of $50,000 pursuant
to its express terms and not cancelable without penalty, other than purchase orders for the purchase of inventory in the Ordinary
Course of Business;

 

(viii)      each
AMMA Contract relating to the disposition or acquisition of material assets or any ownership interest in any Entity, other than
in the Ordinary Course of Business or listed on Section 3.9(c) or Section 3.9(d) of the AMMA Disclosure Schedule,
or any ownership interest in any Entity;

 

(ix)         each
AMMA Contract relating to any mortgages, indentures, loans, notes or credit agreements, security agreements or other agreements
or instruments relating to the borrowing of money or extension of credit in excess of $250,000 or creating any material Encumbrances
with respect to any assets of AMMA or any AMMA Subsidiary or any loans or debt obligations with officers or directors of AMMA;

 

(x)          each
AMMA Contract relating to: (A) any distribution agreement (identifying any that contain exclusivity provisions); (B) any dealer,
distributor, joint marketing, alliance, joint venture, cooperation, development or other agreement currently in force under which
AMMA has continuing obligations to develop or market any product, technology or service, or any agreement pursuant to which AMMA
has continuing obligations to develop any Intellectual Property that will not be owned, in whole or in part, by AMMA; or (C) any
Contract to license any third party to manufacture or produce any product, service or technology of AMMA or any Contract to sell,
distribute or commercialize any products or service of AMMA, except agreements in the Ordinary Course of Business;

 

(xi)         each
AMMA Contract with any Person, including any financial advisor, broker, finder, investment banker or other Person, providing advisory
services to AMMA in connection with the Contemplated Transactions;

 

(xii)        each
AMMA IP Right Agreement other than (A) software license agreements for non-customized software that (1) is so licensed
solely in executable or object code form pursuant to a non-exclusive, internal use software license and other Intellectual Property
associated with such software or (2) is not incorporated into, or material to the development, manufacturing, or distribution
of, any of AMMA’s products or services, (B) agreements for the purchase or use of equipment, reagents or other materials
that include licenses to Intellectual Property ancillary to such purchase or use, (C) non-disclosure agreements, materials
transfer agreements and template agreements entered into in the Ordinary Course of Business, (D) agreements between AMMA and
its employees and consultants and (E) than those that are otherwise immaterial;

 

 

    	 	32	 

     

    

 

(xiii)       each
AMMA Lease; or

 

(xiv)      any
other AMMA Contract that is not terminable at will (with no penalty or payment) by AMMA and (i) which involves payment or receipt
by AMMA after the date of this Agreement under any such agreement, Contract or commitment of more than $50,000 in the aggregate,
or (ii) that is material to the business or operations of AMMA.

 

(b)          AMMA
has delivered or made available to SCWorx accurate and complete copies of all AMMA Material Contracts, including all amendments
thereto. There are no AMMA Material Contracts that are not in written form. Except as disclosed on Section 3.10(b) of the
AMMA Disclosure Schedule, neither AMMA nor any AMMA Subsidiary has, nor to AMMA’s Knowledge, as of the date of this Agreement
has any other party to a AMMA Material Contract, breached, violated or defaulted under, or received notice that it has breached,
violated or defaulted under, any of the terms or conditions of any AMMA Material Contract in such manner as would permit any other
party to cancel or terminate any such AMMA Material Contract, or would permit any other party to seek damages that constitutes
a AMMA Material Adverse Effect. As of the date of this Agreement, each AMMA Material Contract is valid, binding, enforceable and
in full force and effect, subject to: (i) laws of general application relating to bankruptcy, insolvency and the relief of debtors;
and (ii) rules of law governing specific performance, injunctive relief and other equitable remedies.

 

3.11         Undisclosed
Liabilities. As of the date of this Agreement, neither AMMA nor any AMMA Subsidiary has any material Liability, except for:
(a) Liabilities identified as such in the AMMA Unaudited Interim Balance Sheet; (b) normal and recurring current Liabilities that
have been incurred by AMMA since the date of the AMMA Unaudited Interim Balance Sheet in the Ordinary Course of Business; (c) Liabilities
for performance in the Ordinary Course of Business of obligations of AMMA or any AMMA Subsidiary under AMMA Contracts, including
the reasonably expected performance of such AMMA Contracts in accordance with their terms (which would not include, for example,
any instances of breach or indemnification); (d) Liabilities described in Section 3.11 of the AMMA Disclosure Schedule;
and (e) Liabilities incurred in connection with the Contemplated Transactions.

 

3.12         Compliance;
Permits; Restrictions.

 

(a)          AMMA
is, and since inception, each of AMMA and its Subsidiaries has been in compliance with all applicable Legal Requirements except
for any non-compliance that would not constitute a AMMA Material Adverse Effect. No investigation, claim, suit, proceeding, audit
or other action by any Governmental Body or authority is pending or, to the Knowledge of AMMA, threatened against AMMA or any AMMA
Subsidiary. There is no Contract, judgment, injunction, order or decree binding upon AMMA or any AMMA Subsidiary which (i) has
or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of AMMA or any
AMMA Subsidiary, any acquisition of material property by AMMA or any AMMA Subsidiary or the conduct of business by AMMA or any
AMMA Subsidiary as currently conducted, (ii) would reasonably be expected to have an adverse effect on AMMA’s ability to
comply with or perform any covenant or obligation under this Agreement or (iii) would reasonably be expected to have the effect
of preventing, delaying, making illegal or otherwise interfering with the Exchange or any of the Contemplated Transactions.

 

    	 	33	 

     

    

 

(b)          AMMA
and the AMMA Subsidiaries hold all required Governmental Authorizations that are material to the operation of the business of AMMA
(collectively, the “AMMA Permits”) as currently conducted. Section 3.12(b) of the AMMA Disclosure Schedule
identifies any such AMMA Permit. As of the date of this Agreement, AMMA is in material compliance with the terms of the AMMA Permits.
No action, proceeding, revocation proceeding, amendment procedure, writ, injunction or claim is pending or, to the Knowledge of
AMMA, threatened, which seeks to revoke, limit, suspend, or materially modify any AMMA Permit.

 

3.13         Tax
Matters.

 

(a)          AMMA
and each AMMA Subsidiary has timely filed all income Tax Returns and other material Tax Returns that they were required to file
under applicable Legal Requirements. All such Tax Returns were correct and complete in all material respects and have been prepared
in material compliance with all applicable Legal Requirements. Neither AMMA nor any AMMA Subsidiary is currently the beneficiary
of any extension of time within which to file any Tax Return. No claim has ever been made by an authority in a jurisdiction where
AMMA or any AMMA Subsidiary do not file Tax Returns that such company is subject to taxation by that jurisdiction.

 

(b)          All
material Taxes due and owing by AMMA or any AMMA Subsidiary on or before the date hereof (whether or not shown on any Tax Return)
have been paid. The unpaid Taxes of AMMA and the AMMA Subsidiaries through the date of the AMMA Unaudited Interim Balance Sheet
have been reserved for on the AMMA Unaudited Interim Balance Sheet. Since the date of the AMMA Unaudited Interim Balance Sheet,
AMMA and the AMMA Subsidiaries have not incurred any Liability for Taxes outside the Ordinary Course of Business or otherwise inconsistent
with past custom and practice.

 

(c)          AMMA
and each AMMA Subsidiary has withheld and paid all Taxes required to have been withheld and paid in connection with any amounts
paid or owing to any employee, independent contractor, creditor, shareholder or other third party.

 

(d)          There
are no Encumbrances for Taxes (other than Taxes not yet due and payable or Taxes that are being contested in good faith and for
which adequate reserves have been made on the AMMA Unaudited Interim Balance Sheet) upon any of the assets of AMMA or any AMMA
Subsidiary.

 

(e)          No
material deficiencies for Taxes with respect to AMMA or any AMMA Subsidiary have been claimed, proposed or assessed by any Governmental
Body in writing. There are no pending (or, based on written notice, threatened) audits, assessments or other actions for or relating
to any Liability in respect of Taxes of AMMA or any AMMA Subsidiary. No issues relating to Taxes of AMMA or any AMMA Subsidiary
were raised by the relevant Tax authority in any completed audit or examination that would reasonably be expected to result in
a material amount of Taxes in a later taxable period. Neither AMMA nor any AMMA Subsidiary has waived any statute of limitations
in respect of Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency, nor has any request been
made in writing for any such extension or waiver.

 

    	 	34	 

     

    

 

(f)          Neither
AMMA nor any AMMA Subsidiary (i) has agreed, or is required, to make any adjustment under Section 481(a) of the
Code by reason of a change in accounting method or otherwise; nor (ii) has elected at any time to be treated as an S corporation
within the meaning of Sections 1361 or 1362 of the Code.

 

(g)          Neither
AMMA nor any AMMA Subsidiary has been a United States real property holding corporation within the meaning of Section 897(c)(2)
of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.

 

(h)          Neither
AMMA nor any AMMA Subsidiary is a party to any Tax allocation, Tax sharing or similar agreement (including indemnity arrangements),
other than commercial contracts entered into in the Ordinary Course of Business with vendors, customers and landlords, the primary
purpose of which does not relate to Taxes.

 

(i)          Neither
AMMA nor any AMMA Subsidiary has ever been a member of an affiliated group filing a consolidated, combined or unitary Tax Return
(other than a group the common parent of which is AMMA) for federal, state, local or foreign Tax purposes. Neither AMMA nor any
AMMA Subsidiary has any Liability for the Taxes of any Person (other than AMMA) under Treasury Regulations Section 1.1502-6 (or
any similar provision of state, local, or foreign law), as a transferee or successor, or otherwise by operation of applicable Legal
Requirements.

 

(j)          Neither
AMMA nor any AMMA Subsidiary has distributed stock of another Person, or has had its stock distributed by another Person, in a
transaction that was purported or intended to be governed in whole or in part by Section 355 of the Code or Section 361 of the
Code.

 

(k)          Neither
AMMA nor any AMMA Subsidiary is a partner for Tax purposes with respect to any joint venture, partnership, or, to the Knowledge
of AMMA, other arrangement or Contract which is treated as a partnership for Tax purposes.

 

(l)          Neither
AMMA nor any AMMA Subsidiary will be required to include any item of income in, or exclude any item of deduction from, taxable
income for any period (or any portion thereof) beginning after the Closing Date as a result of any (i) installment sale or other
open transaction disposition made on or prior to Closing, (ii) agreement with any Tax authority (including any closing agreement
described in Section 7121 of the Code or any similar provision of state, local or foreign law) made or entered into on or prior
to Closing, (iii) prepaid amount received outside the Ordinary Course of Business on or prior to Closing, (iv) election under Section
108(i) of the Code made on or prior to Closing, or (v) use of an improper method of accounting on or prior to Closing.

 

    	 	35	 

     

    

 

(m)          Neither
AMMA nor any AMMA Subsidiary has entered into any transaction identified as a “listed transaction” for purposes of
Treasury Regulations Sections 1.6011-4(b)(2) or 301.6111-2(b)(2).

 

(n)          Neither
AMMA nor any AMMA Subsidiary has taken any action, or has any Knowledge of any fact or circumstance (including, for the avoidance
of doubt, any actions that may be otherwise permitted pursuant to Section 4.6), that would reasonably be expected to prevent
the Exchange from qualifying as a reorganization within the meaning of Section 368(a) of the Code.

 

(o)          AMMA
has made available to SCWorx for inspection at SCWorx’s office (i) complete and correct copies of all income and other material
Tax Returns of AMMA or any AMMA Subsidiary filed with respect to taxable periods ended on or after December 31, 2015, and (ii)
complete and correct copies of all private letter rulings, examination reports, revenue agent reports, material information document
requests, notices of proposed deficiencies, deficiency notices, protests, petitions, closing agreements, settlement agreements,
pending ruling requests, gain recognition agreements and any similar documents, submitted by, received by or agreed to by or on
behalf of AMMA or any AMMA Subsidiary, in each case relating to Taxes for all taxable periods for which the statute of limitations
has not yet expired.

 

(p)          AMMA
and each AMMA Subsidiary has disclosed on its income Tax Returns all positions that could give rise to the imposition on it of
a substantial understatement penalty under Section 6662 of the Code (or any corresponding or similar provision of state, local
or foreign income Tax law).

 

(q)          All
related party transactions involving AMMA and any AMMA Subsidiary have been conducted at arm’s length in compliance with
Code Section 482 of the Code and the Treasury Regulations promulgated thereunder and any comparable provisions of any other state,
local and non-U.S. Tax Law.

 

(r)          Neither
AMMA nor any AMMA Subsidiary (i) has been required to make a basis reduction pursuant to former Treasury Regulation Section
1.1502-20(b) or Treasury Regulation Section 1.337(d)-2(b); (ii) is or has been required to redetermine or reduce basis pursuant
to Treasury Regulation Section 1.1502-36(b) or (c) has been required to reduce any attributes under Treasury Regulation Section
1.1502-36(d); and (iii) has incurred (or been allocated) any dual consolidated loss within the meaning of Section 1503 of
the Code.

 

(s)          Except
as set forth on Section 3.13(s) to the AMMA Disclosure Schedule, neither AMMA nor any AMMA Subsidiary is subject to Tax
in any jurisdiction outside the jurisdiction of its organization by virtue of (i) having a permanent establishment (within the
meaning of an applicable Tax treaty) or other place of business or (ii) otherwise having a taxable presence in that jurisdiction.

 

(t)          Neither
AMMA nor any AMMA Subsidiary is a shareholder of a “controlled foreign corporation” as defined in Section 957 of the
Code (or any similar provision of state, local or foreign law) or a shareholder in a “passive foreign investment company”
within the meaning of Section 1297 of the Code.

 

    	 	36	 

     

    

 

(u)          Nothing
in this Section 3.13 or otherwise in this Agreement shall be construed as a representation or warranty with respect to (i) the
amount or availability of any net operating loss, capital loss, Tax credits, Tax basis or other Tax asset or attribute of AMMA
or any AMMA Subsidiary in any taxable period (or portion thereof) beginning after the Closing Date, or (ii) except with respect
to the Tax Treatment (as defined in Section 5.12 hereof), any Tax position that AMMA or its Affiliates may take in respect
of any taxable period (or portion thereof) beginning after the Closing Date.

 

3.14         Employee
and Labor Matters; Benefit Plans.

 

(a)          Section
3.14(a) of the AMMA Disclosure Schedule contains a list of all of AMMA and AMMA’s Subsidiaries’ current employees
as of the date of this Agreement (the “AMMA Employees”), and correctly reflects: (i) their name and dates
of hire; (ii) their position, full-time or part-time status, including each AMMA Employee’s classification as either
exempt or non-exempt from the overtime requirements under any applicable law; (iii) their monthly base salary or hourly wage
rate, as applicable; (iv) any other compensation payable to them including housing allowances, compensation payable pursuant
to bonus (for the current fiscal year and the most recently completed fiscal year), deferred compensation or commission arrangements,
overtime payment, vacation entitlement and accrued vacation or paid time-off balance, travel pay or car maintenance or car entitlement,
sick leave entitlement and accrual, recuperation pay entitlement and accrual, entitlement to pension arrangement and/or any other
provident fund (including manager’s insurance and education fund), their respective contribution rates and the salary basis
for such contributions; (v) the city/country of employment, citizenship, manager’s name and work location, date of birth,
any material special circumstances (including pregnancy, disability or military service), and (vi) any promises or commitments
made to any of the AMMA Employees, whether in writing or not, with respect to any future changes or additions to their compensation
or benefits listed in Section 3.14(a) of the AMMA Disclosure Schedule. Other than as listed in Section 3.14(a) of
the AMMA Disclosure Schedule, (i) there are no other employees employed by the AMMA or by any AMMA Subsidiary, and (ii) all current
and former employees of AMMA and the AMMA Subsidiaries have signed an employment agreement substantially in the form delivered
or made available to SCWorx. Other than their base salary, the AMMA Employees are not entitled to any payment or benefit that may
be reclassified as part of their determining salary for all intent and purposes, including for the social contributions. Details
of any Person who has accepted an offer of employment made by AMMA or any AMMA Subsidiary but whose employment has not yet started
are contained in Section 3.15(a) of the AMMA Disclosure Schedule.

 

(b)          Section
3.14(b) of the AMMA Disclosure Schedule contains a list of all of AMMA and AMMA’s Subsidiaries’ current independent
contractors and consultants and, for each, such individual’s compensation and benefits, the initial date of such individual’s
engagement, the term of the engagement, period of notice entitlement prior to termination notice entitlement.

 

    	 	37	 

     

    

 

(c)          Section
3.14(c) of the AMMA Disclosure Schedule lists, as of the date of this Agreement, all written, and describes all non-written,
employee benefit plans (as defined in Section 3(3) of ERISA) and all bonus, equity-based, retention, incentive, deferred compensation,
retirement or supplemental retirement, profit sharing, severance, change in control, golden parachute, disability, life or accident
insurance, paid time off, vacation, cafeteria, dependent care, medical care, employee assistance program, education or tuition
assistance programs, fringe or employee benefit, and all other compensation, plans, programs, agreements or arrangements, including
but not limited to any employment, consulting, independent contractor, severance or executive compensation agreements or arrangements
(other than regular salary or wages), written or otherwise, which are currently in effect relating to any present or former employee,
independent contractor or director of AMMA or any AMMA Affiliate (collectively, “AMMA Service Providers”), or
which is maintained by, administered or contributed to by, or required to be contributed to by, AMMA or any AMMA Affiliate, or
under which AMMA or any AMMA Affiliate has any current or may incur any future Liability (each, an “AMMA Employee Plan”)
(other than offer letters with non-officer employees which are materially consistent with forms delivered or made available by
the AMMA prior to the execution of this Agreement; equity grant notices, and related documentation, with respect to AMMA Employees;
and agreements with consultants entered into in the Ordinary Course of Business and which are materially consistent with forms
delivered or made available by AMMA prior to the execution of this Agreement).

 

(d)          With
respect to each AMMA Employee Plan, AMMA has made available to SCWorx a true and complete copy of, to the extent applicable: (i)
such AMMA Employee Plan, including any amendments thereto; (ii) the three (3) most recent annual reports (Form 5500) as filed
with the United States Department of Labor, including any financial statements and actuarial reports; (iii) each currently effective
trust agreement related to such AMMA Employee Plan; (iv) the most recent summary plan description, with any summary or material
modifications, prospectus or other summary for each AMMA Employee Plan; (v) the most recent United States Internal Revenue Service
determination or opinion letter with respect to any AMMA Employee Plan; (vi) all material notices, letters or other correspondence
to or from any Governmental Body or agency thereof within the last three (3) years; (vii) all non-discrimination and compliance
tests for the most recent three (3) plan years; and (viii) all material written agreements and Contracts currently in effect, including
(without limitation) administrative service agreements, group annuity contracts, and group insurance contracts.

 

(e)          Each
AMMA Employee Plan that is intended to be qualified under Section 401(a) of the Code has received a favorable determination or
may rely on a favorable opinion letter with respect to such qualified status from the United States Internal Revenue Service. To
the Knowledge of AMMA, nothing has occurred that would reasonably be expected to adversely affect the qualified status of any such
AMMA Employee Plan or the exempt status of any related trust.

 

(f)          Each
AMMA Employee Plan has been operated and maintained in compliance in all material respects, with its terms and, both as to form
and operations, with all applicable Legal Requirements, including the Code and ERISA. Neither AMMA nor any AMMA Affiliate is subject
to any Liability or penalty under Sections 4976 through 4980 of the Code or Title I of ERISA with respect to any of the
AMMA Employee Plans. All contributions required to be made by AMMA, any of its Subsidiaries or any AMMA Affiliate to any AMMA Employee
Plan have been made on or before their due dates (and no further contributions will be due or will have accrued thereunder as of
the Closing Date, other than contributions accrued in the Ordinary Course of Business consistent with past practice).

 

    	 	38	 

     

    

 

(g)          Neither
AMMA, nor any AMMA Affiliate has engaged in any transaction in violation of Sections 404 or 406 of ERISA or any “prohibited
transaction,” as defined in Section 4975(c)(1) of the Code, for which no exemption exists under Section 408 of ERISA or Section
4975(c)(2) or (d) of the Code, or has otherwise violated the provisions of Part 4 of Title I, Subtitle B of ERISA. Neither AMMA,
nor any AMMA Affiliate has knowingly participated in a violation of Part 4 of Title I, Subtitle B of ERISA by any plan fiduciary
of any AMMA Employee Plan subject to ERISA and neither AMMA nor any AMMA Affiliate has been assessed any civil penalty under Section
502(l) of ERISA.

 

(h)          No
suit, administrative proceeding, action or other litigation has been initiated against, or to the Knowledge of AMMA, is threatened,
against or with respect to any AMMA Employee Plan, including any audit or inquiry by the United States Internal Revenue Service,
United States Department of Labor or other Governmental Body.

 

(i)          No
AMMA Employee Plan is subject to Title IV or Section 302 of ERISA or Section 412 of the Code, and neither AMMA, nor any AMMA Affiliate
has ever maintained, contributed to or partially or completely withdrawn from, or incurred any obligation or Liability with respect
to, any such plan. No AMMA Employee Plan is a Multiemployer Plan, and neither AMMA, nor any AMMA Affiliate has ever contributed
to or had an obligation to contribute, or incurred any Liability in respect of a contribution, to any Multiemployer Plan. No AMMA
Employee Plan is a Multiple Employer Plan.

 

(j)          No
AMMA Employee Plan provides for medical, welfare, retirement or death benefits beyond termination of service or retirement, other
than (i) pursuant to COBRA or an analogous state law requirement or (ii) death or retirement benefits under a AMMA Employee Plan
qualified under Section 401(a) of the Code. Except as provided in Section 3.15(j) of the AMMA Disclosure Schedule and identified
as a self-funded plan, neither AMMA nor any AMMA Affiliate sponsors or maintains any self-funded employee welfare benefit plan.

 

(k)          To
the Knowledge of AMMA, no payment pursuant to any AMMA Employee Plan or other arrangement to any “service provider”
(as such term is defined in Section 409A of the Code and the regulations and guidance thereunder) from AMMA or any AMMA Subsidiary,
including the grant, vesting or exercise of any stock option, would subject any Person to Tax pursuant to Section 409A of the Code,
whether pursuant to the Contemplated Transactions or otherwise.

 

(l)          Each
AMMA Option grant was properly accounted for in accordance with GAAP in the financial statements (including the related notes)
of AMMA and disclosed in AMMA filings with the Securities and Exchange Commission in accordance with the Exchange Act and all other
applicable Legal Requirements. AMMA has not knowingly granted, and there is no and has been no policy or practice of AMMA of granting,
AMMA Options prior to, or otherwise coordinating the grant of AMMA Options with, the release or other public announcement of material
information regarding AMMA or its results of operations or prospects.

 

    	 	39	 

     

    

 

(m)          No
AMMA Options are subject to the requirements of Section 409A of the Code. Each “nonqualified deferred compensation plan”
(as such term is defined under Section 409A(d)(1) of the Code and the regulations and guidance thereunder) maintained by or under
which AMMA or any of AMMA Subsidiary makes, is obligated to make or promises to make, payments (each, an “AMMA 409A Plan”)
complies in all material respects, in both form and operation, with the requirements of Section 409A of the Code and the regulations
and guidance thereunder. No payment to be made under any AMMA 409A Plan is, or to the Knowledge of AMMA will be, subject to the
penalties of Section 409A(a)(1) of the Code.

 

(n)          AMMA
and the AMMA Subsidiaries are in material compliance with all applicable foreign, federal, state and local laws, rules, regulations,
orders, rulings, judgments, decrees or arbitration awards respecting employment, employment practices, terms and conditions of
employment, worker classification, tax withholding, prohibited discrimination, equal employment, fair employment practices, meal
and rest periods, immigration status, employee safety and health, wages (including overtime wages), compensation, hours of work,
labor relations, leave of absence requirements, occupational health and safety, privacy, harassment, retaliation, immigration and
wrongful discharge and in each case, with respect to employees: (i) has withheld and reported all amounts required by law
or by agreement to be withheld and reported with respect to wages, salaries and other payments to employees, (ii) is not liable
for any arrears of wages, severance pay or any Taxes or any penalty of any material amount for failure to comply with any of the
foregoing, and (iii) is not liable for any payment to any trust or other fund governed by or maintained by or on behalf of any
Governmental Body, with respect to unemployment compensation benefits, social security or other benefits or obligations for employees
(other than routine payments to be made in the normal course of business and consistent with past practice). There are no actions,
suits, claims or administrative matters pending, or to the Knowledge of AMMA, threatened or reasonably anticipated against AMMA
relating to any employee, employment agreement, independent contractor, independent contractor agreement or AMMA Employee Plan.
There are no pending or, to the Knowledge of AMMA, threatened or reasonably anticipated claims or actions against AMMA or any trustee
of AMMA under any worker’s compensation policy or long term disability policy. AMMA is not a party to a conciliation agreement,
consent decree or other agreement or order with any federal, state, or local agency or Governmental Body with respect to employment
practices. AMMA has good labor relations.

 

(o)          No
current or former consultant or independent contractor of AMMA or any AMMA Subsidiary would reasonably be deemed to be a misclassified
employee. Except as set forth on Section 3.14(o) of the AMMA Disclosure Schedule, no independent contractor is eligible
to participate in any AMMA Employee Plan. Neither AMMA nor any AMMA Subsidiary has material Liability with respect to any misclassification
of: (A) any Person as an independent contractor rather than as an employee, (B) any employee leased from another employer, or (C)
any employee currently or formerly classified as exempt from overtime wages.

 

    	 	40	 

     

    

 

(p)          Neither
AMMA nor any AMMA Subsidiary has taken any action which would constitute a “plant closing” or “mass layoff”
within the meaning of the WARN Act or similar state or local law, issued any notification of a plant closing or mass layoff required
by the WARN Act or similar state or local law, or incurred any Liability or obligation under WARN or any similar state or local
law that remains unsatisfied. No terminations of employees of AMMA prior to the Closing would trigger any notice or other obligations
under the WARN Act or similar state or local law.

 

(q)          No
employee of AMMA or any AMMA Subsidiary is covered by an effective or pending collective bargaining agreement or similar labor
agreement, and there has never been any threat of, any strike, slowdown, work stoppage, lockout, job action, union organizing activity,
or any similar activity or dispute, affecting AMMA or any AMMA Subsidiary. No event has occurred, and no condition or circumstance
exists, that might directly or indirectly be likely to give rise to or provide a basis for the commencement of any such strike,
slowdown, work stoppage, lockout, job action, union organizing activity, question concerning representation or any similar activity
or dispute. No union or other collective bargaining unit has been certified or recognized by AMMA or any AMMA Subsidiary as representing
any of its employees.

 

(r)          AMMA
is not, and neither AMMA nor any AMMA Subsidiary, has been, engaged in any unfair labor practice within the meaning of the National
Labor Relations Act. There is no Legal Proceeding, claim, labor dispute or grievance pending or, to the Knowledge of AMMA, threatened
or reasonably anticipated relating to any employment contract, privacy right, labor dispute, wages and hours, leave of absence,
plant closing notification, workers’ compensation policy, long term disability policy, harassment, retaliation, immigration,
employment statute or regulation, safety or discrimination matter involving any AMMA Associate, including charges of unfair labor
practices or discrimination complaints.

 

(s)          There
is no Contract or arrangement to which AMMA or any AMMA Subsidiary is a party or by which it is bound to compensate any of its
current or former employees, independent contractors or directors for additional income or excise Taxes paid pursuant to Sections
409A or 4999 of the Code.

 

(t)          Neither
AMMA nor any AMMA Affiliate is a party to any Contract that has resulted or would reasonably be expected to result, separately
or in the aggregate, in the payment of (i) any “excess parachute payment” within the meaning of Section 280G of the
Code or (ii) any amount the deduction for which would be disallowed under Section 162(m) of the Code.

 

(u)          Except
as set forth in Section 3.14(u) of the AMMA Disclosure Schedule, none of the execution and delivery of this Agreement, or
the consummation of the Contemplated Transactions or any termination of employment or service or any other event in connection
therewith or subsequent thereto will, individually or together or with the occurrence of some other event, (i) result in any
payment (including severance, golden parachute, bonus or otherwise) becoming due to any employee, independent contractor or director
of AMMA, (ii) materially increase or otherwise enhance any benefits otherwise payable by AMMA, (iii) result in the acceleration
of the time of payment or vesting of any such benefits, except as required under Section 411(d)(3) of the Code, (iv) increase
the amount of compensation due to any Person by AMMA or (v) result in the forgiveness in whole or in part of any outstanding
loans made by AMMA to any Person. Each item set forth in Section 3.14(u) of the AMMA Disclosure Schedule has been duly and
properly approved in accordance with any requirements under applicable law.

 

    	 	41	 

     

    

 

(v)         Except
as noted on Section 3.14(v) of the AMMA Disclosure Schedule, all individuals employed by AMMA and its Subsidiaries are employed
at-will and AMMA and its Subsidiaries have no employment or other agreements that contain any severance, change in control, termination
pay liabilities, or advance notice requirements, and all agreements with independent contractors or consultants may be terminated
by AMMA without penalty or Liability with thirty (30) days or less notice.

 

(w)          AMMA
and its Subsidiaries have paid all wages, bonuses, commissions, severance, and other benefits and sums due (and all required Taxes,
insurance, social security and withholding thereon), including all accrued vacation, accrued sick leave, accrued benefits and accrued
payments to its employees and former employees and individuals performing services as independent contractors or consultants, other
than accrued amounts representing wages, bonuses, or commission entitlements due for the current pay period or for the reimbursement
of legitimate expenses.

 

3.15         Environmental
Matters. AMMA and each AMMA Subsidiary is in compliance with all applicable Environmental Laws, which compliance includes the
possession by AMMA of all permits and other Governmental Authorizations required under applicable Environmental Laws and compliance
with the terms and conditions thereof other than any failure to be in compliance or possess any such permits and authorized that
is not a AMMA Material Adverse Effect. Neither AMMA nor any AMMA Subsidiary has received since inception any written notice or
other communication (in writing or otherwise), whether from a Governmental Body, citizens group, employee or otherwise, that alleges
that AMMA or any AMMA Subsidiary is not in compliance with any Environmental Law, and, to the Knowledge of AMMA, there are no circumstances
that may prevent or interfere with AMMA’s compliance with any Environmental Law in the future. To the Knowledge of AMMA:
(a) no current or prior owner of any property leased or controlled by AMMA or any AMMA Subsidiary has received since AMMA’s
inception, any written notice or other communication relating to property owned or leased at any time by AMMA, whether from a Governmental
Body, citizens group, employee or otherwise, that alleges that such current or prior owner or AMMA or any AMMA Subsidiary is not
in compliance with or has violated any Environmental Law relating to such property and (b) neither AMMA nor any AMMA Subsidiary
has any material Liability under any Environmental Law.

 

    	 	42	 

     

    

 

3.16         Insurance.

 

(a)          AMMA
has made available to SCWorx accurate and complete copies of all material insurance policies and all material self-insurance programs
and arrangements relating to the business, assets, liabilities and operations of AMMA and each AMMA Subsidiary, as of the date
of this Agreement. Each of such insurance policies is in full force and effect and AMMA and each AMMA Subsidiary is in compliance
with the terms thereof. Except for a notice of cancellation due to non-payment of a premium, which premium has since been paid,
as of the date of this Agreement, other than customary end of policy notifications from insurance carriers, since January 1, 2018,
neither AMMA nor any AMMA Subsidiary has received any notice or other communication regarding any actual or possible: (a) cancelation
or invalidation of any insurance policy; (b) refusal or denial of any coverage, reservation of rights or rejection of any material
claim under any insurance policy; or (c) material adjustment in the amount of the premiums payable with respect to any insurance
policy. There is no pending workers’ compensation or other claim under or based upon any insurance policy of AMMA or any
AMMA Subsidiary. AMMA and each AMMA Subsidiary have provided timely written notice to the appropriate insurance carrier(s) of each
Legal Proceeding pending or threatened in writing against AMMA or any AMMA Subsidiary, and no such carrier has issued a denial
of coverage or a reservation of rights with respect to any such Legal Proceeding, or informed AMMA or any AMMA Subsidiary of its
intent to do so.

 

(b)          AMMA
has delivered to SCWorx accurate and complete copies of the existing policies (primary and excess) of directors’ and officers’
liability insurance maintained by AMMA and each AMMA Subsidiary as of the date of this Agreement (the “Existing AMMA D&O
Policies”). Section 3.16(b) of the AMMA Disclosure Schedule accurately sets forth, as of the date of this Agreement,
the most recent annual premiums paid by AMMA and each AMMA Subsidiary with respect to the Existing AMMA D&O Policies. All premiums
for the Existing AMMA D&O Policies have been paid.

 

3.17         Legal
Proceedings; Orders.

 

(a)          Except
as set forth in Section 3.17 to the AMMA Disclosure Schedule, there is no pending Legal Proceeding, and, to the Knowledge
of AMMA, no Person has threatened in writing to commence any Legal Proceeding: (i) that involves AMMA or any of the AMMA Subsidiary,
or to the Knowledge of AMMA, any director or officer of AMMA (in his or her capacity as such) or any of the material assets owned
or used by AMMA or any AMMA Subsidiary; or (ii) that challenges, or that would reasonably be expected to have the effect of preventing,
delaying, making illegal or otherwise interfering with, the Contemplated Transactions. To the Knowledge of AMMA, no event has occurred,
and no claim, dispute or other condition or circumstance exists, that will, or that would reasonably be expected to, give rise
to or serve as a basis for the commencement of any such Legal Proceeding.

 

(b)          There
is no order, writ, injunction, judgment or decree to which AMMA or any AMMA Subsidiary, or any of the material assets owned or
used by AMMA or any AMMA Subsidiary, is subject. To the Knowledge of AMMA, no officer of AMMA or any AMMA Subsidiary is subject
to any order, writ, injunction, judgment or decree that prohibits such officer from engaging in or continuing any conduct, activity
or practice relating to the business of AMMA or any AMMA Subsidiary or to any material assets owned or used by AMMA or any AMMA
Subsidiary.

 

    	 	43	 

     

    

 

3.18         Anti-Corruption.
Neither AMMA or any AMMA Subsidiary has, and none of any of AMMA’s directors, managers or employees or, to the Knowledge
of AMMA, any of its agents, Representatives, sales intermediaries, or any other third party, in each case, acting on behalf of
AMMA or in connection with the business of AMMA, has in the last five (5) years or any applicable statute of limitations period
if longer than five (5) years, (i) directly or indirectly offered, promised, authorized, provided, solicited, or accepted any corrupt
or improper payment (such as a bribe or kickback) or benefit (such as an excessive gift, hospitality, favor, or advantage) to or
from any Person in exchange for business, a license or permit, a favorable inspection or other decision, or any other financial
or other advantage or purpose, or (ii) otherwise violated any Anti-Corruption/AML Laws.

 

3.19         Inapplicability
of Anti-takeover Statutes. The AMMA Board of Directors has taken and will take all actions necessary to ensure that the restrictions
applicable to business combinations contained in Section 203 of the DGCL are, and will be, inapplicable to the execution, delivery
and performance of this Agreement and to the consummation of Contemplated Transactions. No other state takeover statute or similar
Legal Requirement applies or purports to apply to the Exchange, this Agreement or any of the other Contemplated Transactions.

 

3.20         No
Financial Advisor. Except as set forth on Section 3.20 of the AMMA Disclosure Schedule, no broker, finder or investment
banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission
in connection with the Contemplated Transactions based upon arrangements made by or on behalf of AMMA or any AMMA Subsidiary.

 

3.21         Bank
Accounts; Deposits.

 

(a)          Section
3.21 of the AMMA Disclosure Schedule provides accurate information with respect to each account maintained by or for the benefit
of AMMA or any AMMA Subsidiary at any bank or other financial institution, including the name of the bank or financial institution,
the account number, the balance as of July 30, 2018 and the names of all individuals authorized to draw on or make withdrawals
from such accounts.

 

(b)          All
existing accounts receivables of AMMA and any AMMA Subsidiary (including those accounts receivable reflected on the AMMA unaudited
financial statements unaudited financial statements that have not yet been collected and those accounts receivable that have arisen
since the date of the AMMA unaudited financial statements and have not yet been collected) represent valid obligations of customers
of AMMA arising from bona fide transactions entered into in the Ordinary Course of Business. All deposits of AMMA and any AMMA
Subsidiary (including those set forth on the AMMA unaudited financial statements) are fully refundable to AMMA.

 

3.22         Transactions
with Affiliates. Except as set forth in the AMMA SEC Documents filed prior to the date of this Agreement, since the date of
AMMA’s annual report on Form 10-K for the fiscal year ended December 31, 2017 with the SEC, no event has occurred that would
be required to be reported by AMMA pursuant to Item 13 of Form 10-K promulgated by the SEC. Section 3.23 of the AMMA Disclosure
Schedule identifies each Person who is (or who may be deemed to be) an Affiliate of AMMA as of the date of this Agreement.

 

    	 	44	 

     

    

 

3.23         Valid
Issuance. The AMMA Shares to be issued in the Exchange will, when issued in accordance with the provisions of this Agreement
be validly issued, fully paid and nonassessable.

 

3.24         Opinion
of Financial Advisor. Prior to the Closing, the AMMA Board of Directors shall receive an opinion of Cassel Salpeter & Co.,
LLC, financial advisor to AMMA, to the effect that the consideration to be issued by AMMA to the SCWorx Stockholders in the Exchange
is fair to AMMA from a financial point of view. AMMA will furnish an accurate and complete copy of such opinion to SCWorx promptly
following receipt of said opinion. The cost of such opinion shall be paid for by AMMA subsequent to the Closing Date.

 

3.25         Shell
Company Status. AMMA is not an issuer identified in Rule 144(i)(1) or of the Securities Act or a shell company as defined in
Rule 12b-2 of the Exchange Act.

 

3.26         Exclusivity
of Representations; Reliance.

 

(a)          Except
as expressly set forth in this Article 3, neither AMMA, the AMMA Subsidiaries, nor any Person on behalf of AMMA or the AMMA
Subsidiaries has made, nor are any of them making, any representation or warranty, written or oral, express or implied, at law
or in equity, including with respect to merchantability or fitness for any particular purpose, in respect of AMMA or its business
in connection with the transactions contemplated hereby, including any representations or warranties about the accuracy or completeness
of any information or documents previously provided (including with respect to any financial or other projections therein), and
any other such representations and warranties are hereby expressly disclaimed.

 

(b)          AMMA
acknowledges and agrees that, except for the representations and warranties of SCWorx set forth in Article 2, none of AMMA
or any of its Representatives is relying on any other representation or warranty of SCWorx or any other Person made outside of
Article 2 of this Agreement, including regarding the accuracy or completeness of any such other representations or warranties
or the omission of any material information, whether express or implied, in each case with respect to the Contemplated Transactions.

 

ARTICLE 4CERTAIN
COVENANTS OF THE PARTIES

 

4.1           Access
and Investigation. During the period commencing on the date of this Agreement and continuing until the earlier of the termination
of this Agreement in accordance with the terms hereto and the Closing Date (the “Pre-Closing Period”), upon
reasonable notice each Party shall, and shall use commercially reasonable efforts to cause such Party’s Representatives to:

 

(a)          provide
the other Party and such other Party’s Representatives with reasonable access during normal business hours to such Party’s
Representatives, personnel and assets and to all existing books, records, Tax Returns, work papers and other documents and information
relating to such Party and its Subsidiaries;

 

    	 	45	 

     

    

 

(b)          provide
the other Party and such other Party’s Representatives with such copies of the existing books, records, Tax Returns, work
papers, product data, and other documents and information relating to such Party and its Subsidiaries, and with such additional
financial, operating and other data and information regarding such Party and its Subsidiaries as the other Party may reasonably
request; and

 

(c)          permit
the other Party’s officers and other employees to meet, upon reasonable notice and during normal business hours, with the
chief financial officer and other officers and managers of such Party responsible for such Party’s financial statements and
the internal controls of such Party to discuss such matters as the other Party may deem necessary or reasonably appropriate. Without
limiting the generality of any of the foregoing, during the Pre-Closing Period, each Party shall promptly make available to the
other Party copies of:

 

(i)          all
material operating and financial reports prepared by such Party for its senior management, including sales forecasts, marketing
plans, development plans, discount reports, write-off reports, hiring reports and capital expenditure reports prepared for its
management;

 

(ii)         any
written materials or communications sent by or on behalf of a Party to its shareholders or stockholders;

 

(iii)        any
material notice, document or other communication sent by or on behalf of a Party to any party to any AMMA Material Contract or
SCWorx Material Contract, as applicable, or sent to a Party by any party to any AMMA Material Contract or SCWorx Material Contract
in connection with the Contemplated Transactions, as applicable;

 

(iv)        any
notice, report or other document filed with or otherwise furnished, submitted or sent to any Governmental Body on behalf of a Party
in connection with the Exchange or any of the Contemplated Transactions;

 

(v)         any
non-privileged notice, document or other communication sent by or on behalf of, or sent to, a Party relating to any pending or
threatened Legal Proceeding involving or affecting such Party; and

 

(vi)        any
material notice, report or other document received by a Party from any Governmental Body.

 

(d)          Notwithstanding
the foregoing, (i) any Party may restrict the foregoing access to the extent that any Legal Requirement applicable to such Party
requires such Party to restrict or prohibit access to any of such Party’s properties or information and (ii) neither Party
nor its respective Representatives or Subsidiaries shall be required to provide access to or disclose information where such access
or disclosure would jeopardize the protection of attorney-client privilege.

 

    	 	46	 

     

    

 

4.2           Operation
of AMMA’s Business.

 

(a)          Except as
set forth on Section 4.2(a) of the AMMA Disclosure Schedule, as expressly required or permitted by this Agreement, or as
required by applicable Legal Requirements, during the Pre-Closing Period, AMMA shall: (i) conduct its business and operations in
the Ordinary Course of Business; (ii) continue to pay outstanding accounts payable and other current Liabilities (including payroll)
when due and payable; and (iii) conduct its business and operations in compliance with all applicable Legal Requirements and the
requirements of all AMMA Contracts that constitute AMMA Material Contracts.

 

(b)          Without
limiting the generality of the foregoing, during the Pre-Closing Period, except as set forth on Section 4.2(b) of the
AMMA Disclosure Schedule, as expressly required or permitted by this Agreement, or as required by applicable Legal Requirements,
AMMA shall not, without the prior written consent of SCWorx (which consent shall not be unreasonably withheld or delayed):

 

(i)          (A)
declare, accrue, set aside or pay any dividend or made any other distribution in respect of any shares of AMMA Capital Stock or
(B) repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities;

 

(ii)         sell,
issue or grant, or authorize the issuance of: (A) any capital stock or other security (except for AMMA Shares issued to settle
AMMA obligations or upon the valid exercise of AMMA Options outstanding as of the date of this Agreement), (B) any option, warrant
or right to acquire any capital stock or any other security except (i) in settlement of AMMA obligations in an amount not to exceed
500,000 shares or (ii) as compensation to AMMA officers in an amount not to exceed 500,000 shares, (C) any equity-based award or
instrument convertible into or exchangeable for any capital stock or other security, or (D) any debt securities or any rights to
acquire any debt securities;

 

(iii)        other
than the Reverse Split and such amendments to the certificate of incorporation as are to be approved at the AMMA Stockholders’
Meeting pursuant to Section 5.1(a), amend the certificate of incorporation, bylaws or other charter or organizational documents
of AMMA or effect or be a party to any Exchange, consolidation, share exchange, business combination, recapitalization, reclassification
of shares, stock split, reverse stock split or similar transaction;

 

(iv)        form
any Subsidiary or acquire any equity interest or other interest in any other Entity;

 

(v)         (A)
lend money to any Person (except for reasonable advances to employees and consultants for travel and other reasonable business
related expenses in the Ordinary Course of Business), (B) incur or guarantee any indebtedness for borrowed money, other than in
the Ordinary Course of Business, (C) guarantee any debt securities of others, or (D) make any capital expenditure or commitment;

 

    	 	47	 

     

    

 

(vi)        (A)
adopt, establish or enter into any AMMA Employee Plan, (B) cause or permit any AMMA Employee Plan to be amended other than
as required by Legal Requirement, including in order to make amendments for the purposes of Section 409A of the Code, subject to
prior review and approval (with such approval not to be unreasonably withheld, conditioned or delayed) by SCWorx, (C) hire any
additional employees or independent contractors or enter into or amend the term of any employment or consulting agreement with
any employee or independent contractor other than as reasonably necessary for the completion of the Contemplated Transactions,
(D) enter into any Contract with a labor union or collective bargaining agreement, (E) except as provided in the AMMA Disclosure
Schedule, pay any bonus or make any profit-sharing or similar payment to (other than in the Ordinary Course of Business), or increase
the amount of the wages, salary, commissions, fringe benefits or other compensation or remuneration payable to, any of its directors
or employees, (F) except as provided in the AMMA Disclosure Schedule, accelerate the vesting of or entitlement to any payment,
award, compensation or benefit with respect to any AMMA Associate, or (G) except as provided in the AMMA Disclosure Schedule, pay
or increase the severance or change of control benefits offered to any AMMA Associate;

 

(vii)       enter
into any material transaction outside the Ordinary Course of Business;

 

(viii)      acquire
any material asset nor sell, lease, or otherwise irrevocably dispose of any of its assets or properties, or grant any Encumbrance
with respect to such assets or properties, other than in the Ordinary Course of Business;

 

(ix)         (A)
make, change or revoke any material Tax election, (B) file any material amendment to any Tax Return, (C) adopt or change any accounting
method in respect of Taxes, (D) change any annual Tax accounting period, (E) enter into any Tax allocation agreement, Tax sharing
agreement or Tax indemnity agreement, other than commercial contracts entered into in the Ordinary Course of Business with vendors,
customers or landlords, (F) enter into any closing agreement with respect to any Tax, (G) settle or compromise any claim, notice,
audit report or assessment in respect of material Taxes, (H) apply for or enter into any ruling from any Tax authority with respect
to Taxes, (I) surrender any right to claim a material Tax refund, or (J) consent to any extension or waiver of the statute
of limitations period applicable to any material Tax claim or assessment;

 

(x)          enter
into, amend or terminate any AMMA Contract that, if effective as of the date hereof, would constitute a AMMA Material Contract
(except for contracts relating to the settlement of existing liabilities and the AMMA Contracts set forth on Section 4.2(b)(x)
of the AMMA Disclosure Schedule);

 

(xi)         initiate
or settle any Legal Proceeding;

 

(xii)        incur
any Liabilities or otherwise take any actions other than in the Ordinary Course of Business;

 

(xiii)       adopt
any shareholder rights plan or similar arrangement;

 

(xiv)      renew,
extend or modify the current lease for AMMA’s principal executive office space; or

 

    	 	48	 

     

    

 

(xv)       agree,
resolve or commit to do any of the foregoing.

 

Notwithstanding the
foregoing, AMMA may enter into agreements to settle disputes and terminate contracts described in the AMMA Disclosure Schedules.
Nothing contained in this Agreement is intended to give SCWorx, directly or indirectly, the right to control or direct AMMA’s
operations during the Pre-Closing Period.

 

4.3           Operation
of SCWorx’s Business.

 

(a)          Except as
set forth on Section 4.3(a) of the SCWorx Disclosure Schedule, as expressly required or permitted by this Agreement or as
required by applicable Legal Requirements, during the Pre-Closing Period, SCWorx shall (i) conduct its business and operations
in the Ordinary Course of Business; (ii) continue to pay outstanding accounts payable and other current Liabilities (including
payroll) when due and payable; and (iii) conduct its business and operations in compliance with all applicable Legal Requirements
and the requirements of all SCWorx Contracts that constitute SCWorx Material Contracts.

 

(b)          Without
limiting the generality of the foregoing, during the Pre-Closing Period, except as set forth on Section 4.3(b) of the
SCWorx Disclosure Schedule, as expressly permitted by this Agreement, or as required by applicable Legal Requirements, SCWorx shall
not, nor shall it permit any of its Subsidiaries to, without the prior written consent of AMMA (which consent shall not be unreasonably
withheld or delayed):

 

(i)          (A)
declare, accrue, set aside or pay any dividend or made any other distribution in respect of any shares of SCWorx Capital Stock
or (B) repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities except pursuant to SCWorx
Contracts existing as of the date of this Agreement;

 

(ii)         sell,
issue or grant, or authorize the issuance of: (A) any capital stock or other security, (B) any option, warrant or right to acquire
any capital stock or any other security, (C) any equity-based award or instrument convertible into or exchangeable for any capital
stock or other security, or (D) any debt securities or any rights to acquire any debt securities;

 

(iii)        amend
the certificate of incorporation, bylaws or other charter or organizational documents of SCWorx, or effect or be a party to any
Exchange, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse
stock split or similar transaction;

 

(iv)        form
any Subsidiary or acquire any equity interest or other interest in any other Entity;

 

(v)         (A)
lend money to any Person (except for reasonable advances to employees and consultants for travel and other reasonable business
related expenses in the Ordinary Course of Business), (B) incur or guarantee any indebtedness for borrowed money, other than in
the Ordinary Course of Business, (C) guarantee any debt securities of others, or (D) make any capital expenditure or commitment
in excess of $50,000 or in excess of $100,000 in the aggregate;

 

    	 	49	 

     

    

 

(vi)        enter
into any Contract with a labor union or collective bargaining agreement;

 

(vii)       enter
into any material transaction outside the Ordinary Course of Business;

 

(viii)      acquire
any material asset nor sell, lease, or otherwise irrevocably dispose of any of its assets or properties, or grant any Encumbrance
with respect to such assets or properties, in each case, other than in the Ordinary Course of Business;

 

(ix)         (A)
make, change or revoke any material Tax election, (B) file any material amendment to any Tax Return, (C) adopt or change any accounting
method in respect of Taxes, (D) change any annual Tax accounting period, (E) enter into any Tax allocation agreement, Tax sharing
agreement or Tax indemnity agreement, other than commercial contracts entered into in the Ordinary Course of Business with vendors,
customers or landlords, (F) enter into any closing agreement with respect to any Tax, (G) settle or compromise any claim, notice,
audit report or assessment in respect of material Taxes, (H) apply for or enter into any ruling from any Tax authority with respect
to Taxes, (I) surrender any right to claim a material Tax refund, or (J) consent to any extension or waiver of the statute
of limitations period applicable to any material Tax claim or assessment;

 

(x)          adopt
any stockholder rights plan or similar arrangement; or

 

(xi)         agree,
resolve or commit to do any of the foregoing.

 

Nothing contained in this Agreement is
intended to give AMMA, directly or indirectly, the right to control or direct SCWorx’s operations during the Pre-Closing
Period.

 

4.4           Notification
of Certain Matters.

 

(a)          During
the Pre-Closing Period, AMMA shall:

 

(i)          promptly
notify SCWorx of: (A) any notice or other communication from any Person alleging that the Consent of such Person is or may be required
in connection with any of the Contemplated Transactions; (B) any Legal Proceeding against, relating to, involving or otherwise
affecting AMMA, or to the Knowledge of AMMA, any director or officer of AMMA, that is commenced or asserted against, or, to the
Knowledge of AMMA, threatened against, AMMA or any director or officer of AMMA; and (C) any notice or other communication from
any Person alleging that any payment or other obligation is or will be owed to such Person at any time before or after the date
of this Agreement, except for invoices or other communications related to agreements or dealings in the Ordinary Course of Business
or payments or obligations identified in this Agreement, including the AMMA Disclosure Schedule; and

 

    	 	50	 

     

    

 

(ii)         promptly
notify SCWorx in writing of: (A) the discovery by AMMA of any event, condition, fact or circumstance that occurred or existed on
or prior to the date of this Agreement and that caused or constitutes an inaccuracy in any representation or warranty made by AMMA
in this Agreement in a manner that causes the condition set forth in Section 8.1 not to be satisfied; (B) any event, condition,
fact or circumstance that occurs, arises or exists after the date of this Agreement and that would cause or constitute an inaccuracy
in any representation or warranty made by AMMA in this Agreement in a manner that causes the condition set forth in Section
8.1 not to be satisfied if: (1) such representation or warranty had been made as of the time of the occurrence, existence or
discovery of such event, condition, fact or circumstance; or (2) such event, condition, fact or circumstance had occurred, arisen
or existed on or prior to the date of this Agreement; (C) any breach of any covenant or obligation of AMMA in a manner that causes
the condition set forth in Section 8.2 not to be satisfied; and (D) any event, condition, fact or circumstance that would
reasonably be expected to make the timely satisfaction of any of the conditions set forth in Article 6, Article 7,
or Article 8 impossible or materially less likely. No notification given to SCWorx pursuant to this Section 4.4(a)
shall change, limit or otherwise affect any of the representations, warranties, covenants or obligations of AMMA contained in this
Agreement or the AMMA Disclosure Schedule for purposes of Section 8.1.

 

(b)          During
the Pre-Closing Period, SCWorx shall:

 

(i)          promptly
notify AMMA of: (A) any notice or other communication from any Person alleging that the Consent of such Person is or may be required
in connection with any of the Contemplated Transactions; (B) any Legal Proceeding against, relating to, involving or otherwise
affecting SCWorx, or to the Knowledge of SCWorx, any director or officer of SCWorx, that is commenced or asserted against, or,
to the Knowledge of SCWorx, threatened against, SCWorx, any of its Subsidiaries, or any director or officer of SCWorx; and (C)
any notice or other communication from any Person alleging that any payment or other obligation is or will be owed to such Person
at any time before or after the date of this Agreement, except for invoices or other communications related to agreements or dealings
in the Ordinary Course of Business or payments or obligations identified in this Agreement; and

 

(ii)         promptly
notify AMMA in writing, of: (i) the discovery by SCWorx of any event, condition, fact or circumstance that occurred or existed
on or prior to the date of this Agreement and that caused or constitutes an inaccuracy in any representation or warranty made by
SCWorx in this Agreement in a manner that causes the condition set forth in Section 7.1 not to be satisfied; (ii) any event,
condition, fact or circumstance that occurs, arises or exists after the date of this Agreement and that would cause or constitute
an inaccuracy in any representation or warranty made by SCWorx in this Agreement in a manner that causes the condition set forth
in Section 7.1 not to be satisfied if: (A) such representation or warranty had been made as of the time of the occurrence,
existence or discovery of such event, condition, fact or circumstance; or (B) such event, condition, fact or circumstance
had occurred, arisen or existed on or prior to the date of this Agreement; (iii) any breach of any covenant or obligation of SCWorx
in a manner that causes the condition set forth in Section 7.2 not to be satisfied; and (iv) any event, condition, fact
or circumstance that would reasonably be expected to make the timely satisfaction of any of the conditions set forth in Article
6, Article 7, or Article 8 impossible or materially less likely. No notification given to AMMA pursuant to this
Section 4.4(b) shall change, limit or otherwise affect any of the representations, warranties, covenants or obligations
of SCWorx contained in this Agreement or the SCWorx Disclosure Schedule for purposes of Section 7.1.

 

    	 	51	 

     

    

 

4.5           No
Solicitation.

 

(a)          Each
Party agrees that neither it nor any of its Subsidiaries shall, nor shall it nor any of its Subsidiaries authorize or permit any
of the Representatives retained by it or any of its Subsidiaries to directly or indirectly: (i) solicit, initiate, respond to or
take any action to facilitate or encourage any inquiries or the communication, making, submission or announcement of any Acquisition
Proposal or Acquisition Inquiry or take any action that could reasonably be expected to lead to an Acquisition Proposal or Acquisition
Inquiry; (ii) enter into or participate in any discussions or negotiations with any Person with respect to any Acquisition Proposal
or Acquisition Inquiry; (iii) furnish any information regarding such Party to any Person in connection with, in response to, relating
to or for the purpose of assisting with or facilitating an Acquisition Proposal or Acquisition Inquiry; (iv) approve, endorse or
recommend any Acquisition Proposal (subject to Sections 5.2 and 5.3); (v) execute or enter into any letter of intent
or similar document or any Contract contemplating or otherwise relating to any Acquisition Transaction (an “Acquisition
Agreement”); or (vi) grant any waiver or release under any confidentiality, standstill or similar agreement (other than
to the other Party).

 

(b)          Notwithstanding
anything contained in Section 4.5(a), prior to receipt of the Required SCWorx Stockholder Vote, in the case of SCWorx, or
the Required AMMA Stockholder Vote, in the case of AMMA, such Party, (i) may enter into discussions or negotiations with, any Person
that has made (and not withdrawn) a bona fide, unsolicited, Acquisition Proposal, which such Party’s Board of Directors determines
in good faith, after consultation with its independent financial advisor, if any, and its outside legal counsel, constitutes, or
would reasonably be expected to result in, a Superior Offer, and (ii) thereafter furnish to such Person non-public information
regarding such Party pursuant to an executed confidentiality agreement containing provisions (including nondisclosure provisions,
use restrictions, non-solicitation provisions, no hire provisions and “standstill” provisions) at least as favorable
to such Party as those contained in the Confidentiality Agreement, but in each case of the foregoing clauses (i) and (ii), only
if: (A) neither such Party nor any Representative of such Party has breached this Section 4.5; (B) the Board of Directors
of such Party determines in good faith based on the advice of outside legal counsel, that the failure to take such action would
constitute a breach of the fiduciary duties of the Board of Directors of such Party under applicable Legal Requirements; (C) at
least three (3) Business Days prior to furnishing any such non-public information to, or entering into discussions with, such Person,
such Party gives the other Party written notice of the identity of such Person and of such Party’s intention to furnish nonpublic
information to, or enter into discussions with, such Person; and (D) at least three (3) Business Days prior to furnishing any such
non-public information to such Person, such Party furnishes such non-public information to SCWorx or AMMA, as applicable (to the
extent such non-public information has not been previously furnished by such Party to SCWorx or AMMA, as applicable). Without limiting
the generality of the foregoing, each Party acknowledges and agrees that, in the event any Representative of such Party (whether
or not such Representative is purporting to act on behalf of such Party) takes any action that, if taken by such Party, would constitute
a breach of this Section 4.5 by such Party, the taking of such action by such Representative shall be deemed to constitute
a breach of this Section 4.5 by such Party for purposes of this Agreement.

 

    	 	52	 

     

    

 

(c)          If
any Party or any Representative of such Party receives an Acquisition Proposal or Acquisition Inquiry at any time during the Pre-Closing
Period, then such Party shall promptly (and in no event later than 24 hours after such Party becomes aware of such Acquisition
Proposal or Acquisition Inquiry) advise the other Party orally and in writing of such Acquisition Proposal or Acquisition Inquiry
(including the identity of the Person making or submitting such Acquisition Proposal or Acquisition Inquiry, and the terms thereof).
Such Party shall keep the other Party fully informed, on a current basis, in all material respects with respect to the status and
terms of any such Acquisition Proposal or Acquisition Inquiry and any modification or proposed modification thereto. In addition
to the foregoing, each Party shall provide the other Party with at least five (5) Business Days’ written notice of a meeting
of its board of directors (or any committee thereof) at which its board of directors (or any committee thereof) is reasonably expected
to consider an Acquisition Proposal or Acquisition Inquiry it has received.

 

(d)          Each
Party shall and shall cause its respective Representatives to, cease immediately and cause to be terminated, and shall not authorize
or knowingly permit any of its or their Representatives to continue, any and all existing activities, discussions or negotiations,
if any, with any third party conducted prior to the date hereof with respect to any Acquisition Proposal. The Parties shall promptly
(and in any event within three (3) Business Days following the date hereof) request in writing each Person which as heretofore
executed a confidentiality agreement in connection with its consideration of an Acquisition Proposal to return all confidential
information heretofore furnished to such Person by or on behalf of the respective Party, and such Party shall use commercially
reasonable efforts to have such information returned or destroyed (to the extent destruction of such information is permitted by
such confidentiality agreement).

 

ARTICLE 5ADDITIONAL
AGREEMENTS OF THE PARTIES

 

5.1           AMMA
Stockholders’ Meeting and Proxy Statement.

 

(a)          As
soon as reasonably practicable following the date of this Agreement AMMA shall (i) establish a record date for, duly call, give
notice of and, as soon as reasonably practicable thereafter in conformity with this Section 5.1, but in no event later than
the 75th Calendar Day after the date hereof, convene the AMMA Stockholders Meeting, and (ii) publish the notice of the AMMA Stockholders’
Meeting (the “AMMA Stockholders’ Meeting Notice”). In addition, AMMA shall prepare, with the cooperation
of SCWorx, and cause to be submitted to the SEC the Proxy Statement.

 

    	 	53	 

     

    

 

(b)          AMMA
covenants and agrees that the Proxy Statement will not, at the time that the Proxy Statement or any amendment or supplement
thereto is filed with or submitted to the SEC or is first mailed to the AMMA Stockholders, at the time of the AMMA Stockholders’
Meeting and at the Closing Date, contain any untrue statement of a material fact or omit to state any material fact required to
be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they
were made, not misleading. Notwithstanding the foregoing, AMMA makes no covenant, representation or warranty with respect to statements
made in the Proxy Statement (and the letter to shareholders, notice of meeting and form of proxy included therewith), if any,
based on information furnished in writing by SCWorx specifically for inclusion therein. Each of the Parties shall use commercially
reasonable efforts to cause the Proxy Statement to comply with the applicable rules and regulations promulgated by the SEC in all
material respects.

 

(c)          AMMA
shall notify SCWorx promptly of the receipt of any comments from the SEC or the staff of the SEC, if any, and of any request by
the SEC or the staff of the SEC, if any, for amendments or supplements to the Proxy Statement or for additional information and
shall supply SCWorx with copies of all correspondence between AMMA or any of its Representatives, on the one hand, and the SEC
or the staff of the SEC, on the other hand, with respect to the Proxy Statement or the Contemplated Transactions. AMMA shall use
its commercially reasonable efforts to respond as promptly as reasonably practicable to any comments of the SEC or the staff of
the SEC with respect to the Proxy Statement, and shall give SCWorx and its counsel a reasonable opportunity to participate in the
formulation of any response to any such comments of the SEC or its staff.

 

(d)          Each
of the Parties shall use commercially reasonable efforts to cause the Proxy Statement to comply with the applicable rules and regulations
promulgated by the SEC and the Companies Law, to respond promptly to any comments of the SEC or its staff. Each of the Parties
shall use commercially reasonable efforts to cause the Proxy Statement to be submitted to the SEC within forty (40) Business Days
of the date hereof and then, subject to compliance with Legal Requirements, mailed to the AMMA Stockholders. Each Party shall promptly
furnish to the other Party all information concerning such Party and such Party’s subsidiaries and such Party’s shareholders
that may be required or reasonably requested in connection with any action contemplated by this Section 5.1. If any event
relating to SCWorx occurs, or if SCWorx becomes aware of any information, that should be disclosed in an amendment or supplement
to the Proxy Statement, then SCWorx shall promptly inform AMMA thereof and shall cooperate fully with AMMA in filing such amendment
or supplement with the SEC and, if appropriate, in mailing such amendment or supplement to the shareholders of AMMA. No filing
of, or amendment or supplement to the Proxy Statement will be made by AMMA without providing SCWorx a reasonable opportunity to
review and comment thereon.

 

(e)          Prior
to the Closing Date, AMMA shall, subject to SCWorx undertaking in Section 5.18 below, use commercially reasonable efforts
to obtain all regulatory approvals needed to ensure that the AMMA Shares to be issued in the Exchange (to the extent required)
be exempt from registration or qualification under the Securities Act and every jurisdiction of the United States in which any
registered holder of SCWorx Capital Stock has an address of record on the Closing Date; provided, however, that AMMA shall not
be required: (i) to qualify to do business as a foreign corporation in any jurisdiction in which it is not now qualified; or (ii)
to file a general consent to service of process in any jurisdiction.

 

    	 	54	 

     

    

 

(f)          Each
of SCWorx and AMMA agree to provide promptly to the other such information concerning its business and financial statements and
affairs as, in the reasonable judgment of the providing party or its counsel, may be required or appropriate for inclusion in the
Proxy Statement, or in any amendments or supplements thereto, and to cause its counsel and auditors to cooperate with the other’s
counsel and auditors in the preparation of the Proxy Statement. AMMA shall not include in the Proxy Statement any information with
respect to SCWorx or its Affiliates, the form and content of which information shall not have been approved by SCWorx prior to
such inclusion.

 

5.2           [Reserved].

 

5.3           AMMA
Stockholders’ Meeting.

 

(a)          As
promptly as practicable after the date hereof, AMMA shall (i) take all action necessary under applicable Legal Requirements to
call, give notice of (pursuant to publication of the AMMA Stockholders’ Meeting Notice in accordance with Section 5.1
above) and hold a meeting of the holders of AMMA Shares for the purpose of seeking approval of the following items, (A) the amendment
of AMMA’s certificate of incorporation to increase the authorized AMMA Shares, (B) the amendment of AMMA’s certificate
of incorporation to effect the Reverse Split, (C) the amendment of AMMA’s certificate of incorporation to effect the name
change of AMMA, (D) to approve the purchase by AMMA of a “runoff” directors’ and officers’ liability insurance
policy for a period of seven years following the Closing, (E) the Contemplated Transactions, and (F) any other matter required,
at the reasonable discretion of the Board of Directors of AMMA and agreed to by SCWorx, in order to give effect to the transactions
contemplated by this Agreement (the matters contemplated by the foregoing clauses (A)–(F), collectively, the “AMMA
Stockholder Matters”) and (ii) mail to the AMMA Stockholders as of the record date established for shareholders’
meeting of AMMA, the Proxy Statement (such meeting, the “AMMA Stockholders’ Meeting”).

 

(b)          AMMA
agrees that, subject to Section 5.3(c): (i) the AMMA Board of Directors shall recommend that the holders of AMMA Shares
vote to approve the AMMA Stockholder Matters; (ii) the Proxy Statement shall include a statement to the effect that the AMMA Board
of Directors recommends that AMMA Stockholders vote to approve the AMMA Stockholder Matters (the “AMMA Board Recommendation”);
(iii) the AMMA Board of Directors shall use commercially reasonable efforts to solicit such approval within the timeframe set forth
in Section 5.1 above; and (iv) (A) the AMMA Board Recommendation shall not be withdrawn or modified in a manner adverse
to SCWorx, and no resolution by the AMMA Board of Directors or any committee thereof to withdraw or modify the AMMA Board Recommendation
in a manner adverse to SCWorx shall be adopted or proposed and (B) the AMMA Board of Directors shall not recommend any Acquisition
Transaction (collectively with any failure to make or include the recommendation as set forth in sub-sections (i) and (ii) above,
an “AMMA Board Adverse Recommendation Change”).

 

    	 	55	 

     

    

 

(c)          Notwithstanding
the foregoing, at any time prior to the receipt of the Required AMMA Stockholder Vote, the AMMA Board of Directors may make a AMMA
Board Adverse Recommendation Change, if the AMMA Board of Directors has received an Acquisition Proposal that the AMMA Board of
Directors has determined in its reasonable, good faith judgment, after consultation with AMMA’s outside legal counsel, constitutes
a Superior Offer, the AMMA Board of Directors determines in its good faith judgment, after consultation with AMMA’s outside
legal counsel, that a failure to make AMMA Board Adverse Recommendation Change would reasonably constitute a breach of its fiduciary
obligations under applicable Legal Requirements; provided, however, that prior to AMMA taking any action permitted under this Section
5.3(c), AMMA must (1) promptly notify SCWorx, in writing, at least five (5) Business Days before making a AMMA Board Adverse
Recommendation Change, of its intention to take such action with respect to a Superior Offer, which notice shall state expressly
that AMMA has received an Acquisition Proposal that the AMMA Board of Directors intends to declare a Superior Offer and that the
AMMA Board of Directors intends to make a AMMA Board Adverse Recommendation Change, and (2) attach to such notice the most current
version of the proposed agreement (which version shall be updated on a prompt basis) and the identity of the third party making
such Superior Offer.

 

(d)          Notwithstanding
Section 5.3(c), AMMA’s obligation to call, give notice of and hold the AMMA Stockholders’ Meeting in accordance
with Section 5.1 shall not be limited or otherwise affected by the commencement, disclosure, announcement or submission
of any Superior Offer or Acquisition Proposal, or by any withdrawal or modification of the AMMA Board Recommendation.

 

(e)          Nothing
contained in this Agreement shall prohibit AMMA or its Board of Directors from making any disclosure to the AMMA Stockholders if
the AMMA Board of Directors determines in good faith, after consultation with its outside legal counsel, that such disclosure is
required for the AMMA Board of Directors to comply with its fiduciary duties to the AMMA Stockholders under applicable Legal Requirements;
provided, however, that (i) in the case of any such disclosure or public statement shall be deemed to be a AMMA Board Adverse Recommendation
Change subject to the terms and conditions of this Agreement unless the AMMA Board of Directors reaffirms the AMMA Board Recommendation
in such disclosure or public statement or within five (5) Business Days of such disclosure or public statement; and (ii) AMMA shall
not effect a AMMA Board Adverse Recommendation Change unless specifically permitted pursuant to the terms of Section 5.3(c).

 

5.4           Regulatory
Approvals.

 

(a)          Each
Party shall use commercially reasonable efforts to take, or cause to be taken, all actions necessary to comply promptly with all
Legal Requirements that may be imposed on such Party with respect to the Contemplated Transactions and, subject to the conditions
set forth in Article 6 hereof, to consummate the Contemplated Transactions, as promptly as practicable. In furtherance and
not in limitation of the foregoing, each Party agrees to file or otherwise submit, as soon as practicable after the date of this
Agreement, but in any event no later than 20 Business Days of the date hereof, all applications, notices, reports, undertakings
and other documents reasonably required to be filed by such Party with or otherwise submitted by such Party to any Governmental
Body with respect to the Contemplated Transactions, and to submit promptly any additional information requested by any such Governmental
Body.

 

    	 	56	 

     

    

 

(b)          Each
of the Parties shall use its commercially reasonable efforts to (i) cooperate in all respects with each other in connection
with timely making all required filings and submissions and timely obtaining all related consents, permits, authorizations or approvals
pursuant to Section 5.4(a); and (ii) keep SCWorx or AMMA, as applicable, informed in all material respects and on a reasonably
timely basis of any communication received by such Party from, or given by such Party to, any Governmental Body relating to the
Contemplated Transactions. Subject to applicable Legal Requirements relating to the exchange of information, each Party shall,
to the extent practicable, give the other party reasonable advance notice of all material communications with any Governmental
Body relating to the Contemplated Transactions and each Party shall have the right to attend or participate in material conferences,
meetings and telephone or other communications between the other Parties and regulators concerning the Contemplated Transactions.

 

5.5           [Reserved.]

 

5.6           [Reserved.]

 

5.7           AMMA
Employee and Benefits Matters.

 

(a)          Unless
otherwise agreed in writing by SCWorx pursuant to a written notice provided to AMMA no later than three (3) calendar days prior
to the Closing Date, effective as of the Closing Date, and subject to any applicable law, AMMA shall, and shall cause any AMMA
Subsidiary to, terminate the employment and service of each AMMA Associate (the “Terminated AMMA Associates”)
other than those employees which SCWorx shall notify AMMA should not be terminated, such that neither AMMA nor any AMMA Subsidiary
shall have any AMMA Associate in its employ or service as of the Closing Date other than those employees which SCWorx has designated.
AMMA shall, and shall cause any of its Subsidiaries to, terminate the employment and service of each AMMA Associate in full compliance
with applicable laws, regulations, precedents and contractual agreements (including due process).

 

(b)          As
a condition to payment of any Terminated AMMA Associate Payment to a Terminated AMMA Associate and prior to the Closing Date, AMMA
will use commercially reasonable efforts to obtain from each Terminated AMMA Associate an effective release of claims subject to
applicable Law, the form of which shall be subject to approval by SCWorx, which approval shall not be unreasonably withheld, and
effective as of the Closing Date. Prior to the Closing, AMMA shall use commercially reasonable efforts to comply, in all material
respects, with all of the requirements of the WARN Act and any applicable state.

 

(c)          Schedule
6.7(c) sets forth, with respect to each Previously Terminated AMMA Associate (together, the “Former AMMA Associates”),
AMMA’s good faith estimate of the amount of all change of control payments, severance payments, termination or similar payments,
notice payments and/or obligations, retention payments, bonuses and other payments and benefits (including any COBRA costs), owed
to or to be paid or provided to each Former AMMA Associate, and the amount by which any of such Former AMMA Associate’s compensation
or benefits may be accelerated or increased, and any related Tax or contribution payable by AMMA, in each case, whether under any
AMMA Employee Plan or otherwise, as a result of (i) the execution of this Agreement, (ii) the consummation of the Contemplated
Transactions, or (iii) the termination of employment or service of such Former AMMA Associate at or at any time prior to the Closing
Date (together, the “Terminated AMMA Associate Payments”). To the extent required to be paid prior to the Closing,
AMMA shall cause all Terminated AMMA Associate Payments to be paid and satisfied in full such that AMMA, the Surviving Corporation,
SCWorx and any of their Affiliates shall not have any Tax or other Liability with respect to the Former AMMA Associates on or following
the Closing Date.

 

    	 	57	 

     

    

 

(d)          Effective
no later than the day immediately preceding the Closing Date, AMMA shall take all required action to terminate (i) all AMMA Employee
Plans that are “employee benefit plans” within the meaning of ERISA, including but not limited to any AMMA Employee
Plans intended to include a Code Section 401(k) arrangement (each, a “AMMA 401(k) Plan”), and (ii) each other
AMMA Employee Plan set forth on Schedule 6.7(d) attached hereto unless written notice is provided by SCWorx to AMMA no later
than three (3) calendar days prior to the Closing Date, instructing AMMA not to terminate any such AMMA Employee Plan. AMMA shall
provide SCWorx with evidence that such AMMA Employee Plan(s) have been terminated (or with respect to any health and welfare benefit
plan with a monthly coverage period that irrevocable action to terminate such AMMA Employee Plan(s) at the end of such monthly
period has been taken) effective no later than the day immediately preceding the Closing Date pursuant to resolutions of the AMMA
Board of Directors. The form and substance of such resolutions shall be subject to reasonable review and approval of SCWorx. AMMA
also shall take such other actions in furtherance of terminating such AMMA Employee Plan(s) as SCWorx may reasonably require. In
the event that termination of the AMMA Employee Plans would reasonably be anticipated to trigger liquidation charges, surrender
charges or other fees then AMMA shall take such actions as are necessary to reasonably estimate the amount of such charges and/or
fees and provide such estimate in writing to SCWorx no later than 14 calendar days prior to the Closing Date.

 

(e)          This
Section 5.7 shall be binding upon and inure solely to the benefit of each of the Parties to this Agreement. Nothing in this
Section 5.7, express or implied, will (i) constitute or be treated as an amendment of any AMMA Employee Plan or SCWorx Employee
Plan (or an undertaking to amend any such plan), (ii) prohibit AMMA, any AMMA Affiliate, SCWorx, or any SCWorx Affiliate from amending,
modifying or terminating any AMMA Employee Plan or SCWorx Employee Plan pursuant to, and in accordance with, the terms thereof,
or (iii) confer any rights or benefits on any Person other than AMMA and SCWorx.

 

5.8           Indemnification
of Officers and Directors.

 

(a)          From
the Closing Date through the seventh anniversary of the date on which the Closing Date occurs, AMMA shall indemnify and hold harmless
each person who is now, or has been at any time prior to the date hereof, or who becomes prior to the Closing Date, a director
or officer of AMMA (the “D&O Indemnified Parties”), against all claims, losses, liabilities, damages, judgments,
fines and reasonable fees, costs and expenses, including attorneys’ fees and disbursements, incurred in connection with any
claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of or pertaining
to the fact that the D&O Indemnified Party is or was a director or officer of AMMA, whether asserted or claimed prior to, at
or after the Closing Date, to the fullest extent permitted under the DGCL.

 

    	 	58	 

     

    

 

(b)          The
certificate of incorporation of AMMA shall contain provisions no less favorable with respect to indemnification, advancement of
expenses and exculpation of present and former directors and officers of each of AMMA than are presently set forth in the certificate
of incorporation of AMMA and the certificate of incorporation and bylaws of SCWorx, as applicable, which provisions shall not be
amended, modified or repealed for a period of seven years’ time from the Closing Date in a manner that would adversely affect
the rights thereunder of individuals who, at or prior to the Closing Date, were officers or directors of AMMA.

 

(c)          AMMA
shall purchase a “tail” insurance policy for AMMA’s officers and directors with an effective date as of the Closing
Date, which shall remain effective for seven years following the Closing Date, with at least the same coverage and amounts and
containing the same terms and conditions that are not less favorable to the AMMA officers and directors than the Existing AMMA
D&O Policies.

 

(d)          AMMA
shall pay all reasonable expenses, including reasonable attorneys’ fees, that may be incurred by the persons referred to
in this Section 5.8 in connection with their enforcement of their rights provided in this Section 5.8.

 

(e)          The
provisions of this Section 5.8 are intended to be in addition to the rights otherwise available to the D&O Indemnified
Parties by law, charter, statute, bylaw, certificate of incorporation or agreement. The obligations of AMMA under this Section
5.8 shall survive the consummation of the Exchange and shall not be terminated or modified in such a manner as to adversely
affect any D&O Indemnified Party to whom this Section 5.8 applies without the consent of such affected D&O Indemnified
Party (it being expressly agreed that the D&O Indemnified Parties to whom this Section 5.8 applies, as well as their
heirs and representatives, shall be third party beneficiaries of this Section 5.8, each of whom may enforce the provisions
of this Section 5.8).

 

(f)          In
the event AMMA or any of its successors or assigns (i) consolidates with or merges into any other Person and shall not be the continuing
or surviving corporation or Entity of such consolidation or Exchange, or (ii) transfers all or substantially all of its properties
and assets to any Person, then, and in each such case, proper provision shall be made so that the successors and assigns of AMMA
shall succeed to the obligations set forth in this Section 5.8.

 

5.9           Additional
Agreements. The Parties shall (a) use commercially reasonable efforts to cause to be taken all actions necessary to consummate
the Contemplated Transactions and (b) reasonably cooperate with the other Parties and provide the other Parties with such
assistance as may be reasonably requested for the purpose of facilitating the performance by each Party of its respective obligations
under this Agreement and to enable the Surviving Corporation to continue to meet its obligations under this Agreement following
the Closing. Without limiting the generality of the foregoing, each Party to this Agreement: (i) shall make all filings and other
submissions (if any) and give all notices (if any) required to be made and given by such Party in connection with the Contemplated
Transactions; (ii) shall use commercially reasonable efforts to lift any injunction prohibiting, or any other legal bar to, the
Contemplated Transactions; and (iii) shall use commercially reasonable efforts to satisfy the conditions precedent to the consummation
of this Agreement.

 

    	 	59	 

     

    

 

5.10         Disclosure.
Without limiting SCWorx’s or AMMA’s obligations under the Confidentiality Agreement, each Party shall not, and shall
not permit any of its Subsidiaries or any Representative of such Party to, issue any press release or make any disclosure (to any
customers or employees of such Party, to the public or otherwise) regarding the Contemplated Transactions unless: (a) the other
Party has approved such press release or disclosure in writing, such approval not to be unreasonably withheld, conditioned or delayed;
(b) such Party has determined in good faith, upon the advice of outside legal counsel, that such disclosure is required by applicable
Legal Requirements and, to the extent practicable, before such press release or disclosure is issued or made, such Party advises
the other Party of, and consults with the other Party regarding, the text of such press release or disclosure; (c) such press release
or disclosure is consistent with previous press releases, public disclosures or public statements made jointly by the Parties (or
individually, if approved by the other Party); or (d) such press release or disclosure is to be issued or made in accordance with
the provisions of Section 4.3(e).

 

5.11         Listing.
AMMA shall use its commercially reasonable efforts to: (a) maintain its existing listing on the NASDAQ Capital Market and to obtain
approval of the listing of the combined company on the NASDAQ Capital Market; and (b) effect the Reverse Split. Without derogating
from the generality of the requirements of the foregoing sentence, and to the extent required by the rules and regulations of NASDAQ,
AMMA shall use its commercially reasonable efforts to (i) prepare and submit a notification form for the listing of the AMMA Shares
to be issued in the Exchange, (ii) cause such shares to be approved for listing (subject to notice of issuance), and (iii)
to the extent required by NASDAQ Marketplace Rule 5110, file an initial listing for the AMMA Shares on the NASDAQ Capital Market
(the “Nasdaq Listing Application”) and cause such Nasdaq
Listing Application to be approved for listing (subject to official notice of issuance). SCWorx will cooperate with AMMA as reasonably
requested by AMMA with respect to the Nasdaq Listing Application and promptly furnish to AMMA all information concerning SCWorx
and the SCWorx Stockholders that may be required or reasonably requested in connection with any action contemplated by this Section
5.11.

 

5.12         Tax
Matters.

 

(a)          The
Parties acknowledge and agree that (i) in the Exchange, AMMA will acquire substantially all of the properties held directly or
indirectly by SCWorx within the meaning of Code Section 7874(a)(2)(B)(i) and after such acquisition, at least 80% of the stock
of AMMA will be held by the former stockholders of SCWorx by reason of holding stock in SCWorx, and (ii) the Exchange should qualify
as a “reorganization” under Code Section 368(a) (collectively, the “Tax Treatment”). The Parties
shall not take any tax reporting position inconsistent with the Tax Treatment for U.S. federal, state, local or other applicable
Tax purposes, unless otherwise required pursuant to a “determination” within the meaning of Section 1313(a) of the
Code.

 

    	 	60	 

     

    

 

(b)          AMMA
and SCWorx shall use their respective commercially reasonable efforts to cause the Exchange to qualify, and agree not to, and not
to permit or cause any Affiliate or any Subsidiary to, take any actions or cause any action to be taken which would reasonably
be expected to prevent the Exchange from qualifying, as a “reorganization” under Section 368(a) of the Code.

 

(c)          This
Agreement is intended to constitute, and the Parties hereby adopt this Agreement as, a “plan of reorganization” within
the meaning of Treasury Regulations Section 1.368-2(g). The Parties shall treat and shall not take any tax reporting position inconsistent
with the treatment of the Exchange as a “reorganization” within the meaning of Section 368(a) of the Code for U.S.
federal, state and other relevant Tax purposes, unless otherwise required pursuant to a “determination” within the
meaning of Section 1313(a) of the Code.

 

(d)          All
transfer, documentary, sales, use, stamp, registration and other such Taxes and fees (including any penalties and interest) incurred
in connection with the Exchange (collectively, “Transfer Taxes”) shall be paid when due by the party, without
deduction from any amount payable to the Shareholders, upon which such Taxes and fees are imposed under applicable Legal Requirements,
and such party will, at its own expense, file all necessary Tax Returns and other documentation with respect to all such Transfer
Taxes, and, if required by applicable Law, the applicable Stockholders and the Parties will, and will cause their applicable Affiliates
to, join in the execution of any such Tax Returns and other documentation; provided that any Transfer Taxes with respect to interests
in real property owned, directly or indirectly, by SCWorx or any of its Subsidiaries shall be borne by AMMA and expressly shall
not be a Liability of the Stockholders.

 

5.13         Legends.
AMMA shall be entitled to place appropriate legends on the book entries and/or certificates evidencing any AMMA Shares to be received
in the Exchange by the SCWorx Stockholders for purposes of Rules 144 and 145 under the Securities Act reflecting the restrictions
set forth in Rules 144 and 145 and to issue appropriate stop transfer instructions to the transfer agent for AMMA Shares.

 

5.14         Directors
and Officers. Immediately prior to the Closing Date, (i) AMMA shall cause such members of the AMMA Board of Directors as agreed
upon between AMMA and SCWorx to tender their resignation from the Board of Directors of AMMA effective immediately (such resigning
directors, the “AMMA Director Resignees”), (ii) the AMMA Board of Directors shall appoint that number of new
members selected by SCWorx to the AMMA Board of Directors, but in any event not fewer than three (the “SCWorx Designees”),
and (iii) the AMMA Board of Directors shall appoint each of the directors to the committees of the AMMA Board of Directors
as to be determined by SCWorx, provided that after (i), (ii) and (iii) above shall have taken place, the majority of the members
of AMMA’s Board of Directors and of each of the AMMA committees shall be designated by SCWorx and shall satisfy the requisite
independence requirements for the AMMA Board of Directors, as well as the sophistication, expertise and independence requirements
for the required committees of the AMMA Board of Directors, pursuant to NASDAQ’s listing standards. In addition, the AMMA
Board of Directors and AMMA Chief Executive Officer, as the case may be, shall take all necessary action to appoint each of the
individuals set forth on Schedule 6.14, and as may be selected by SCWorx prior to Closing, as officers of AMMA to hold
the offices set forth opposite his or her name to be effective at the Closing Date.

 

    	 	61	 

     

    

 

5.15         Takeover
Statutes. If any “control share acquisition”, “fair price”, “moratorium” or other anti-takeover
Legal Requirement becomes or is deemed to applicable to AMMA, SCWorx, or the Contemplated Transactions, then each of AMMA, SCWorx
and their respective board of directors shall grant such approvals and take such actions as are necessary so that the Contemplated
Transactions may be consummated as promptly as practicable on the terms contemplated hereby and otherwise act to render such anti-takeover
Legal Requirement inapplicable to the foregoing.

 

5.16         Validity
of Private Placement. SCWorx shall provide reasonable evidence to AMMA that the issuance of AMMA Shares in the Exchange shall
validly qualify for an exemption from the registration and prospectus delivery requirements of the Securities Act and the equivalent
state “blue-sky” laws.

 

5.17         Stockholder
Litigation. AMMA shall control any Legal Proceeding brought by AMMA Stockholders against AMMA and/or its directors relating
to the Contemplated Transactions (“Stockholder Litigation”); provided, that AMMA shall give SCWorx the right
to review and comment in advance on all material filings or responses to be made by AMMA in connection with any Stockholder Litigation,
the right to participate (at SCWorx’s expense) in such Stockholder Litigation, and the right to consult on the settlement
with respect to such Stockholder Litigation, and AMMA shall in good faith take such comments into account, and, no such settlement
shall be agreed to without SCWorx’s prior written consent, which consent shall not be unreasonably withheld, conditioned
or delayed. AMMA shall promptly notify SCWorx of any such Stockholder Litigation brought, or threatened, against AMMA and/or members
of AMMA Board of Directors and shall keep SCWorx informed on a current basis with respect to the status thereof.

 

ARTICLE 6CONDITIONS
PRECEDENT TO OBLIGATIONS OF EACH PARTY

 

The obligations of
each Party to effect the Exchange and otherwise consummate the transactions to be consummated at the Closing are subject to the
satisfaction or, to the extent permitted by applicable Legal Requirements, the written waiver by each of the Parties, at or prior
to the Closing, of each of the following conditions:

 

6.1           No
Restraints. No temporary restraining order, preliminary or permanent injunction or other order preventing the consummation
of the Exchange has been issued by any court of competent jurisdiction or other Governmental Body of competent jurisdiction and
remain in effect, and there shall not be any Legal Requirement which has the effect of making the consummation of the Exchange
illegal.

 

6.2           Stockholder
Approval. (a) SCWorx has obtained the Required SCWorx Stockholder Vote, and (b) AMMA has obtained the Required AMMA Stockholder
Vote.

 

    	 	62	 

     

    

 

6.3           Listing.
(a) The existing AMMA Shares shall have been continually listed on the NASDAQ Capital Market or be listed on the NASDAQ Capital
Market as of and from the date of this Agreement through the Closing Date, (b) the AMMA Shares to be issued in the Exchange shall
be approved for listing (subject to official notice of issuance) on the NASDAQ Capital Market as of the Closing Date, and (c) to
the extent required by NASDAQ Marketplace Rule 5110, the Nasdaq Listing Application
shall have been approved for listing (subject to official notice of issuance).

 

6.4           No
Governmental Proceedings Relating to Contemplated Transactions or Right to Operate Business. There shall not be any Legal Proceeding
pending, or overtly threatened in writing by an official of a Governmental Body in which such Governmental Body indicates that
it intends to conduct any Legal Proceeding or taking any other action: (a) challenging or seeking to restrain or prohibit the consummation
of the Exchange; (b) relating to the Exchange and seeking to obtain from AMMA or SCWorx any damages or other relief that may be
material to AMMA or SCWorx; (c) seeking to prohibit or limit in any material and adverse respect a Party’s ability to vote,
transfer, receive dividends with respect to or otherwise exercise ownership rights with respect to the stock of AMMA; (d) that
would materially and adversely affect the right or ability of AMMA or SCWorx to own the assets or operate the business of AMMA
or SCWorx; or (e) seeking to compel SCWorx, AMMA or any AMMA Subsidiary to dispose of or hold separate any material assets as a
result of the Exchange.

 

ARTICLE 7ADDITIONAL
CONDITIONS PRECEDENT TO OBLIGATIONS OF AMMA

 

The obligations of
AMMA to effect the Exchange and otherwise consummate the transactions to be consummated at the Closing are subject to the satisfaction
or the written waiver by AMMA, at or prior to the Closing, of each of the following conditions:

 

7.1           Accuracy
of Representations. (a) The representations and warranties of SCWorx in Section 2.4(a), Section 2.4(b), and Section
2.4(c) (Capitalization), are true and correct in all but de minimis respects as of the date of this Agreement and are true
and correct in all but de minimis respects on and as of the Closing Date with the same force and effect as if made on the Closing
Date, except for those representations and warranties which address matters only as of a particular date (which representations
were so true and correct as of such particular date); (b) the representations and warranties of SCWorx set forth in clause “(b)”
of the first sentence of Section 2.6 (Absence of Changes) shall have been true and correct in all respects as of the date
of the Agreement and shall be true and correct in all respects at and as of the Closing Date as if made on and as of such time
(it being understood that any update of or modification to the SCWorx Disclosure Schedule made or purported to have been made after
the date of the Agreement shall be disregarded); (c) the representations and warranties of SCWorx set forth in Section 2.13(n)
and of AMMA set forth in Section 3.14(n) shall have been true and correct in all respects as of the date of the Agreement
and shall be true and correct in all respects at and as of the Closing Date as if made on and as of such time; and (d) all other
representations and warranties of SCWorx in Article 2 of this Agreement are true and correct as of the date of this Agreement
and are true and correct on and as of the Closing Date with the same force and effect as if made on the Closing Date except (i)
in each case, or in the aggregate, where the failure to be true and correct would not have a SCWorx Material Adverse Effect (provided
that all “SCWorx Material Adverse Effect” qualifications and other materiality qualifications limiting the scope of
the representations and warranties of SCWorx in Article 2 of this Agreement will be disregarded), or (ii) for those representations
and warranties which address matters only as of a particular date (which representations were so true and correct, subject to the
qualifications as set forth in the preceding clause (i), as of such particular date).

 

    	 	63	 

     

    

 

7.2           Performance
of Covenants. Each of the covenants and obligations in this Agreement that SCWorx is required to comply with or to perform
at or prior to the Closing have been complied with and performed by SCWorx in all material respects.

 

7.3           No
SCWorx Material Adverse Effect. Since the date of this Agreement, there has not occurred any SCWorx Material Adverse Effect
that is continuing.

 

7.4           Documents.

 

(a)          AMMA
shall have received from SCWorx a certificate executed by the Chief Executive Officer and Chief Financial Officer of SCWorx confirming
that the conditions set forth in Sections 7.1, 7.2, 7.3 and ‎7.4
have been duly satisfied.

 

(b)          (i)
certificates of good standing of SCWorx in its jurisdiction of organization (to the extent applicable) and the various foreign
jurisdictions in which each is qualified to do business, (ii) certified copies of the certificate of incorporation and bylaws of
SCWorx, (iii) a certificate as to the incumbency of the Chief Executive Officer and Chief Financial Officer of each of SCWorx,
and (iv) the adoption of resolutions of the SCWorx Board of Directors authorizing the execution of this Agreement and the consummation
of the Contemplated Transactions to be performed by SCWorx hereunder; and

 

7.5           Fairness
Opinion. AMMA shall have received an opinion of Cassel Salpeter & Co., LLC, financial advisor to AMMA, to the effect that
the consideration to be issued by AMMA to the SCWorx Stockholders in the Exchange is fair to AMMA from a financial point of view,
pursuant to Section 3.24.

 

7.6           SCWorx
Allocation Certificate. AMMA shall have received from SCWorx the Allocation Certificate.

 

7.7           Lock-up
Agreements. The Lock-up Agreements executed by the SCWorx Lock-Up Signatories will continue to be in full force and effect
as of immediately following the Closing Date.

 

7.8            Audited Financial Statements of SCWorx.
The SCWorx Audited Financials shall be in form and substance reasonably satisfactory to AMMA, including without limitation they
shall not vary materially from the unaudited versions thereof delivered to AMMA on or about August 13, 2018.

 

    	 	64	 

     

    

 

ARTICLE 8ADDITIONAL
CONDITIONS PRECEDENT TO OBLIGATIONS OF SCWORX

 

The obligations of
SCWorx to effect the Exchange and otherwise consummate the transactions to be consummated at the Closing are subject to the satisfaction
or the written waiver by SCWorx, at or prior to the Closing, of each of the following conditions:

 

8.1           Accuracy
of Representations. (a) The representations and warranties of AMMA in Section 3.4(a), Section 3.4(b), Section
3.4(c) and Section 3.4(e) (Capitalization), are true and correct in all but de minimis respects as of the date of this
Agreement and are true and correct in all but de minimis respects on and as of the Closing Date with the same force and effect
as if made on the Closing Date, except for those representations and warranties which address matters only as of a particular date
(which representations were so true and correct as of such particular date); (b) the representations and warranties of AMMA set
forth in clause “(b)” of the first sentence of Section 3.6 (Absence of Changes) shall have been true and correct
in all respects as of the date of the Agreement and shall be true and correct in all respects at and as of the Closing Date as
if made on and as of such time (it being understood that any update of or modification to the AMMA Disclosure Schedule made or
purported to have been made after the date of the Agreement shall be disregarded); (c) the representations and warranties
of SCWorx set forth in Section 2.13(n) and of AMMA set forth in Section 3.14(n) shall have been true and correct
in all respects as of the date of the Agreement and shall be true and correct in all respects at and as of the Closing Date as
if made on and as of such time; and (d) all other representations and warranties of AMMA in Article 3 of this Agreement
are true and correct as of the date of this Agreement and are true and correct on and as of the Closing Date with the same force
and effect as if made on the Closing Date except (i) in each case, or in the aggregate, where the failure to be true and correct
would not have a AMMA Material Adverse Effect (provided that all “AMMA Material Adverse Effect” qualifications and
other materiality qualifications limiting the scope of the representations and warranties of AMMA in Article 3 of this Agreement
will be disregarded), or (ii) for those representations and warranties which address matters only as of a particular date
(which representations were so true and correct, subject to the qualifications as set forth in the preceding clause (i), as of
such particular date).

 

8.2           Performance
of Covenants. Each of the covenants and obligations in this Agreement that AMMA is required to comply with or to perform at
or prior to the Closing have been complied with and performed in all material respects.

 

8.3           No
AMMA Material Adverse Effect. Since the date of this Agreement, there has not occurred any AMMA Material Adverse Effect that
is continuing.

 

8.4           Termination
of Contracts. SCWorx has received evidence, in form and substance satisfactory to it, that all AMMA Contracts (other than the
AMMA Contracts listed on Schedule 8.4) have been (a) terminated, assigned, or fully performed by AMMA and (b) all obligations
of AMMA thereunder have been fully satisfied, waived or otherwise discharged.

 

8.5           Board
of Directors and Officers. AMMA has caused the AMMA Board of Directors and the officers of AMMA, to be constituted as set forth
in Section 5.14 of this Agreement effective as of the Closing Date.

 

    	 	65	 

     

    

 

8.6           Sarbanes-Oxley
Certifications. Neither the principal executive officer nor the principal financial officer of AMMA has failed to provide,
with respect to any AMMA SEC Document filed (or required to be filed) with the SEC on or after the date of this Agreement, any
necessary certification in the form required under Rule 13a-14 under the Exchange Act and 18 U. S.C. Section 1350.

 

8.7           Satisfaction
of Liabilities. AMMA has satisfied all of its Liabilities with respect to the matters listed on Schedule 8.7 as of the
Closing Date and SCWorx has received payoff letters or other proof of payment evidencing the satisfaction of such Liabilities and
release of any related to such Liabilities, in form and substance satisfactory to SCWorx.

 

8.8           Amendments
to Certificate of Incorporation. AMMA has provided a copy of the amendments to AMMA’s certificate of incorporation effecting
the Reverse Split and increase in the number of authorized AMMA Shares certified by its Chief Executive Officer.

 

8.9           Reserved.

 

8.10         Documents.
SCWorx has received the following documents, each of which shall be in full force and effect as of the Closing Date:

 

(a)          a
certificate executed by the Chief Executive Officer and Chief Financial Officer confirming that the conditions set forth in Sections
8.1, 8.2, 8.3, 8.4, 8.5, 8.6, and 8.7, have been duly satisfied;

 

(b)          (i)
certificates of good standing of AMMA in its jurisdiction of organization (to the extent applicable) and the various foreign jurisdictions
in which each is qualified to do business, (ii) certified copies of the certificate of incorporation and bylaws of AMMA, (iii)
a certificate as to the incumbency of the Chief Executive Officer and Chief Financial Officer of each of AMMA, and (iv) the adoption
of resolutions of the AMMA Board of Directors authorizing the execution of this Agreement and the consummation of the Contemplated
Transactions to be performed by AMMA hereunder; and

 

(c)          resignations
and/or separation and general release agreements in forms satisfactory to SCWorx, dated as of the Closing Date and effective as
of the Closing executed by all officers and directors of AMMA who are not to continue as officers or directors of AMMA pursuant
to Section 5.14 hereof.

 

8.11         SCWorx
Designees. The AMMA Director Resignees shall have resigned from the AMMA Board of Directors and the SCWorx Designees shall
have been appointed to the AMMA Board of Directors to serve until the balance of the term of the AMMA Director Resignees.

 

8.12         Fairness
Opinion. AMMA shall have provided SCWorx with an opinion of Cassel Salpeter & Co., LLC, financial advisor to AMMA, to the
effect that the consideration to be issued by AMMA to the SCWorx Stockholders in the Exchange is fair to AMMA from a financial
point of view, pursuant to Section 3.24.

 

    	 	66	 

     

    

 

ARTICLE 9TERMINATION

 

9.1           Termination.
This Agreement may be terminated prior to the Closing Date (whether before or after adoption of this Agreement by the SCWorx Stockholders
or whether before or after approval of the AMMA Stockholder Matters by the AMMA Stockholders, as applicable, unless otherwise specified
below):

 

(a)          by
mutual written consent duly authorized by the Boards of Directors of AMMA and SCWorx;

 

(b)          by
either AMMA or SCWorx if the Exchange shall not have been consummated by December 3, 2018 (the “Outside Date”);
provided that if the AMMA Shares do not qualify for an exemption from the registration and prospectus delivery requirements of
the Securities Act, the equivalent state “blue-sky” laws, the Outside Date shall be extended by two (2) months; and
provided, further, that the right to terminate this Agreement under this Section 9.1(b) shall not be available to SCWorx,
on the one hand, or to AMMA, on the other hand, if such Party’s action or failure to act has been a principal cause of the
failure of the Exchange to occur on or before the Outside Date and such action or failure to act constitutes a breach of this Agreement;

 

(c)          by
either AMMA or SCWorx if a court of competent jurisdiction or other Governmental Body has issued a final and nonappealable order,
decree or ruling, or has taken any other action, having the effect of permanently restraining, enjoining or otherwise prohibiting
the Exchange;

 

(d)          by
AMMA if the Required SCWorx Stockholder Vote shall not have been obtained by the Outside Date; provided, however, that once the
Required SCWorx Stockholder Vote has been obtained, AMMA may not terminate this Agreement pursuant to this Section 9.1(d);

 

(e)          by
either AMMA or SCWorx if (i) the AMMA Stockholders’ Meeting (including any adjournments and postponements thereof) has been
held and completed and the AMMA Stockholders have taken a final vote on the AMMA Stockholder Matters and (ii) the AMMA Stockholder
Matters have not been approved at the AMMA Stockholders’ Meeting (or any adjournment or postponement thereof) by the Required
AMMA Stockholder Vote; provided, however, that the right to terminate this Agreement under this Section 9.1(e) shall not
be available to AMMA where the failure to obtain the Required AMMA Stockholder Vote has been caused by the action or failure to
act of AMMA and such action or failure to act constitutes a material breach by AMMA of this Agreement;

 

(f)          by
SCWorx (at any time prior to obtaining the Required AMMA Stockholder Vote) if any of the following events have occurred: (i) AMMA
failed to include the AMMA Board Recommendation in the Proxy Statement; (ii) the AMMA Board of Directors have approved, endorsed
or recommended any Acquisition Proposal; (iii) AMMA has failed to hold the AMMA Stockholders’ Meeting within 60 calendar
days of the mailing of the Proxy Statement (other than to the extent that the Proxy Statement is subject to any stop order or proceeding
(or threatened proceeding by the SEC) seeking a delay with respect to the Proxy Statement, in which case such 60-calendar day period
shall be tolled for the earlier of thirty (30) calendar days or so long as such SEC mandated delay remains in effect or such proceeding
or threatened proceeding remains pending); (iv) AMMA has entered into any Acquisition Agreement (other than a confidentiality agreement
permitted pursuant to Section 4.5); or (v) AMMA or any of its Representatives has willfully and intentionally breached the
provisions set forth in Section 4.5;

 

    	 	67	 

     

    

 

(g)          by
AMMA (at any time prior to the approval of the Exchange by the Required SCWorx Stockholder Vote) if any of the following events
have occurred: (i) the SCWorx Board of Directors (i) failed to provide the SCWorx Board Recommendation to the SCWorx Stockholders;
(ii) the SCWorx Board of Directors have approved, endorsed or recommended any Acquisition Proposal; (iii) SCWorx has entered into
any Acquisition Agreement (other than a confidentiality agreement permitted pursuant to Section 4.5); or (iv) SCWorx or
any of its Representatives has willfully and intentionally breached the provisions set forth in Section 4.5 of the Agreement;

 

(h)          by
SCWorx, upon a breach of any representation, warranty, covenant or agreement on the part of AMMA set forth in this Agreement, or
if any representation or warranty of AMMA has become inaccurate, in either case such that the conditions set forth in Section
8.1 or Section 8.2 would not be satisfied; provided, however, that if such inaccuracy in AMMA’s representations
and warranties or breach by AMMA is curable by AMMA, then this Agreement shall not terminate pursuant to this Section 9.1(h)
as a result of such particular breach or inaccuracy unless such breach remains uncured 15 calendar days following the date of written
notice from SCWorx to AMMA of such breach or inaccuracy and its intention to terminate pursuant to this Section 9.1(h);
provided further, however, that no termination may be made pursuant to this Section 9.1(h) solely as a result of the failure
to obtain the Required AMMA Stockholder Vote (in which case, termination must be made pursuant to Section 8.1(e));

 

(i)          by
AMMA, upon a breach of any representation, warranty, covenant or agreement on the part of SCWorx set forth in this Agreement, or
if any representation or warranty of SCWorx has become inaccurate, in either case such that the conditions set forth in Section
7.1 or Section 7.2 would not be satisfied; provided, however, that if such inaccuracy in SCWorx’s representations
and warranties or breach by SCWorx is curable by SCWorx, then this Agreement shall not terminate pursuant to this Section 9.1(i)
as a result of such particular breach or inaccuracy unless such breach remains uncured 15 calendar days following the date of written
notice from AMMA to SCWorx of such breach or inaccuracy and its intention to terminate pursuant to this Section 9.1(i);
provided further, however, that no termination may be made pursuant to this Section 9.1(i) solely as a result of the failure
to obtain the Required SCWorx Stockholder Vote (in which case, termination must be made pursuant to Section 9.1(d);

 

The Party desiring to terminate this Agreement
pursuant to this Section 9.1 (other than pursuant to Section 9.1(a)) shall give a notice of such termination to the
other Party specifying the provisions hereof pursuant to which such termination is made and the basis therefor described in reasonable
detail.

 

    	 	68	 

     

    

 

9.2           Effect
of Termination. In the event of the termination of this Agreement as provided in Section 9.1, this Agreement shall be
of no further force or effect; provided, however, that (i) this Section 9.2, Section 9.3, and Article 10 shall
survive the termination of this Agreement and shall remain in full force and effect, and (ii) the termination of this Agreement
shall not relieve any Party for its fraud or from any liability for any willful and material breach of any representation, warranty,
covenant, obligation or other provision contained in this Agreement.

 

9.3           Expenses;
Termination Fees.

 

(a)          Except
as set forth in this Section 9.3, all fees and expenses incurred in connection with this Agreement and the Contemplated
Transactions shall be paid by the Party incurring such expenses, whether or not the Exchange is consummated; provided, further,
that AMMA shall pay for all fees and expenses incurred by engagement of any Exchange Agent and in relation to the printing (e.g.,
paid to a financial printer) and filing with the SEC of the Proxy Statement (including any financial statements and exhibits) and
any amendments or supplements thereto.

 

(i)          If
this Agreement is terminated by AMMA or SCWorx pursuant to Section 9.1(f) and, at any time before the AMMA Stockholders’
Meeting, an Acquisition Proposal with respect to AMMA has been publicly announced, disclosed or otherwise communicated to the AMMA
Board of Directors, then AMMA shall pay to SCWorx, within 10 Business Days after termination, a nonrefundable fee in an amount
equal to $75,000 (the “SCWorx Termination Fee”), which such SCWorx Termination Fee shall be payable in cash,
in addition to any amount payable to SCWorx pursuant to Section 9.3(b) or Section 9.3(c).

 

(ii)         If
(A) this Agreement is terminated by AMMA pursuant to Section 9.1(d) or Section 9.1(g), (B) at any time before obtaining
the Required SCWorx Stockholder Vote an Acquisition Proposal with respect to SCWorx has been publicly announced, disclosed or otherwise
communicated to the SCWorx Board of Directors, and (C) in the event this Agreement is terminated pursuant Section 9.1(d),
within 12 months after the date of such termination, SCWorx enters into a definitive agreement with respect to a Subsequent Transaction
or consummates a Subsequent Transaction, then SCWorx shall pay to AMMA, within 10 Business Days after termination (or, if applicable,
upon the earlier of such entry into a definitive agreement with respect to a Subsequent Transaction or consummation of a Subsequent
Transaction), a nonrefundable fee in an amount equal to $75,000 (the “AMMA Termination Fee”), which such AMMA
Termination Fee may be payable in cash, in addition to any amount payable to AMMA pursuant to Section 9.3(c) or Section
9.3(d).

 

    	 	69	 

     

    

 

(b)          (i)
If this Agreement is terminated by SCWorx pursuant to Section 9.1( f) or Section 9.1(h), or (ii) in the event of
a failure of SCWorx to consummate the transactions to be consummated at the Closing solely as a result of a AMMA Material Adverse
Effect as set forth in Section 8.3 (provided, that at such time all of the other conditions precedent to AMMA’s obligation
to close set forth in Article 6 and Article 7 of this Agreement have been satisfied by SCWorx, are capable of being
satisfied by SCWorx or have been waived by AMMA), then AMMA shall reimburse SCWorx for all reasonable fees and expenses incurred
by SCWorx in connection with this Agreement and the transactions contemplated hereby, including: (A) all fees and expenses incurred
in connection with the preparation, printing and filing, as applicable, of the Proxy Statement (including any preliminary materials
related thereto and all amendments and supplements thereto, as well as any financial statements and schedules thereto), excluding
legal fees and expenses; and (B) all fees and expenses incurred in connection with the preparation and filing under any filing
requirement of any Governmental Body applicable to this Agreement and the transactions contemplated hereby; provided, however,
the fees and expenses for clauses (A) and (B) above (collectively referred to as the “Third-Party Expenses”)
shall be capped at a maximum of $50,000 for such Third-Party Expenses; plus (C) reimbursement of all fees and expenses
of SCWorx’s legal counsel in connection with preparation of the Proxy Statement (“Proxy Statement Expenses”).
Such payment shall be made by wire transfer of same-day funds within 10 Business Days following the date on which SCWorx submits
to AMMA true and correct copies of reasonable documentation supporting such Third-Party Expenses and Proxy Statement Expenses.

 

(c)          (i)
If this Agreement is terminated by AMMA pursuant to Section 9.1(d), Section 9.1(g), or Section 9.1(i), or
(ii) in the event of a failure of AMMA to consummate the transactions to be consummated at the Closing solely as a result of a
SCWorx Material Adverse Effect as set forth in Section 7.3 (provided, that at such time all of the other conditions precedent
to SCWorx’s obligation to close set forth in Article 6 and Article 8 of this Agreement have been satisfied
by AMMA, are capable of being satisfied by AMMA or have been waived by SCWorx), then SCWorx shall reimburse AMMA for all Third-Party
Expenses incurred by AMMA up to a maximum of $50,000, plus reimbursement of all fees and expenses of AMMA’s legal
counsel in connection with preparation of the Proxy Statement by wire transfer of same-day funds within 10 Business Days following
the date on which AMMA submits to SCWorx true and correct copies of reasonable documentation supporting such Third-Party Expenses
and Proxy Statement Expenses.

 

(d)          If
either Party fails to pay when due any amount payable by such Party under Section 9.3(b), Section 9.3(c), or Section
9.3(d), then (i) such Party shall reimburse the other Party for reasonable costs and expenses (including reasonable fees and
disbursements of counsel) incurred in connection with the collection of such overdue amount and the enforcement by the other Party
of its rights under this Section 8.3, and (ii) such Party shall pay to the other Party interest on such overdue amount (for
the period commencing as of the date such overdue amount was originally required to be paid and ending on the date such overdue
amount is actually paid to the other Party in full) at a rate per annum equal to the “prime rate” (as (as published
in the Wall Street Journal)) in effect on the date such overdue amount was originally required to be paid.

 

    	 	70	 

     

    

 

(e)          The
Parties agree that the payment of the fees and expenses set forth in this Section 9.3, subject to Section 9.2, shall
be the sole and exclusive remedy of each Party following a termination of this Agreement under the circumstances described in this
Section 9.3, it being understood that in no event shall either AMMA or SCWorx be required to pay fees or damages payable
pursuant to this Section 9.3 on more than one occasion. Subject to Section 9.2, the payment of the fees and expenses
set forth in this Section 9.3, and the provisions of Section 10.10, each of the Parties and their respective Affiliates
will not have any liability, will not be entitled to bring or maintain any other claim, action or proceeding against the other,
shall be precluded from any other remedy against the other, at law or in equity or otherwise, and shall not seek to obtain any
recovery, judgment or damages of any kind against the other (or any partner, member, shareholder, director, officer, employee,
Subsidiary, Affiliate, agent or other Representative of such Party) in connection with or arising out of the termination of this
Agreement, any breach by any Party giving rise to such termination or the failure of the Contemplated Transactions to be consummated.
Each of the Parties acknowledges that (i) the agreements contained in this Section 9.3, are an integral part of the Contemplated
Transactions, (ii) without these agreements, the Parties would not enter into this Agreement and (iii) any amount payable pursuant
to this Section 9.3, is not a penalty, but rather is liquidated damages in a reasonable amount that will compensate the
Parties in the circumstances in which such amount is payable.

 

ARTICLE 10MISCELLANEOUS
PROVISIONS

 

10.1         SCWorx
Indemnification.

 

(a)          Survival.
All representations and warranties of SCWorx contained in this Agreement shall survive the Closing Date and will remain operative
and in full force and effect for twelve (12) months following the Closing Date. Subject to the limitations set forth in this Section
10.1, from and after the Closing, the SCWorx Stockholders listed on Appendix B (the “Majority SCWorx Stockholders”),
on a joint and several basis, agree to indemnify and hold harmless AMMA, its officers, directors, members, managers, employees,
subsidiaries and affiliates (each, an “AMMA Indemnified Party”) from and against any and all claims, damages,
losses, actions, suits, proceedings, demands, assessments, adjustments, payments, costs and expenses including, without limitation,
reasonable legal fees (collectively, “Losses”) related to or arising out of any breach by SCWorx of any representation
or warranty given or made by SCWorx in this Agreement or any other document executed by it pursuant hereto any and all actions,
suits, claims or legal, administrative, arbitrative, governmental or other proceedings or investigations against any AMMA Indemnified
Party arising out of such breach. Any Losses payable hereunder by the Majority SCWorx Stockholders shall, at the option of the
Majority SCWorx Stockholders, be paid exclusively in such number of shares of AMMA Common Stock equal to the quotient of (i) the
amount of Losses divided by (ii) the closing price of AMMA Shares used for the calculation of the Exchange Ratio (per Exhibit
B).

 

(b)          Limitations.
Except for claims for Losses based on fraud, no claim for indemnification of an AMMA Indemnified Party under Section 10.1(a)
may be made by an AMMA Indemnified Party against the Majority SCWorx Stockholders unless and until the aggregate of all such claims
exceeds a threshold of $50,000, after which the AMMA Indemnified Party may only recover its Losses represented by such claims in
excess of such threshold. The maximum aggregate liability of the Majority SCWorx Stockholders to the AMMA Indemnified Parties hereunder
shall not exceed $1,000,000. For the sole purpose of determining the amount of any claims under this Section 10.1 (and not
for determining whether or not any breaches of representations or warranties have occurred), any representation or warranty of
SCWorx shall not be deemed qualified by any references to any materiality, Material Adverse Effect or other similar qualification
contained in or otherwise applicable to such representation or warranty.

 

    	 	71	 

     

    

 

10.2         Non-Survival
of Representations and Warranties. Except as provided in Section 10.1, the representations and warranties of SCWorx,
AMMA and the SCWorx Stockholders contained in this Agreement or any certificate or instrument delivered pursuant to this Agreement
shall terminate at the Closing Date, and only the covenants that by their terms survive the Closing Date and this Section 10.2
shall survive the Closing Date.

 

10.3         Amendment.
This Agreement may be amended with the approval of the respective Boards of Directors of SCWorx and AMMA at any time (whether before
or after obtaining the Required AMMA Stockholder Vote or the Required SCWorx Stockholder Vote); provided, however, that after any
such adoption and approval of this Agreement by a Party’s shareholders, no amendment shall be made, which by applicable Legal
Requirement requires further approval of the shareholders of such Party, without the further approval of such shareholders. This
Agreement may not be amended except by an instrument in writing signed on behalf of each of SCWorx and AMMA.

 

10.4         Waiver.

 

(a)          No
failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part
of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power,
right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any
other or further exercise thereof or of any other power, right, privilege or remedy.

 

(b)          No
Party shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this
Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly
executed and delivered on behalf of such Party; and any such waiver shall not be applicable or have any effect except in the specific
instance in which it is given.

 

10.5         Entire
Agreement; Counterparts; Exchanges by Facsimile. This Agreement and the other agreements referred to in this Agreement constitute
the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the
Parties with respect to the subject matter hereof and thereof. This Agreement may be executed in several counterparts, each of
which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed
Agreement (in counterparts or otherwise) by all Parties by facsimile or electronic transmission in PDF format shall be sufficient
to bind the Parties to the terms and conditions of this Agreement.

 

10.6         Applicable
Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware,
regardless of the laws that might otherwise govern under applicable principles of conflicts of laws. In any action or suit between
any of the Parties arising out of or relating to this Agreement or any of the Contemplated Transactions: (a) each of the Parties
irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the state and federal courts located
in the State of Delaware; (b) if any such action or suit is commenced in a state court, then, subject to applicable Legal Requirements,
no Party shall object to the removal of such action or suit to any federal court located in the District of Delaware; and (c) each
of the Parties irrevocably waives the right to trial by jury.

 

    	 	72	 

     

    

 

10.7         Attorneys’
Fees. In any action at law or suit in equity to enforce this Agreement or the rights of any of the Parties under this Agreement,
the prevailing Party in such action or suit shall be entitled to receive a reasonable sum for its attorneys’ fees and all
other reasonable costs and expenses incurred in such action or suit.

 

10.8         Assignability;
No Third Party Beneficiaries. This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit
of, the Parties and their respective successors and assigns; provided, however, that neither this Agreement nor any of a Party’s
rights or obligations hereunder may be assigned or delegated by such Party without the prior written consent of each other Party,
and any attempted assignment or delegation of this Agreement or any of such rights or obligations by such Party without each other
Party’s prior written consent shall be void and of no effect. Nothing in this Agreement, express or implied, is intended
to or shall confer upon any Person (other than (a) the Parties and (b) the D&O Indemnified Parties to the extent of their respective
rights pursuant to Section 5.8) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.

 

10.9         Notices.
Any notice or other communication required or permitted to be delivered to any Party under this Agreement shall be in writing and
shall be deemed properly delivered, given and received when delivered by hand, by registered mail, by courier or express delivery
service, electronic mail, or by facsimile to the address, electronic mail address, or facsimile telephone number set forth beneath
the name of such Party below (or to such other address, electronic mail address, or facsimile telephone number as such Party has
specified in a written notice given to the other Parties):

 

if to AMMA:

 

Alliance MMA, Inc.

590 Madison Ave.

New York, NY 10022

with a copy to:

 

The Nossiff Law firm,
LLP300 Brickstone sq., Suite 201

Andover, MA 01810

Attention: John G.
Nossiff, Esq.

Email: jnossiff@nossiff-law.com

 

if to SCWorx or the
SCWorx Stockholders:

 

SCWorx Corp.

980 N. Federal Highway, Suite 304

Boca Raton, FL 33432

 

    	 	73	 

     

    

 

with a copy to:

 

Zysman, Aharoni,
Gayer and Sullivan & Worcester LLP

1633 Broadway

New York,
NY 10019

Facsimile No.: (212) 660-3001

Attention: Oded Har Even, Esq.

E-Mail: ohareven@zag-sw.com

10.10         Severability.
Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect
the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the
offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction
declares that any term or provision of this Agreement is invalid or unenforceable, the Parties agree that the court making such
determination will have the power to limit such term or provision, to delete specific words or phrases or to replace such term
or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid
or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does
not exercise the power granted to it in the prior sentence, the Parties agree to replace such invalid or unenforceable term or
provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and
other purposes of such invalid or unenforceable term or provision.

 

10.11         Other
Remedies; Specific Performance. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a
Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party,
and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. The Parties agree that irreparable
damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific
terms or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to an injunction or injunctions to
prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any court of the United States
or any state having jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity, and
each of the Parties waives any bond, surety or other security that might be required of any other Party with respect thereto.

 

10.12         Construction.

 

(a)          For
purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine
gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the
neuter gender shall include masculine and feminine genders.

 

(b)          The
Parties agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting Party shall
not be applied in the construction or interpretation of this Agreement.

 

    	 	74	 

     

    

 

(c)          As
used in this Agreement, the words “include” and “including,” and variations thereof, shall not be deemed
to be terms of limitation, but rather shall be deemed to be followed by the words “without limitation.”

 

(d)          Except
as otherwise indicated, all references in this Agreement to “Sections,” “Articles,” “Exhibits”
and “Schedules” are intended to refer to Sections or Articles of this Agreement and Exhibits and Schedules to this
Agreement, respectively.

 

(e)          The
bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this
Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.

 

[Remainder of page intentionally left blank]

 

    	 	75	 

     

    

 

 

IN WITNESS WHEREOF,
the Parties have caused this Agreement to be executed as of the date first above written.

 

	 	ALLIANCE MMA, INC.
	 	 	 
	 	By:	/s/ John Price
	 	Name:	John Price
 
	 	Title:   	 
	 	 	 
	 	SCWORX CORP.
	 	 	 
	 	By:	/s/ Mark Schessel
	 	Name:	Mark Schessel

	 	Title:	 

 

[SCWORX STOCKHOLDERS SIGNATURE PAGES
FOLLOWS]

 

    	 	76	 

     

    

 

	 	SCWORX STOCKHOLDERS
	 	 
	 	/s/ Mark E. Munro
	 	Mark E. Munro
	 	 
	 	/s/ Marc S. Schessel 
	 	Marc S. Schessel 
	 	 
	 	/s/ Double02 LLC 
	 	Double02 LLC 
	 	 
	 	/s/ Riverside Merchant Partners
	 	Riverside Merchant Partners 
	 	 
	 	/s/ Zachary Hirsch 
	 	Zachary Hirsch 
	 	 
	 	/s/ RDW Capital LLC
	 	RDW Capital LLC
	 	 
	 	/s/ Osher Capital Partners LLC 
	 	Osher Capital Partners LLC 
	 	 
	 	/s/ Michael Ference 
	 	Michael Ference 
	 	 
	 	/s/ Thomas Rose 
	 	Thomas Rose 
	 	 
	 	/s/ Harry Loannou
	 	Harry Loannou
	 	 
	 	/s/ Dominion Capital LLC
	 	Dominion Capital LLC
	 	 
	 	/s/ Adam Stern
	 	Adam Stern
	 	 
	 	/s/ M2B Funding Corporation
	 	M2B Funding Corporation
	 	 
	 	/s/ Lawrence Sands 
	 	Lawrence Sands 

 

    	 	77	 

     

    

 

Exhibit
A

 

CERTAIN DEFINITIONS

 

For purposes of the
Agreement (including this Exhibit A):

 

“2016 Plan”
has the meaning set forth in Section 3.4(b).

 

“Acquisition
Agreement” has the meaning set forth in Section 4.5(a).

 

“Acquisition
Inquiry” means, with respect to a Party, an inquiry, indication of interest or request for information (other than an
inquiry, indication of interest or request for information made or submitted by SCWorx, on the one hand, or AMMA, on the other
hand, to the other Party) that would reasonably be expected to lead to an Acquisition Proposal with such Party.

 

“Acquisition
Proposal” means, with respect to a Party, any offer or proposal, whether written or oral (other than an offer or proposal
made or submitted by or on behalf of SCWorx or any of its Affiliates, on the one hand, or by or on behalf of AMMA or any of its
Affiliates, on the other hand, to the other Party) made by a third party contemplating or otherwise relating to any Acquisition
Transaction with such Party.

 

“Acquisition
Transaction” means any transaction or series of transactions involving:

 

(a)          any
merger, consolidation, amalgamation, share exchange, business combination, issuance of securities, acquisition of securities, reorganization,
recapitalization, tender offer, exchange offer or other similar transaction: (i) in which a Party is a constituent corporation;
(ii) in which a Person or “group” (as defined in the Exchange Act and the rules promulgated thereunder) of Persons
directly or indirectly acquires beneficial or record ownership of securities representing more than 20% of the outstanding securities
of any class of voting securities of a Party or any of its Subsidiaries; or (iii) in which a Party or any of its Subsidiaries issues
securities representing more than 20% of the outstanding securities of any class of voting securities of such Party or any of its
Subsidiaries;

 

(b)          any
sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses or assets that constitute or
account for 20% or more of the consolidated book value or the fair market value of the assets of a Party and its Subsidiaries,
taken as a whole (other than any lease, exchange, transfer, license, disposition, partnership, or collaboration involving less
than substantially all of the assets of SCWorx pursuant to a collaboration agreement, partnership agreement or similar arrangement);
or

 

(c)          any
tender offer or exchange offer, that if consummated would result in any Person beneficially owning 20% or more of the outstanding
equity securities of a Party or any of its Subsidiaries.

 

“Affiliates”
has the meaning for such term as used in Rule 145 under the Securities Act.

 

“Agreement”
has the meaning set forth in the Preamble as it may be amended from time to time.

 

     

     

    

 

“Allocation
Certificate” has the meaning set forth in Section 1.7.

 

“Anti-Corruption/AML
Laws” mean the U.S. Foreign Corrupt Practices Act of 1977, as amended, the Anti-Kickback Act of 1986, as amended, the
U.S. Domestic Bribery Statute (18 U.S.C. Section 201), the U.S. Travel Act (18 U.S.C. Section 1952), the UK Bribery Act of 2010,
the UK Proceeds of Crime Act 2002, the USA PATRIOT Act, and other anti-bribery, anti-corruption, anti-kickback, anti-money laundering,
anti-terrorist financing, anti-fraud, anti-embezzlement, or conflict of interest Laws in all of the jurisdictions in which the
Acquired Corporations have operations, including the Anti-Bribery Laws of the People’s Republic of China or any applicable
Laws of similar effect, and the related regulations and published interpretations thereunder.

 

“AMMA”
has the meaning set forth in the Preamble.

 

“AMMA 401(k)
Plan” has the meaning set forth in Section 5.7(d).

 

“AMMA 409A
Plan” has the meaning set forth in Section 3.15(n).

 

“AMMA Affiliate”
means any Person that is or has been in the six year period ending with the Closing Date under common control with AMMA within
the meaning of Sections 414(b), (c), (m) and (o) of the Code, and the regulations issued thereunder, or Sections 4001(a)(14) or
4001(b)(1) of ERISA, and the regulations issued thereunder.

 

“AMMA Associate”
means any current or former employee, independent contractor, officer or director of AMMA, any of its Subsidiaries or any Affiliate
of AMMA.

 

“AMMA Audited
Financial Statements” means the audited consolidated financial statements included in AMMA’s Report on Form 10-K
filed with the SEC for the period ended December 31, 2017.

 

“AMMA Board
Adverse Recommendation Change” has the meaning set forth in Section 5.3(b).

 

“AMMA Board
of Directors” means the board of directors of AMMA.

 

“AMMA Board
Recommendation” has the meaning set forth in Section 5.3(b).

 

“AMMA Capital
Stock” means AMMA Shares.

 

“AMMA Contract”
means any Contract: (a) to which AMMA or any AMMA Subsidiary is a Party; or (b) by which AMMA or any AMMA Subsidiary or any AMMA
IP Rights or any other asset of AMMA or its Subsidiaries is bound or under which AMMA or any AMMA Subsidiary has any obligation.

 

“AMMA Disclosure
Schedule” has the meaning set forth in Article 3.

 

“AMMA Director
Resignees” has the meaning set forth in Section 5.14.

 

    	2	 	 

     

    

 

“AMMA Employee(s)”
has the meaning set forth in Section 3.15(a).

 

“AMMA Employee
Plan” has the meaning set forth in Section 3.15(c).

 

“AMMA IP Rights”
means all Intellectual Property owned, licensed or controlled by AMMA that is necessary or used in the business of AMMA as presently
conducted or as presently proposed to be conducted).

 

“AMMA IP Rights
Agreement” means any instrument or agreement governing, related or pertaining to any AMMA IP Rights.

 

“AMMA Leases”
has the meaning set forth in Section 3.8.

 

“AMMA Indemnified
Party” has the meaning set forth in Section 10.1(a).

 

“AMMA Material
Adverse Effect” means any Effect that, considered together with all other Effects that have occurred prior to the date
of determination of the occurrence of the AMMA Material Adverse Effect, is or would reasonably be expected to be materially adverse
to, or has or would reasonably be expected to have or result in a material adverse effect on: (a) the business, condition (financial
or otherwise), capitalization, assets, operations or financial performance of AMMA and its Subsidiaries taken as a whole; or (b)
the ability of AMMA to consummate the Contemplated Transactions or to perform any of its covenants or obligations under the Agreement
in all material respects; provided, however, that Effects from the following shall not be deemed to constitute (nor shall Effects
from any of the following be taken into account in determining whether there has occurred) a AMMA Material Adverse Effect: (i)
any rejection by a Governmental Body of a registration or filing by AMMA relating to the AMMA IP Rights; (ii) conditions generally
affecting the industries in which AMMA and its Subsidiaries participate or the United States or global economy or capital markets
as a whole, to the extent that such conditions do not have a disproportionate impact on AMMA and its Subsidiaries taken as a whole;
(iii) any failure of AMMA or any AMMA Subsidiary to meet internal projections or forecast, third-party revenue or earnings predictions
or any change in the price or trading volume of AMMA Shares (it being understood, however, that any Effect causing or contributing
to any such failure to meet projections or predictions or any change in stock price or trading volume may constitute a AMMA Material
Adverse Effect and may be taken into account in determining whether a AMMA Material Adverse Effect has occurred); (iv) the execution,
delivery, announcement or performance of the obligations under this Agreement or the announcement, pendency or anticipated consummation
of the Exchange; (v) any natural disaster or any acts of terrorism, sabotage, military action or war or any escalation or
worsening thereof; or (vi) any changes (after the date of this Agreement) in GAAP or applicable Legal Requirements.

 

“AMMA Material
Contract” has the meaning set forth in Section 3.10(a).

 

“AMMA Options”
means options to purchase AMMA Shares issued or granted by AMMA.

 

“AMMA Shares”
has the meaning set forth in Section 3.4(a).

 

“AMMA Outstanding
Shares Certificate” has the meaning set forth in Section 1.11(a).

 

    	3	 	 

     

    

 

“AMMA Permits”
has the meaning set forth in Section 3.12(b).

 

“AMMA Registered
IP” means all AMMA IP Rights that are registered, filed or issued under the authority of, with or by any Governmental
Body, including all patents, registered copyrights and registered trademarks and all applications for any of the foregoing.

 

“AMMA SEC
Documents” shall have the meaning set forth in Section 3.5(a).

 

“AMMA Service
Providers” has the meaning set forth in Section 3.15(c).

 

“AMMA Shares”
has the meaning set forth in the Recitals.

 

“AMMA Stockholder”
means each holder of AMMA Capital Stock as determined immediately prior to the Closing Date, and “AMMA Stockholders”
means all AMMA Stockholders.

 

“AMMA Stockholder
Matters” has the meaning set forth in Section 5.3(a).

 

“AMMA Stockholders’
Meeting” has the meaning set forth in Section 5.3(a).

 

“AMMA Stockholders’
Meeting Notice” has the meaning set forth in Section 5.1(a).

 

“AMMA Subsidiaries”
has the meaning set forth in Section 3.1(a).

 

“AMMA Termination
Fee” has the meaning set forth in Section 9.3(b)(ii).

 

“AMMA Unaudited
Interim Balance Sheet” means the unaudited consolidated balance sheet of AMMA for the period ended June 30, 2018 delivered
to SCWorx on or about the date hereof.

 

“Business
Day” means any day other than a day on which banks in the State of New York are authorized or obligated to be closed.

 

“Certificate
of Exchange” has the meaning set forth in Section 1.3.

 

“Certifications”
has the meaning set forth in Section 3.5(a).

 

“Closing”
has the meaning set forth in Section 1.2.

 

“Closing Date”
has the meaning set forth in Section 1.2.

 

“COBRA”
means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, as set forth in Section 4980B of the Code and Part
6 of Title I, Subtitle B of ERISA.

 

“Code”
means the United States Internal Revenue Code of 1986, as amended.

 

“Confidentiality
Agreement” means the Confidentiality Agreement, dated May 15, 2018, between SCWorx and AMMA.

 

    	4	 	 

     

    

 

“Consent”
means any approval, consent, ratification, permission, waiver or authorization (including any Governmental Authorization).

 

“Contemplated
Transactions” means the Exchange, the Reverse Split, and the other transactions and actions contemplated by the Agreement.

 

“Contract”
shall, with respect to any Person, mean any written agreement, contract, subcontract, lease (whether real or personal property),
mortgage, understanding, arrangement, instrument, note, option, warranty, purchase order, license, sublicense, insurance policy,
benefit plan or legally binding commitment or undertaking of any nature to which such Person is a party or by which such Person
or any of its assets are bound or affected under applicable law.

 

“D&O Indemnified
Parties” has the meaning set forth in Section 5.8(a).

 

“DGCL”
means the General Corporation Law of the State of Delaware.

 

“Effect”
means any effect, change, event, circumstance, or development.

 

“Encumbrance”
means any lien, pledge, hypothecation, charge, mortgage, security interest, encumbrance, claim, infringement, interference, option,
right of first refusal, preemptive right, community property interest or restriction of any nature (including any restriction on
the voting of any security, any restriction on the transfer of any security or other asset, any restriction on the receipt of any
income derived from any asset, any restriction on the use of any asset and any restriction on the possession, exercise or transfer
of any other attribute of ownership of any asset).

 

“Entity”
means any corporation (including any non-profit corporation), partnership (including any general partnership, limited partnership
or limited liability partnership), joint venture, estate, trust, company (including any company limited by shares, limited liability
company or joint stock company), firm, society or other enterprise, association, organization or Entity, and each of its successors.

 

“Environmental
Law” means any federal, state, local or foreign Legal Requirement relating to pollution or protection of human health
or the environment (including ambient air, surface water, ground water, land surface or subsurface strata), including any law or
regulation relating to emissions, discharges, releases or threatened releases of Hazardous Materials, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials.

 

“ERISA”
means the United States Employee Retirement Income Security Act of 1974, as amended.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“Exchange”
has the meaning set forth in Section 1.1.

 

“Exchange
Agent” has the meaning set forth in Section 1.7(a).

 

    	5	 	 

     

    

 

“Exchange
Consideration” has the meaning set forth in Section 1.5(a)(ii).

 

“Existing
AMMA D&O Policies” has the meaning set forth in Section 3.17(b).

 

“Existing
SCWorx D&O Policies” has the meaning set forth in Section 2.16(b).

 

“Former AMMA
Associates” has the meaning set forth in Section 5.7(c).

 

“GAAP”
has the meaning set forth in Section 2.5(a).

 

“Governmental
Authorization” means any: (a) permit, license, certificate, franchise, permission, variance, exceptions, orders,
clearance, registration, qualification or authorization issued, granted, given or otherwise made available by or under the authority
of any Governmental Body or pursuant to any Legal Requirement; or (b) right under any Contract with any Governmental Body.

 

“Governmental
Body” means any: (a) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction
of any nature; (b) federal, state, local, municipal, foreign or other government; (c) governmental or regulatory body, or quasi-governmental
body of any nature (including any governmental division, department, administrative agency or bureau, commission, authority, instrumentality,
official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance
of doubt, any Tax authority) or other body exercising similar powers or authority; or (d) self-regulatory organization (including
NASDAQ and the Financial Industry Regulatory Authority).

 

“Hazardous
Materials” means any pollutant, chemical, substance and any toxic, infectious, carcinogenic, reactive, corrosive, ignitable
or flammable chemical, or chemical compound, or hazardous substance, material or waste, whether solid, liquid or gas, that is subject
to regulation, control or remediation under any Environmental Law, including crude oil or any fraction thereof, and petroleum products
or by-products.

 

“Intellectual
Property” means (a) United States, foreign and international patents, patent applications, including provisional applications,
statutory invention registrations, invention disclosures and inventions, (b) trademarks, service marks, trade names, domain names,
URLs, trade dress, logos and other source identifiers, including registrations and applications for registration thereof, (c) copyrights,
including registrations and applications for registration thereof, and (d) software, formulae, customer lists, trade secrets, know-how,
confidential information and other proprietary rights and intellectual property, whether patentable or not.

 

“IRS”
means the United States Internal Revenue Service.

 

“Knowledge”
means, with respect to an individual, that such individual is actually aware of the relevant fact or such individual would reasonably
be expected to know such fact in the ordinary course of the performance of the individual’s employee or professional responsibility.
Any Person that is an Entity shall have Knowledge if any officer or director of such Person as of the date such Knowledge is imputed
has Knowledge of such fact or other matter.

 

    	6	 	 

     

    

 

“Legal Proceeding”
means any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate
proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise
involving, any court or other Governmental Body or any arbitrator or arbitration panel.

 

“Legal Requirement”
shall mean any federal, state, foreign, material local or municipal or other law, statute, constitution, principle of common law,
resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented
or otherwise put into effect by or under the authority of any Governmental Body (or under the authority of the NASDAQ Stock Market
or the Financial Industry Regulatory Authority).

 

“Liability”
has the meaning set forth in Section 2.11.

 

“Losses”
has the meaning set forth in Section 10.1(a).

 

“Multiemployer
Plan” means (a) a “multiemployer plan,” as defined in Section 3(37) or 4001(a)(3) of ERISA,
or (b) a plan which if maintained or administered in or otherwise subject to the laws of the United States would be described in
paragraph (a).

 

“Multiple
Employer Plan” means (a) a “multiple employer plan” within the meaning of Section 413(c) of the Code, or
a “multiple employer welfare arrangement,” within the meaning of Section 3(40) of ERISA, or (b) a plan which if maintained
or administered in or otherwise subject to the laws of the United States would be described in paragraph (a).

 

“NASDAQ”
has the meaning set forth in the Recitals.

 

“Nasdaq Listing
Application” has the meaning set forth in Section 5.11.

 

“Ordinary
Course of Business” means, in the case of each of SCWorx and AMMA and for all periods, such actions taken in the ordinary
course of its normal operations and consistent with its past practices, and for periods following the date of this Agreement consistent
with its operating plans delivered to the other Party pursuant to Section 5.1(c)(i); provided, however, that during the Pre-Closing
Period, (a) the Ordinary Course of Business of each Party shall also include any actions expressly required or permitted by this
Agreement, including the Contemplated Transactions, and (b) the Ordinary Course of Business for SCWorx shall also include (i) actions
undertaken in connection with preparing to become a SEC reporting company listed on the NASDAQ Capital Market and (ii) actions
required to engage with one or more third parties regarding a potential lease, exchange, transfer, license, disposition, partnership,
or collaboration involving less than substantially all of the assets of SCWorx pursuant to a collaboration agreement, partnership
agreement or similar arrangement.

 

“Outside Date”
has the meaning set forth in Section 9.1(b).

 

“Party”
or “Parties” means SCWorx, AMMA and the SCWorx Stockholders.

 

“Person”
means any individual, Entity or Governmental Body.

 

    	7	 	 

     

    

 

“Personal
Information” has the meaning set forth in Section 3.9(i).

 

“Pre-Closing
Period” has the meaning set forth in Section 4.1.

 

“Previously
Terminated AMMA Associate” means a AMMA Associate whose employment or service with AMMA, any of its Subsidiaries, or
any AMMA Affiliate terminated prior to the date of this Agreement.

 

“Proxy Statement”
means the proxy statement to be furnished to the SEC and addressed to the AMMA Stockholders in connection with the approval of
the AMMA Stockholder Matters and in connection with the AMMA Stockholders’ Meeting.

 

“Proxy Statement
Expenses” has the meaning set forth in Section 10.3(c).

 

“Representatives”
means directors, officers, other employees, agents, attorneys, accountants, investment bankers, advisors and representatives.

 

“Required
AMMA Stockholder Vote” has the meaning set forth in Section 3.2(b).

 

“Required
SCWorx Stockholder Vote” has the meaning set forth in Section 2.2(b).

 

“Reverse Split”
means a reverse stock split of all outstanding AMMA Shares at a reverse stock split ratio in the range mutually agreed to by AMMA
and SCWorx which (i) shall be reasonably sufficient to insure that at the Closing AMMA meets the original listing qualifications
of the Nasdaq Capital Market and (ii) agreed upon by the AMMA Board of Directors.

 

“Sarbanes-Oxley
Act” means the Sarbanes-Oxley Act of 2002, as it may be amended from time to time.

 

“SEC”
means the United States Securities and Exchange Commission.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“SCWorx”
has the meaning set forth in the Preamble.

 

“SCWorx 409A
Plan” has the meaning set forth in Section 2.14(k).

 

“SCWorx Affiliate”
means any Person that is or has been in the six year period ending with the Closing Date under common control with SCWorx within
the meaning of Sections 414(b), (c), (m) and (o) of the Code, and the regulations issued thereunder, or Sections 4001(a)(14) or
4001(b)(1) of ERISA, and the regulations issued thereunder.

 

“SCWorx Associate”
means any current or former employee, independent contractor, officer or director of SCWorx, any of its Subsidiaries or any Affiliate
of SCWorx.

 

“SCWorx Audited
Financials” has the meaning set forth in Section 2.5(a).

 

“SCWorx Board
of Directors” means the board of directors of SCWorx.

 

    	8	 	 

     

    

 

“SCWorx Capital
Stock” means the SCWorx Common Stock.

 

“SCWorx Common
Stock” has the meaning set forth in Section 2.4(a).

 

“SCWorx Contract”
means any Contract: (a) to which SCWorx is a Party; or (b) by which SCWorx or any SCWorx IP Rights or any other asset of SCWorx
or its Subsidiaries is bound or under which SCWorx has any obligation.

 

“SCWorx Designees”
has the meaning set forth in Section 5.14.

 

“SCWorx Disclosure
Schedule” has the meaning set forth in Article 2.

 

“SCWorx Employee
Plan” has the meaning set forth in Section 2.14(a).

 

“SCWorx Financials”
has the meaning set forth in Section 2.5(a).

 

“SCWorx IP
Rights” means all Intellectual Property owned, licensed or controlled by SCWorx that is necessary or used in the business
of SCWorx and its Subsidiaries as presently conducted or as presently proposed to be conducted.

 

“SCWorx IP
Rights Agreement” means any instrument or agreement governing, related or pertaining to any SCWorx IP Rights.

 

“SCWorx Leases”
has the meaning set forth in Section 2.8.

 

“SCWorx Lock-up
Signatories” means each of the directors and officers of SCWorx.

 

“SCWorx Material
Adverse Effect” means any Effect that, considered together with all other Effects that have occurred prior to the date
of determination of the occurrence of the SCWorx Material Adverse Effect, is or would reasonably be expected to be materially adverse
to, or has or would reasonably be expected to have or result in a material adverse effect on: (a) the business, condition (financial
or otherwise), capitalization, assets, operations or financial performance of SCWorx and its Subsidiaries taken as a whole; or
(b) the ability of SCWorx to consummate the Contemplated Transactions or to perform any of its covenants or obligations under the
Agreement in all material respects; provided, however, that Effects from the following shall not be deemed to constitute (nor shall
Effects from any of the following be taken into account in determining whether there has occurred) a SCWorx Material Adverse Effect:
(i) any rejection by a Governmental Body of a registration or filing by SCWorx relating to the SCWorx IP Rights; (ii) conditions
generally affecting the industries in which SCWorx and its Subsidiaries participate or the United States or global economy or capital
markets as a whole, to the extent that such conditions do not have a disproportionate impact on SCWorx and its Subsidiaries taken
as a whole; (iii) any failure by SCWorx to meet internal projections or forecasts on or after the date of this Agreement (it being
understood, however, that any Effect causing or contributing to any such failure to meet projections or forecasts may constitute
a SCWorx Material Adverse Effect and may be taken into account in determining whether a SCWorx Material Adverse Effect has occurred);
(iv) the execution, delivery, announcement or performance of the obligations under this Agreement or the announcement, pendency
or anticipated consummation of the Exchange; (v) any natural disaster or any acts of terrorism, sabotage, military action
or war or any escalation or worsening thereof; or (vi) any changes (after the date of this Agreement) in GAAP or applicable Legal
Requirements.

 

    	9	 	 

     

    

 

“SCWorx Material
Contract(s)” has the meaning set forth in Section 2.10(a).

 

“SCWorx Permits”
has the meaning set forth in Section 2.12(b).

 

“SCWorx Registered
IP” means all SCWorx IP Rights that are registered, filed or issued under the authority of, with or by any Governmental
Body, including all patents, registered copyrights and registered trademarks and all applications for any of the foregoing.

 

“SCWorx Shares”
has the meaning set forth in the Recitals.

 

“SCWorx Stock
Certificate” has the meaning set forth in Section 1.6.

 

“SCWorx Stockholder”
has the meaning set forth in the Preamble.

 

“SCWorx Stockholder
Matters” has the meaning set forth in Section 2.2(a).

 

“SCWorx Stockholder
Written Consent(s)” has the meaning set forth in Section 2.2(b).

 

“SCWorx Termination
Fee” has the meaning set forth in Section 9.3(b)(i).

 

“SCWorx Unaudited
Financials” shall mean the unaudited balance sheet, statement of operations, cash flows and shareholders’ equity
of SCWorx for the six months ended June 30, 2018, provided to AMMA prior to the date of this Agreement.

 

“Stockholder
Litigation” has the meaning set forth in Section 6.19.

 

“Subsequent
Transaction” means any Acquisition Transaction (with all references to 20% in the definition of Acquisition Proposal
being treated as references to 50% for these purposes).

 

“Subsidiary”
means an Entity of which another Person directly or indirectly owns or purports to own, beneficially or of record, (a) an amount
of voting securities of other interests in such Entity that is sufficient to enable such Person to elect at least a majority of
the members of such Entity’s board of directors or other governing body, or (b) at least 50% of the outstanding equity, voting,
beneficial or financial interests in such Entity.

 

“Superior
Offer” means an unsolicited, bona fide written Acquisition Proposal (with all references to 20% in the definition of
Acquisition Transaction being treated as references to 50% for these purposes) made by a third party that (a) was not obtained
or made as a direct or indirect result of a breach of (or in violation of) this Agreement; and (b) is on terms and conditions that
the AMMA Board of Directors or the SCWorx Board of Directors, as applicable, determines, in its reasonable, good faith judgment,
after obtaining and taking into account such matters that its Board of Directors deems relevant following consultation with its
outside legal counsel and financial advisor, if any (i) is more favorable, from a financial point of view, to the AMMA Stockholders
or the SCWorx Stockholders, as applicable, than the terms of the Exchange; and (ii) is reasonably capable of being consummated;
provided, however, that any such offer shall not be deemed to be a “Superior Offer” if (A) any financing required to
consummate the transaction contemplated by such offer is not committed and is not reasonably capable of being obtained by such
third party or (B) if the consummation of such transaction is contingent on any such financing being obtained.

 

    	10	 	 

     

    

 

“Tax”
means any federal, state, local, foreign or other tax, including any income tax, franchise tax, capital gains tax, gross receipts
tax, value-added tax, surtax, estimated tax, unemployment tax, national health insurance tax, excise tax, ad valorem tax, transfer
tax, stamp tax, sales tax, use tax, property tax, business tax, withholding tax, payroll tax, customs duty, alternative or add-on
minimum or other tax of any kind whatsoever, and including any fine, penalty, addition to tax or interest, whether disputed or
not, attributable thereto or to the failure to timely or properly file any Tax Return.

 

“Tax Return”
means any return (including any information return), report, statement, declaration, estimate, schedule, notice, notification,
form, election, certificate or other document or information, and any amendment or supplement to any of the foregoing, filed with
or submitted to, or required to be filed with or submitted to, any Governmental Body in connection with the determination, assessment,
collection or payment of any Tax or in connection with the administration, implementation or enforcement of or compliance with
any Legal Requirement relating to any Tax.

 

“Tax Treatment”
has the meaning set forth in Section 5.12(a).

 

“Terminated
AMMA Associate Payments” has the meaning set forth in Section 5.7(c).

 

“Terminated
AMMA Associates” has the meaning set forth in Section 5.7(a).

 

“Termination
Permits” has the meaning set forth in Section 5.7(a).

 

“Third-Party
Expenses” has the meaning set forth in Section 9.3(c).

 

“Transfer
Taxes” has the meaning set forth in Section 5.12(c).

 

“Treasury
Regulations” means the United States Treasury regulations promulgated under the Code.

 

“WARN Act”
means the United States Worker Adjustment and Retraining Notification Act of 1988, as amended.

 

    	11	 	 

     

    

 

EXHIBIT B

 

Calculation of Exchange Ratio and Adjustment

 

The 74,626,866 Acquisition Shares to be issued to SCWorx Stockholders
pursuant to Section 1.1(b) assumes a $0.67 price per AMMA Share on the Closing Date and is based on a valuation of $50 million
for the Acquisition Shares. In the event that on the Closing Date, the closing price per AMMA Share is less than $0.67, the number
of Acquisition Shares issuable to the SCWorx Stockholders shall be proportionally adjusted such that the SCWorx Stockholders shall
receive such number of Acquisition Shares equal to $50 million divided by the closing price per AMMA Share on the Closing Date.
For illustrative purposes only, if, on the Closing Date, the closing price per AMMA Share equals $0.50, then the number of Acquisition
Shares issuable at Closing shall total 100,000,000. There shall be no adjustment to the number of Acquisition Shares in the event
the closing price per AMMA Share on the Closing Date is greater than $0.67.

 

     

     

    

 

ANNEX
A

 

SCWorx Stockholders

 

Mark E. Munro

Marc S. Schessel

Double02 LLC

Riverside Merchant Partners

Zachary Hirsch

RDW Capital LLC

Osher Capital Partners LLC

Michael Ference

Thomas Rose

Harry Loannou

Dominion Capital LLC

Adam Stern

M2B Funding Corporation

Lawrence Sands

     

     

    

 

ANNEX
B

 

Majority SCWorx Stockholders

 

Mark Munro and Marc SchesselExhibit 10.5

 

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase
Agreement (this “Agreement”) is dated as of November 29, 2018, between Alliance MMA, Inc., a Delaware corporation
(the “Company”) and the purchasers set forth on the signature pages affixed hereto (each a “Purchaser”
and collectively, the “Purchasers”).

 

WHEREAS, subject to
the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to the Purchasers,
and the Purchasers severally and not jointly desire to purchase from the Company, securities of the Company as more fully described
in this Agreement.

 

NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

 

ARTICLE
I

DEFINITIONS

 

1.1          Definitions.
In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have
the meanings set forth in this Section 1.1:

 

“Acquiring Person”
shall have the meaning ascribed to such term in Section 4.7.

 

“Action” shall
have the meaning ascribed to such term in Section 3.1(j).

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Board
of Directors” means the board of directors of the Company.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.

 

“Certificate
of Designations” means the Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred
Stock of the Company in the form of Exhibit A attached hereto.

 

“Closing”
means the closing of a purchase and sale of the Securities pursuant to Section 2.1.

 

“Closing
Date” means the Trading Day on which all of the Transaction Documents with respect to a particular Closing have been
executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchaser’s obligations
to pay the relevant Subscription Amount and (ii) the Company’s obligations to deliver the corresponding Securities, in each
case, have been satisfied or waived.

 

    1

     

    

 

“Closing
Statement” means the Closing Statement in the form on Annex A attached hereto.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Common
Stock” means the common shares of the Company, par value $0.001 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.

 

“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.

 

“Company
Counsel” means The Nossiff Law Firm LLP, with offices located at 300 Brickstone Sq., Suite 201, Andover, MA 01810.

 

“Disclosure
Schedules” shall have the meaning ascribed to such term in Section 3.1.

 

“Evaluation
Date” shall have the meaning ascribed to such term in Section 3.1(p).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Exchange
Approval” means approval of the Common Stock or Common Stock Equivalents contemplated by this Agreement by Nasdaq, which
approval shall be obtained no later than ten (10) Trading Days after shareholder approval of the transactions contemplated by this
Agreement.

 

“FCPA”
means the Foreign Corrupt Practices Act of 1977, as amended.

 

“GAAP”
shall have the meaning ascribed to such term in Section 3.1(h).

 

“Intellectual
Property Rights” shall have the meaning ascribed to such term in Section 3.1(m).

 

“Legend
Removal Date” shall have the meaning ascribed to such term in Section 4.1(c).

 

“Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

    2

     

    

 

“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

 

“Material
Permits” shall have the meaning ascribed to such term in Section 3.1(l).

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Preferred
Shares” up to $ 9,000,000 of Series A Convertible Preferred Stock at a purchase price of $10.00 per share.

 

“Purchaser
Party” shall have the meaning ascribed to such term in Section 4.10.

 

“Required
Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

 

“Required
Minimum” means, as of any date, 200% of the maximum aggregate number of shares of Common Stock then issued or potentially
issuable in the future pursuant to the Transaction Documents, including any Underlying Shares.

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“SEC
Reports” shall have the meaning ascribed to such term in Section 3.1(h).

 

“Securities”
means the Preferred Shares, the Warrants and the Underlying Shares.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Short
Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall
not be deemed to include any sale of Securities pursuant to Rule 144).

 

“Subscription
Amount” means the aggregate amount to be paid for the Preferred Shares, Warrants purchased hereunder as specified below
each Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription Amount,”
in United States dollars and in immediately available funds.

 

“Subsidiary”
means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.

 

    3

     

    

 

“Trading
Day” means a day on which the principal Trading Market is open for trading.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange or the OTCB Bulletin Board (or any successors to any of the foregoing).

 

“Transaction
Documents” means this Agreement, the Certificate of Designations, the Warrants, the Registration Rights Agreement all
exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated
hereunder.

 

“Transaction
Offer” shall have the meaning set forth in Section 4.14.

 

“Transfer
Agent” means Transfer Online, Inc., the current transfer agent of the Company, with a mailing address of 12 SE Salmon
St, Portland, OR 97214, and any successor transfer agent of the Company.

 

“Underlying
Shares” means the shares of Common Stock issuable upon conversion of the Preferred Shares and exercise of the Warrants.

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market other than the OTC Bulletin Board, the daily volume weighted average price of the Common Stock for
such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported
by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTC
Bulletin Board is the Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the OTC Bulletin Board, (c) if the Common Stock is not then listed or quoted for trading on a Trading Market and if prices
for the Common Stock are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the holders of a majority in interest of the aggregate principal amount of the then outstanding Preferred Shares
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

“Warrants”
means the Common Stock purchase warrants to be issued by the Company to the Purchaser hereunder, in the form of Exhibit B attached
hereto.

 

    4

     

    

 

ARTICLE
II

PURCHASE AND SALE

 

2.1          Purchase.
Upon the terms and subject to the conditions set forth herein, the Purchasers shall, severally, and not jointly, purchase in the
aggregate up to $9,000,000 of the Preferred Shares, together with Warrants, in the respective amounts set forth on the signature
pages attached hereto in exchange for the Purchase Price, which will also be reflected opposite such Purchaser’s name on
Schedule 2.1. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company shall sell and issue
to the Purchasers, and the Purchasers shall purchase from the Company:

 

(a)          a
duly issued stock certificate representing the Preferred Shares equal to the amount funded by the Purchaser on such Closing Date
divided by the Purchase Price per share; and

 

(b)          a
Warrant to purchase such number of shares of Common Stock as equal the Subscription Amount multiplied by 50%, divided by the conversion
price of the Preferred Shares), issued to the Purchaser or its designees.

 

2.2          Closing.
On the Closing Date, upon the terms and subject to the conditions set forth herein, concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers agrees to purchase, the Preferred Shares
and Warrants as set forth above. At the Closing, the Purchaser shall deliver to the Company, via wire transfer to an account designated
by the Company, immediately available funds equal to the Purchaser’s Subscription Amount, and the Company shall deliver to
the Purchaser its duly issued stock certificates representing the Preferred Shares and Warrants as set forth in Section 2.3,
and the Company and the Purchaser shall deliver the other items set forth in Section 2.3 deliverable at the Closing. Upon
satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4 for Closing, such Closing shall occur at the
offices of Sichenzia Ross Ference LLP or such other location as the parties hereto shall mutually agree, and may by agreement be
undertaken remotely by electronic exchange of Closing documentation.

 

2.3          Deliveries.

 

(a)          On
or prior to the Closing Date (except as noted), the Company shall deliver or cause to be delivered to each Purchaser the following:

 

(i)          this
Agreement duly executed by the Company;

 

(ii)         a
duly issued stock certificate equal to the amount the Purchaser’s subscription divided by the Purchase price per Preferred
Share;

 

(iii)        the
Warrants, duly executed by the Company;

 

(iv)        the
Transfer Agent Instruction Letter, duly executed by the Company and the Transfer Agent;

 

    5

     

    

 

(v)         the
Registration Rights Agreement in the form attached hereto as Exhibit C, duly executed by the Company;

 

(vi)        a
certificate evidencing the formation and good standing of the Company and each of its Subsidiaries in each such entity’s
jurisdiction of formation issued by the Secretary of State (or comparable office) of such jurisdiction of formation as of a date
within ten (10) days of the Closing Date;

 

(vii)       a
certificate evidencing the Company’s qualification as a foreign corporation and good standing issued by the Secretary of
State (or comparable office) of each jurisdiction, if any, in which the Company conducts business and is required to so qualify,
as of a date within ten (10) days of the Closing Date;

 

(viii)      a
certificate executed by the Secretary of the Company and dated as of the Closing Date, as to (i) the resolutions, as adopted by
the Board of Directors in a form reasonably acceptable to the Purchasers, approving the entering into and performance of this Agreement
and the other Transaction Documents and the issuance, offering and sale of the Securities, (ii) the Company’s certificate
of incorporation (including the Certificate of Designations duly filed with the Secretary of State of the State of Delaware), and
(iii) the Company’s bylaws, each as in effect at the Closing; and

 

(ix)         such
other documents, instruments or certificates relating to the transactions contemplated by this Agreement as the Purchaser or its
counsel may reasonably request.

 

(b)          On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, as applicable, the following:

 

(i)          this
Agreement, duly executed by the Purchaser;

 

(ii)         the
Purchaser’s Subscription Amount by wire transfer to an escrow account designated by the Company; and

 

(iii)        the
Registration Rights Agreement, duly executed by the Purchaser;

 

2.4          Closing
Conditions.

 

(a)          The
obligations of the Company hereunder in connection with any Closing are subject to the following conditions being met:

 

(i)          the
accuracy in all material respects on the applicable Closing Date of the representations and warranties of the applicable Purchaser
contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);

 

    6

     

    

 

(ii)         all
obligations, covenants and agreements of the applicable Purchaser required to be performed at or prior to an applicable Closing
Date shall have been performed; and

 

(iii)        the
delivery by the applicable Purchaser of the items set forth in Section 2.3(b) of this Agreement.

 

(b)          The
respective obligations of each Purchaser hereunder in connection with the Closing are subject to the following conditions being
met:

 

(i)          the
accuracy in all material respects when made and on the applicable Closing Date of the representations and warranties of the Company
contained herein (unless such representation or warranty is made as of a specific date therein);

 

(ii)         all
obligations, covenants and agreements of the Company required to be performed at or prior to the applicable Closing Date shall
have been performed; and

 

(iii)        the
delivery by the Company of the items set forth in Section 2.3(a) of this Agreement;

 

(iv)        from
the date hereof to the relevant Closing Date, trading in the Common Stock shall not have been suspended by the Commission or any
Trading Market (except as previously disclosed in the SEC Reports) and, at any time prior to the Closing Date, trading in securities
generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established
on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared
either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of
hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in,
any financial market which, in each case, in the reasonable judgment of the Purchaser, makes it impracticable or inadvisable to
purchase the Securities at the Closing.

 

ARTICLE
III

REPRESENTATIONS AND WARRANTIES

 

3.1          Representations
and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be
deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained
in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and
warranties to each Purchaser as of the date hereof and at each Closing Date:

 

(a)          Subsidiaries.
All of the direct and indirect subsidiaries of the Company are set forth on Schedule 3.1(a)(i). Except as set forth on Schedule
3.1(a)(ii), the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free
and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company
has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

 

    7

     

    

 

(b)          Organization
and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted except where the failure
to be in good standing would not have a Material Adverse Effect. Neither the Company nor any Subsidiary is in material violation
nor material default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as
a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it
makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any
Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial
or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s
ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or
(iii), a “Material Adverse Effect”).

 

(c)          Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by
it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company
and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith
or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the
terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.

 

    8

     

    

 

(d)          No
Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not: (i) subject to the Required Approvals, conflict with or violate any material provision of the
Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents,
(ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under,
result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any
rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which
the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected,
or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject
(including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary
is bound or affected; except in the case of each of clauses (ii) and (iii), such as are waived or could not reasonably be expected
to result in a Material Adverse Effect.

 

(e)          Filings,
Consents and Approvals. Other than as set forth on Schedule 3.1(e), the Company is not required to obtain any consent, waiver,
authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local
or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the
Transaction Documents, other than: (i) the filings required pursuant to Section 4.6 of this Agreement, (ii) the notice and/or
application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Underlying
Shares for trading thereon in the time and manner required thereby, (iii) the filing of preliminary and definitive proxy statements
with the Commission, (iv) the Shareholder Approval required by Section 4.16 of this Agreement, and (iv) the filing of Form D with
the Commission and such filings as are required to be made under applicable state securities laws (collectively, the “Required
Approvals”).

 

(f)          Issuance
of the Securities. Subject to the Required Approvals, the Securities are duly authorized and, when issued and paid for in accordance
with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all
Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Underlying Shares,
when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free
and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents.

 

    9

     

    

 

(g)          Capitalization.
Schedule 3.1(g) sets forth the capitalization of the Company which also includes the number of shares of Common Stock reserved
for issuance and shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
Except as set forth in Schedule 3.1(g), since the date if its most recently filed periodic report under the Exchange Act, the Company
has not issued any capital stock other than pursuant to the exercise of employee stock options under the Company’s stock
option plans, the issuance of shares of Common Stock to (i) consultants for services and (ii) employees pursuant to the Company’s
employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the
date of the most recently filed periodic report under the Exchange Act. Except as set forth on Schedule 3.1(g), no Person has any
right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated
by the Transaction Documents. Except as set forth in Schedule 3.1(g) or as a result of the purchase and sale of the Securities,
there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to
subscribe for or acquire any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company
or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. Except as set
forth on Schedule 3.1(g), the issuance and sale of the Securities will not obligate the Company to issue shares of Common Stock
or other securities to any Person (other than the Purchaser) and will not result in a right of any holder of Company securities
to adjust the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of capital
stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all
federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar
rights to subscribe for or purchase securities. Except as set forth on Schedule 3.1(g) and shareholder approval required by Section
4.16, no further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and
sale of the Securities. Except as set forth on Schedule 3.1(g), there are no stockholders agreements, voting agreements or other
similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the
Company, between or among any of the Company’s stockholders.

 

(h)          SEC
Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) of the Exchange
Act, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file
such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being
collectively referred to herein as the “SEC Reports”). As of their respective dates, the SEC Reports, taken
as a whole with all amendments) complied in all material respects with the requirements of the Securities Act and the Exchange
Act, as applicable, and none of the SEC Reports, when filed and taking into account amendments, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company
included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company
and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods
then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

    10

     

    

 

(i)          Material
Changes; Undisclosed Events, Liabilities or Developments. Except as set forth on Schedule 3.1(i), since the date of the latest
audited financial statements included within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed
prior to the date hereof: (i) there has been no event, occurrence or development that has had or that could reasonably be expected
to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than
(A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the
Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem
any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for
confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability,
fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to
the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would
be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made
that has not been publicly disclosed at least one Trading Day prior to the date that this representation is made.

 

(j)          Litigation.
Except as set forth on Schedule 3.1(j), there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local
or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the legality, validity or
enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have
or reasonably be expected to result in a Material Adverse Effect. Except as set forth on Schedule 3.1(j), neither the Company nor
any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of
or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge
of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current
or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

    11

     

    

 

(k)          Compliance.
Except as set forth in the SEC Reports or on Schedule 3.1(k), neither the Company nor any Subsidiary: (i) is in default under or
in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in
a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is
in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to
which it is a party or by which it or any of its properties is bound except for claims which individually or in the aggregate would
not have a Material Adverse Effect (whether or not such default or violation has been waived), (ii) is in violation of any judgment,
decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule,
ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws
relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor
matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(l)          Regulatory
Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material
Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation
or modification of any Material Permit.

 

(m)          Intellectual
Property. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights as described in the SEC Reports as necessary or required for use in connection with their respective businesses
and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”).
None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual
Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2)
years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited
financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual
Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have
a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is
no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except
where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(n)          Insurance.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and
in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the
Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without
a significant increase in cost.

 

    12

     

    

 

(o)          Transactions
With Affiliates and Employees. Except as set forth in the SEC Reports, none of the officers or directors of the Company or
any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party
to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or
personal property to or from providing for the borrowing of money from or lending of money to, or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director,
or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case
in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered, reimbursement for expenses
incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan
of the Company.

 

(p)          Sarbanes-Oxley;
Internal Accounting Controls. Except as set forth in the SEC Reports, as of December 31, 2017, the Company and the Subsidiaries
are in compliance with any and all applicable requirements of the Sarbanes- Oxley Act of 2002 that are effective as of the date
hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the
date hereof and as of the Closing Date and that are applicable to the Company. Except as set forth in the SEC Reports, the Company
and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions
are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets
is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
Except as set forth in the SEC Reports, the Company and the Subsidiaries have established disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls
and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the
Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules
and forms. The Company’s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of
the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange
Act (such date, the “Evaluation Date”). The Company presented in its most recently filed periodic report under
the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based
on their evaluations as of the Evaluation Date. Except as set forth on Schedule 3.1(p), since the Evaluation Date, there have been
no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) that have materially
affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.

 

    13

     

    

 

(q)          Certain
Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiaries to any broker,
financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents. The Purchaser shall have no obligation with respect to any fees or with respect to any
claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with
the transactions contemplated by the Transaction Documents.

 

(r)          Private
Placement. Assuming the accuracy of each Purchaser’s representations and warranties set forth in Section 3.2,
no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchaser as
contemplated hereby. Subject to the Required Approvals, the issuance and sale of the Securities hereunder does not contravene the
rules and regulations of the Trading Market.

 

(s)          Investment
Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will
not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as
amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject
to registration under the Investment Company Act of 1940, as amended.

 

(t)          Registration
Rights. Other than as disclosed in the Schedule 3.1(t), no Person has any right to cause the Company to effect the registration
under the Securities Act of any securities of the Company or any Subsidiaries.

 

(u)          Listing
and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not
in compliance with the listing or maintenance requirements of such Trading Market. Except as set forth in the SEC Reports, the
Company is in compliance with all such listing and maintenance requirements.

 

(v)         Application
of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company’s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and
the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation
as a result of the Company’s issuance of the Securities and the Purchaser’s ownership of the Securities.

 

    14

     

    

 

(w)          Disclosure.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, and the
information with regard to the business prospects of SCWorx Corp., as to which the Company makes no representation or warranty,
the Company confirms that neither it nor any other Person acting on its behalf has provided the Purchasers or their respective
agents or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company
understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its
Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this
Agreement, is true and correct in all material respects and does not contain any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they
were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement
and incorporated into the SEC Reports taken as a whole do not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made and when made, not misleading. The Company acknowledges and agrees that the Purchaser makes no nor has
made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth
in Section 3.2 hereof.

 

(x)          No
Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section
3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this
offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would
require the registration of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions
of any Trading Market on which any of the securities of the Company are listed or designated.

 

(y)          Tax
Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local
income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject,
(ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due
on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of
all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or
of any Subsidiary know of no basis for any such claim.

 

    15

     

    

 

(z)          No
General Solicitation. Neither the Company nor any person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchaser
and certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

 

(aa)         Foreign
Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent
or other person acting on behalf of the Company or any Subsidiary, has: (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any
unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns
from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person
acting on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision
of FCPA.

 

(bb)         Accountants.
The Company’s accounting firm is Friedman LLP. To the knowledge and belief of the Company, such accounting firm: (i) is a
registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial
statements to be included in the Company’s Annual Report for the fiscal year ended December 31, 2018, unless such firm is
replaced prior to such date.

 

(cc)         No
Disagreements with Accountants and Lawyers. Except as set forth in the SEC Reports, there are no disagreements of any kind
presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers formerly
or presently employed by the Company and the Company is current with respect to any fees owed to its accountants and lawyers which
could affect the Company’s ability to perform any of its obligations under any of the Transaction Documents.

 

(dd)         Regulation
M Compliance. The Company has not, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold,
bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or paid or agreed to pay to any
Person any compensation for soliciting another to purchase any other securities of the Company.

 

(ee)         Stock
Option Plans. Each compensatory stock option granted by the Company to a consultant or employee of the Company was granted
(i) in accordance with the terms of the applicable stock option plan of the Company and (ii) with an exercise price at least equal
to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable
law. No stock option granted under the Company’s stock option plan has been backdated. The Company has not knowingly granted,
and there is no and has been no policy or practice of the Company to knowingly grant, stock options prior to, or otherwise knowingly
coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company
or its Subsidiaries or their financial results or prospects.

 

    16

     

    

 

(ff)         Office
of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer,
agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office
of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

(gg)         U.S.
Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the
meaning of Section 897 of the Internal Revenue Code of 1986, as amended.

 

(hh)         Bank
Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act
of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the
“Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly
or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or
more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither
the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

(ii)         Money
Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record- keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970,
as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge
of the Company or any Subsidiary, threatened.

 

(jj)         Management.
Except as set forth in Schedule 3.1(jj) hereto, during the past five-year period, no current officer or director or,
to the knowledge of the Company, no current ten percent (10%) or greater stockholder of the Company or any of its Subsidiaries
has been the subject of:

 

(i)          a
petition under bankruptcy laws or any other insolvency or moratorium law or the appointment by a court of a receiver, fiscal agent
or similar officer for such Person, or any partnership in which such person was a general partner at or within two years before
the filing of such petition or such appointment, or any corporation or business association of which such person was an executive
officer at or within two years before the time of the filing of such petition or such appointment;

 

(ii)         a
conviction in a criminal proceeding or a named subject of a pending criminal proceeding (excluding traffic violations that do not
relate to driving while intoxicated or driving under the influence);

 

    17

     

    

 

(iii)        any
order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently
or temporarily enjoining any such person from, or otherwise limiting, the following activities:

 

(1)         Acting
as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage
transaction merchant, any other person regulated by the United States Commodity Futures Trading Commission or an associated person
of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person,
director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing
any conduct or practice in connection with such activity;

 

(2)         Engaging
in any particular type of business practice; or

 

(3)         Engaging
in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of securities
laws or commodities laws;

 

(iv)        any
order, judgment or decree, not subsequently reversed, suspended or vacated, of any authority barring, suspending or otherwise limiting
for more than sixty (60) days the right of any such person to engage in any activity described in the preceding sub paragraph,
or to be associated with persons engaged in any such activity;

 

(v)         a
finding by a court of competent jurisdiction in a civil action or by the SEC or other authority to have violated any securities
law, regulation or decree and the judgment in such civil action or finding by the SEC or any other authority has not been subsequently
reversed, suspended or vacated; or

 

(vi)        a
finding by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated
any federal commodities law, and the judgment in such civil action or finding has not been subsequently reversed, suspended or
vacated.

 

(kk)         No
Disqualification Events. With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b) under the 1933
Act (“Regulation D Securities”), none of the Company, any of its predecessors, any affiliated issuer, any director,
executive officer, other officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20%
or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter
(as that term is defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at the time of sale (each,
an “Issuer Covered Person” and, together, “Issuer Covered Persons”) is subject to any of
the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the 1933 Act (a “Disqualification
Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable
care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent
applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchaser a copy of any disclosures provided
thereunder.

 

    18

     

    

 

(ll)         Payments
of Cash. Neither the Company, its directors or officers, or any Affiliates or agents of the Company, have withdrawn or paid
cash to any vendor in an aggregate amount that exceeds Five Thousand Dollars ($5,000) for any purpose.

 

3.2          Representations
and Warranties of each Purchaser. Each Purchaser hereby represents and warrants, severally and not jointly, as of the date
hereof and as of the Closing Date on which the Purchaser is purchasing Securities to the Company as follows (unless as of a specific
date therein):

 

(a)          Organization;
Authority. If the Purchaser is an entity, the Purchaser is an entity duly incorporated or formed, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations hereunder and thereunder. If the Purchaser is an entity, the execution and
delivery of the Transaction Documents and performance by the Purchaser of the transactions contemplated by the Transaction Documents
have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable,
on the part of the Purchaser. Each Transaction Document to which it is a party has been duly executed by the Purchaser, and when
delivered by the Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of the
Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable
bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

(b)          Own
Account. Each Purchaser understands that the Securities are “restricted securities” and have not been registered
under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account
and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act
or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities
Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to
distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities
law. The Purchaser is acquiring the Securities hereunder in the ordinary course of its business.

 

(c)          Purchaser
Status. At the time the Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on
which it exercises any Warrants it will be either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a)
under the Securities Act.

 

    19

     

    

 

(d)          Experience
of the Purchaser. Each Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk
of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e)          Reliance
on Exemptions. Each Purchaser understands that the Securities are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon
the truth and accuracy of, and the Purchaser’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility
of the Purchaser to acquire the Securities.

 

(f)          Information.
Each Purchaser and its advisors, if any, have been furnished with all materials relating to the business, finances and operations
of the Company and materials relating to the offer and sale of the Securities that have been requested by the Purchaser. Each Purchaser
understands that its investment in the Securities involves a high degree of risk. Such Purchaser has sought such accounting, legal
and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.

 

(g)          No
Governmental Review. Each Purchaser understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment
in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

(h)          General
Solicitation. The Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented
at any seminar or any other general solicitation or general advertisement.

 

(i)          Certain
Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, the Purchaser has not directly
or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with the Purchaser, executed any purchases
or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that the Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Other than to other Persons
party to this Agreement, the Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction).

 

    20

     

    

 

The Company acknowledges and
agrees that the representations contained in Section 3.2  shall not modify, amend or affect the Purchasers’ right
to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this
Agreement or the consummation of the transaction contemplated hereby.

 

ARTICLE
IV

OTHER AGREEMENTS OF THE PARTIES

 

4.1          Transfer
Restrictions.

 

(a)          The
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in
connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to
the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, at the Company’s sole
expense in the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of such transferred Securities under the Securities Act. Such opinion may be a blanket opinion covering
the transfer of all shares by the Purchaser. As a condition of transfer, any such transferee shall agree in writing to be bound
by the terms of this Agreement and shall have the rights and obligations of a Purchaser under this Agreement.

 

(b)          Each
Purchaser agrees to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in
the following form:

 

[NEITHER] THIS SECURITY [NOR
THE SECURITIES INTO WHICH THIS SECURITY IS [CONVERTIBLE/EXERCISABLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY
A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THIS SECURITY [AND THE SECURITIES ISSUABLE UPON [CONVERSION/EXERCISE] OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA
FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER- DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR”
AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

    21

     

    

 

The Company
acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an “accredited
investor” as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of this Agreement,
if required under the terms of such arrangement, the Purchaser may transfer pledged or secured Securities to the pledgees or secured
parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the
pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge.
At the appropriate Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or
secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities.

 

(c)          Certificates
evidencing the Underlying Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof):
(i) while a registration statement covering the resale of such security is effective under the Securities Act, (ii) following any
sale of Underlying Shares pursuant to Rule 144, or (ii) if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its
counsel to issue a legal opinion to the Transfer Agent promptly to effect the removal of the legend hereunder or upon request of
a Purchaser in compliance with Rule 144, at no cost to the Purchaser, if applicable. If all or any portion of a Warrant is exercised
or a Note is converted at a time when there is an effective registration statement to cover the resale of the Underlying Shares,
or if such Underlying Shares may be sold under Rule 144 without the requirement for the Company to be in compliance with the current
public information required under Rule 144 as to such Underlying Shares and without volume or manner-of- sale restrictions or if
such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and
pronouncements issued by the staff of the Commission) then such Underlying Shares shall be issued free of all legends. The Company
agrees that following the Effective Date or such time as such legend is no longer required under this Section 4.1(c), it
will, no later than three Trading Days following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate
representing Underlying Shares, as applicable, issued with a restrictive legend (such third Trading Day, the “Legend Removal
Date”), deliver or cause to be delivered to the Purchaser a certificate representing such shares that is free from all
restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent
that enlarge the restrictions on transfer set forth in this Section 4. Certificates for Underlying Shares subject to legend
removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s
prime broker with the Depository Trust Company System as directed by the Purchaser.

 

(d)          In
addition to the Purchaser’s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated
damages and not as a penalty, for each $1,000 of Underlying Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading
Day (increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after
the Legend Removal Date until such certificate is delivered without a legend. Nothing herein shall limit the Purchaser’s
right to pursue actual damages for the Company’s failure to deliver certificates representing any Securities as required
by the Transaction Documents, and the Purchaser shall have the right to pursue all remedies available to it at law or in equity
including, without limitation, a decree of specific performance and/or injunctive relief.

 

    22

     

    

 

(e)          The
Purchaser agrees with the Company that the Purchaser will sell any Securities pursuant to either the registration requirements
of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if Securities
are sold pursuant to a registration statement, they will be sold in compliance with the plan of distribution set forth therein,
and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth in this Section
4.1 is predicated upon the Company’s reliance upon this understanding.

 

4.2          Acknowledgment
of Dilution. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares
of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that, subject
to obtaining the Required Approvals, its obligations under the Transaction Documents, including, without limitation, its obligation
to issue the Underlying Shares pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right
of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against
any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the
Company.

 

4.3          Furnishing
of Information; Public Information.

 

(a)          Until
no Purchaser owns Securities, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g)
of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all
reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then
subject to the reporting requirements of the Exchange Act.

 

(b)          At
any time during the period commencing from the six (6)-month anniversary of the date hereof and ending at such time that all of
the Securities have been sold or may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and
otherwise without restriction or limitation pursuant to Rule 144, if the Company shall fail for any reason to satisfy the current
public information requirement under Rule 144(c) (a “Public Information Failure”) then, in addition to the Purchaser’s
other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by
reason of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to two percent (2.0%) of
the aggregate Subscription Amount of the Purchaser’s Securities on the day of a Public Information Failure and on every thirtieth
(30th) day (pro-rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such
Public Information Failure is cured and (b) such time that such public information is no longer required  for the Purchaser
to transfer the Underlying Shares pursuant to Rule 144.  The payments to which a Purchaser shall be entitled pursuant to this
Section 4.3(b) are referred to herein as “Public Information Failure Payments”.  Public Information Failure Payments
shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments
are incurred and (ii) the third (3rd) Business Day after the event or failure giving rise to the Public Information
Failure Payments is cured.  In the event the Company fails to make Public Information Failure Payments in a timely
manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months)
until paid in full. Nothing herein shall limit the Purchaser’s right to pursue actual damages for the Public Information
Failure, and the Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief.

 

    23

     

    

 

4.4          Integration.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require
the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the
Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior
to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.

 

4.5          Conversion
and Exercise Procedures.  The form of Notice of Conversion included in the Certificate of Designations and form of
Notice of Exercise included in any Warrant sets forth the totality of the procedures required of the Purchaser in order to convert
such Note or exercise such Warrant.  Without limiting the preceding sentences, no ink-original Notice of Conversion or
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice
of Conversion or Notice of Exercise form be required in order to convert the Preferred Shares or exercise the Warrants.  No
additional legal opinion, Notice of Conversion, Notice of Exercise or other information or instructions shall be required of the
Purchaser to convert such Preferred Shares or exercise such Warrant.  The Company shall honor conversions of any Preferred
Share and exercise any Warrant, and shall deliver the Underlying Shares, in accordance with the terms, conditions and time periods
set forth in the Transaction Documents.

 

4.6          Disclosure
of Transactions and Other Material Information.

 

(a)          Disclosure
of Transaction. The Company shall, on or before 9:30 a.m., New York time, on the third (3rd) Business Day after the date
of this Agreement, issue a press release (the “Press Release”) reasonably acceptable to the Purchaser disclosing
all the material terms of the transactions contemplated by the Transaction Documents. On or before 9:30 a.m., New York time, on
the third (3rd) Business Day after the date of this Agreement, the Company shall file a Current Report on Form 8-K describing all
the material terms of the transactions contemplated by the Transaction Documents in the form required by the 1934 Act and attaching
all the material Transaction Documents (including, without limitation, this Agreement) (including all attachments, the “8-K
Filing”). From and after the filing of the 8-K Filing, except with respect to information with regard to the business
prospects of SCWorx Corp., the Company shall have disclosed all material, non-public information (if any) provided to the Purchaser
by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents in connection with
the transactions contemplated by the Transaction Documents. In addition, effective upon the filing of the 8-K Filing, the Company
acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between
the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one
hand, and the Purchaser or any of their affiliates, on the other hand, shall terminate, provided however that the Purchasers acknowledge
their obligations under the federal securities laws concerning information disclosed to Purchasers with regard to the business
prospects of SCWorx Corp.

 

    24

     

    

 

(b)          Limitations
on Disclosure. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective
officers, directors, employees and agents not to, provide any Purchaser with any material, non-public information regarding the
Company or any of its Subsidiaries from and after the date hereof without the express prior written consent of such Purchaser (which
may be granted or withheld in each Purchaser’s sole discretion). Subject to the foregoing, neither the Company, its Subsidiaries
nor any Purchaser shall issue any press releases or any other public statements with respect to the transactions contemplated hereby
without the prior approval of Mark Munro (“Munro”); provided, however, the Company shall be entitled, without the prior
approval of Munro ), to make the Press Release and any press release or other public disclosure with respect to such transactions
(i) in substantial conformity with the 8-K Filing and contemporaneously therewith and (ii) as is required by applicable law and
regulations (provided that in the case of clause (i) Munro shall be consulted by the Company in connection with any such press
release or other public disclosure prior to its release). Without the prior written consent of the applicable Purchaser (which
may be granted or withheld in the Purchaser’s sole discretion), the Company shall not (and shall cause each of its Subsidiaries
and affiliates to not) disclose the name of the Purchaser in any filing, announcement, release or otherwise, unless required by
applicable law.

 

(c)          Other
Confidential Information. Disclosure Failures; Disclosure Delay Payments. In addition to other remedies set forth in this Section
4.6, and without limiting anything set forth in any other Transaction Document, at any time after the Closing Date if the Company,
any of its Subsidiaries, or any of their respective officers, directors, employees or agents, provides any Purchaser with material
non-public information relating to the Company or any of its Subsidiaries (each, the “Confidential Information”),
other than pursuant to a non-disclosure agreement between the Company and the Purchaser, the Company shall, on or prior to the
applicable Required Disclosure Date (as defined below), publicly disclose such Confidential Information on a Current Report on
Form 8-K or otherwise (each, a “Disclosure”). From and after such Disclosure, the Company shall have disclosed
all Confidential Information provided to the Purchasers by the Company or any of its Subsidiaries or any of their respective officers,
directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition, effective
upon such Disclosure, the Company acknowledges and agrees that any and all confidentiality or similar obligations regarding Confidential
Information under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective
officers, directors, affiliates, employees or agents, on the one hand, and the Purchasers or any of their affiliates, on the other
hand, shall terminate. In the event that the Company fails to effect such Disclosure on or prior to the Required Disclosure Date
and the Purchasers shall have possessed Confidential Information for at least ten (10) consecutive Trading Days (each, a “Disclosure
Failure”), then, as partial relief for the damages to the Purchasers by reason of any such delay in, or reduction of,
its ability to buy or sell shares of Common Stock after such Required Disclosure Date (which remedy shall not be exclusive of any
other remedies available at law or in equity), the Company shall pay to the Purchasers an amount in cash equal to the greater of
(I) two percent (2%) of the aggregate Purchase Price and (II) the applicable Disclosure Restitution Amount, on each of the following
dates (each, a “Disclosure Delay Payment Date”): (i) on the date of such Disclosure Failure and (ii) on every
thirty (30) day anniversary such Disclosure Failure until the earlier of (x) the date such Disclosure Failure is cured and (y)
such time as all such non-public information provided to the Purchasers shall cease to be Confidential Information (as evidenced
by a certificate, duly executed by an authorized officer of the Company to the foregoing effect) (such earlier date, as applicable,
a “Disclosure Cure Date”). Following the initial Disclosure Delay Payment for any particular Disclosure Failure,
without limiting the foregoing, if a Disclosure Cure Date occurs prior to any thirty (30) day anniversary of such Disclosure Failure,
then such Disclosure Delay Payment (prorated for such partial month) shall be made on the third (3rd) Business Day after such Disclosure
Cure Date. The payments to which a Purchaser shall be entitled pursuant to this Section 4.6 are referred to herein as “Disclosure
Delay Payments.” In the event the Company fails to make Disclosure Delay Payments in a timely manner in accordance with
the foregoing, such Disclosure Delay Payments shall bear interest at the rate of two percent (2%) per month (prorated for partial
months) until paid in full.

 

    25

     

    

 

(d)          For
the purpose of this Agreement the following definitions shall apply:

 

(i)          “Disclosure
Failure Market Price” means, as of any Disclosure Delay Payment Date, the price computed as the quotient of (I) the sum
of the five (5) highest VWAPs of the Common Stock during the applicable Disclosure Restitution Period (as defined below), divided
by (II) five (5) (such period, the “Disclosure Failure Measuring Period”). All such determinations to be appropriately
adjusted for any share dividend, share split, share combination, reclassification or similar transaction that proportionately decreases
or increases the Common Stock during such Disclosure Failure Measuring Period.

 

(ii)         “Disclosure
Restitution Amount” means, as of any Disclosure Delay Payment Date, the product of (x) difference of (I) the Disclosure
Failure Market Price less (II) the lowest purchase price, per share of Common Stock, of any Common Stock issued or issuable to
the Purchaser pursuant to this Agreement or any other Transaction Documents, multiplied by (y) 10% of the aggregate daily dollar
trading volume (as reported on Bloomberg L.P. ) of the Common Stock on the Principal Market for each Trading Day either (1) with
respect to the initial Disclosure Delay Payment Date, during the period commencing on the applicable Required Disclosure Date through
and including the Trading Day immediately prior to the initial Disclosure Delay Payment Date or (2) with respect to each other
Disclosure Delay Payment Date, during the period commencing the immediately preceding Disclosure Delay Payment Date through and
including the Trading Day immediately prior to such applicable Disclosure Delay Payment Date (such applicable period, the “Disclosure
Restitution Period”).

 

    26

     

    

 

(iii)        “Required
Disclosure Date” means (x) if the Purchaser authorized the delivery of such Confidential Information, either (I) if the
Company and the Purchaser have mutually agreed upon a date (as evidenced by an e-mail or other writing) of Disclosure of such Confidential
Information, such agreed upon date or (II) otherwise, the seventh (7th) calendar day after the date the Purchaser first
received any Confidential Information or (y) if the Purchasers did not authorize the delivery of such Confidential Information,
the first (1st) Business Day after such Purchaser’s receipt of such Confidential Information.

 

4.7          Shareholder
Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any
Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities
under the Transaction Documents or under any other agreement between the Company and the Purchaser.

 

4.8          Non-Public
Information. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company covenants and agrees that neither it, nor any other Person acting on its behalf, will provide any Purchaser or its
agents or counsel with any information that the Company believes constitutes material non- public information of the Company, unless
prior thereto the Purchaser shall have entered into a written agreement with the Company regarding the confidentiality and use
of such information. The Company understands and confirms that the Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company.

 

4.9          Use
of Proceeds. Subject to Section 4.18, the Company shall use the net proceeds from the sale of the Securities hereunder for
working capital purposes and shall not use such proceeds: (a) for the redemption of any Common Stock or Common Stock Equivalents,
(b) for the settlement of any outstanding litigation or (c) in violation of FCPA or OFAC regulations.

 

4.10        Indemnification
of Purchasers. Subject to the provisions of this Section 4.10, the Company will indemnify and hold the Purchasers and
their respective directors, officers, shareholders, members and partners (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls the Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
members or partners (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from
any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts
paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any the Purchaser Party may
suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements
made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser
Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate
of the Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is
based upon a breach of the Purchaser Party’s representations, warranties or covenants under the Transaction Documents or
any agreements or understandings the Purchaser Party may have with any such stockholder or any violations by the Purchaser Party
of state or federal securities laws or any conduct by the Purchaser Party which constitutes fraud, gross negligence, willful misconduct
or malfeasance).

 

    27

     

    

 

If any action shall
be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, the Purchaser Party
shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of
its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel
in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of
the Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action
there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and
the position of the Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no
more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (x) for any settlement
by a Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed;
or (y) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s
breach of any of the representations, warranties, covenants or agreements made by the Purchaser Party in this Agreement or in the
other Transaction Documents. The indemnification required by this Section 4.10 shall be made by periodic payments of the
amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity
agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company
or others and any liabilities the Company may be subject to pursuant to law.

 

4.11        Reservation
and Listing of Securities.

 

(a)          The
Company shall, after the closing of the SCWorx Acquisition, maintain a reserve from its duly authorized shares of Common Stock
for issuance pursuant to the Transaction Documents 200% of such amount as may from time to time be required to fulfill its obligations
in full under the Transaction Documents and shall confirm and adjust the adequacy of such reserve at least monthly.

 

(b)          If,
on any date after the closing of the SCWorx Acquisition, the number of authorized but unissued (and otherwise unreserved) shares
of Common Stock is less than 200% of the Required Minimum on such date, then the Board of Directors shall use commercially reasonable
efforts to amend the Company’s certificate or articles of incorporation to increase the number of authorized but unissued
shares of Common Stock to at least 200% of the Required Minimum at such time, as soon as possible and in any event not later than
the 75th day after such date; provided that the Company will not be required at any time to authorize a number of shares of Common
Stock greater than the maximum remaining number of shares of Common Stock that could possibly be issued after such time pursuant
to the Transaction Documents.

 

    28

     

    

 

(c)          The
Company shall, if applicable, subject to Section 4.16: (i) in the time and manner required by the principal Trading Market, prepare
and file with such Trading Market an additional shares listing application covering a number of shares of Common Stock at least
equal to the Required Minimum on the date of such application; (ii) take all steps necessary to cause such shares of Common Stock
to be approved for listing or quotation on such Trading Market as soon as possible thereafter; (iii) provide to the Purchaser evidence
of such listing or quotation; and (iv) maintain the listing or quotation of such Common Stock on any date at least equal to the
Required Minimum on such date on such Trading Market or another Trading Market. The Company agrees to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in
connection with such electronic transfer.

 

4.12        Certain
Transactions and Confidentiality.

 

(a)          Each
Purchaser covenants, severally and not jointly, that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding
with it will execute any Short Sales of any of the Company’s securities during the period commencing with the execution of
this Agreement and ending on the date the Purchaser’s Preferred Shares are no longer outstanding.

 

(b)          Each
Purchaser covenants, severally and not jointly, that until such time as the transactions contemplated by this Agreement are publicly
disclosed by the Company, the Purchaser will maintain the confidentiality of the existence and terms of this transaction and the
information included in the Transaction Documents and the Disclosure Schedules.

 

(c)          Except
as set forth in Sections 4.6(a), 4.12(a) and 4.12(b) above and in any non-disclosure agreement between the Company
and the Purchaser, the Company expressly acknowledges and agrees that (i) the Purchaser shall not be restricted from effecting
transactions in any securities of the Company in accordance with applicable securities laws after the time that the transactions
contemplated by this Agreement are first publicly announced, and (ii) the Purchaser shall not have any duty of confidentiality
to the Company or its Subsidiaries after the transactions contemplated by this Agreement are first publicly announced.

 

4.13        Form
D; Blue Sky Filings. The Company shall file a Form D with respect to the Securities as required under Rule 506 of Regulation
D and to provide a copy thereof to each Purchaser promptly after such filing. Without limiting any other obligation of the Company
under this Agreement, the Company shall timely make all filings and reports relating to the offer and sale of the Securities required
under all applicable securities laws (including, without limitation, all applicable federal securities laws and all applicable
“Blue Sky” laws), and the Company shall comply with all applicable foreign, federal, state and local laws, statutes,
rules, regulations and the like relating to the offering and sale of the Securities to the Purchaser and shall provide evidence
of any such action so taken to the Purchaser.

 

    29

     

    

 

4.14         Offerings
of Variable Rate Securities. Until the expiration of 24 months from the final Closing Date of Securities sold hereunder, the
Company shall not, directly or indirectly, (i) issue or sell any convertible securities either (A) at a conversion, exercise or
exchange rate or other price that is based upon and/or varies with the trading prices of, or quotations for, the shares of Common
Stock at any time after the initial issuance of such convertible securities, or (B) with a conversion, exercise or exchange price
that is subject to being reset at some future date after the initial issuance of such convertible securities or upon the occurrence
of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock,
or (ii) enter into any agreement (including, without limitation, an “equity line of credit” or an “at-the-market
offering”) whereby the Company or any of its subsidiaries may sell securities at a future determined price (other than standard
and customary “preemptive” or “participation” rights). The Purchaser shall be entitled to obtain injunctive
relief against the Company and its subsidiaries to preclude any such issuance, which remedy shall be in addition to any right to
collect damages.

 

4.15         Reporting
Status. Until the date on which the Purchaser shall have sold all of the Underlying Securities (the “Reporting Period”),
the Company shall timely file all reports required to be filed with the SEC pursuant to the 1934 Act, and the Company shall not
terminate its status as an issuer required to file reports under the 1934 Act even if the 1934 Act or the rules and regulations
thereunder would no longer require or otherwise permit such termination.

 

4.16         Shareholder
Approval. No later than 30 days from the Closing Date, the Company shall file a proxy statement (the “Proxy Statement”)
with the Securities and Exchange Commission and take all other necessary corporate actions in order to obtain the approval of the
Company’s shareholders holding at a majority of the Company’s Common Stock to approve the change of control of the
Company resulting from completion of the of the acquisition of SCWorx Corp. as contemplated by that certain Share Exchange Agreement
between among others the Company and SCWorx Corp. dated June 28, 2018 (the “SCWorx Acquisition”), the Transaction Documents
and the transactions contemplated therein including the issuance of the Preferred Stock and Warrants and the Underlying Shares.

 

4.17         No later than fifteen (15) days from the date of shareholder Approval required by Section 4.16, the Company shall have received
the approval of Nasdaq with respect to the Transaction Agreement and the transactions contemplated therein including the listing
of the Underlying Shares.

 

4.18         Cash
ReserveWhile any Securities are outstanding, the Company shall at all times maintain a minimum cash reserve of $4,500,000
until the closing of the SCWorx Acquisition.

 

4.19         Amendments to Share Exchange Agreement. The Company shall not, prior to the closing of the SCWorx Acquisition, make a material
change to the Share Exchange Agreement dated August 20, 2018, as amended by the draft amendment attached hereto as Annex B, or
waive any material condition to the closing of such agreement, without the prior written consent of a majority-in-interest of the
preferred shareholders, which consent shall not be unreasonably withheld, conditioned or delayed. For purposes of this Section
4.19, Sections 7.5 and 8.12 of the Share Exchange Agreement shall be deemed not to be a “material condition” of to
the closing of the Share Exchange Agreement.

 

    30

     

    

 

ARTICLE
V

MISCELLANEOUS

 

5.1           Termination.
This Agreement may be terminated by either party if the Closing has not been consummated on or before October31, 2018; provided,
however, that such termination will not affect the right of any party to sue for any breach by any other party (or parties).

 

5.2           Fees
and Expenses. The Purchasers shall be responsible for their own attorney’s fees and expenses for the transactions contemplated
by this Agreement. The Company shall deliver to the Purchasers, prior to the Closing, a completed and executed copy of the Closing
Statement, attached hereto as Annex A. The Company shall pay all expenses incurred by the Company in connection with the offer
and sale of the Securities, Transfer Agent fees (including, without limitation, any fees required for same-day processing of any
instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and
duties levied in connection with the delivery of any Securities to the Purchaser.

 

5.3           Entire
Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of
the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or
written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

5.4           Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number set forth on the signature pages attached hereto at or prior to 4:00 p.m. (New York City
time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via
facsimile at the facsimile number set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 4:00 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing,
if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is
required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

 

5.5           Amendments;
Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by each of the Company and a majority in interest of the Preferred Shares or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent
default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise
any right hereunder in any manner impair the exercise of any such right.

 

    31

     

    

 

5.6           Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.

 

5.7           Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
a majority in interest of the Preferred Shares (other than by merger). A Purchaser may assign any or all of its rights under this
Agreement to any Person to whom the Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing
to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchaser.”

 

5.8           No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in Section 4.10 and this Section 5.8.

 

5.9           Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party
hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect
to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action
or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding
is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence
an action, suit or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the
Company under Section 4.10, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party
for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such action or proceeding.

 

5.10         Survival.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.

 

    32

     

    

 

5.11         Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being
understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.

 

5.12         Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

 

5.13         Rescission
and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of)
any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then the Purchaser
may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand
or election in whole or in part without prejudice to its future actions and rights.

 

5.14         Replacement
of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or
in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory
to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall
also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.

 

5.15         Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of
the Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation
the defense that a remedy at law would be adequate.

 

5.16         Payment
Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or
exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from,
disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person
under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action),
then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived
and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

    33

     

    

 

5.17         Liquidated
Damages. The Company’s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other
amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages
or other amounts are due and payable shall have been canceled.

 

5.18         Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.

 

5.19         Construction.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting
party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and
every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after
the date of this Agreement.

 

5.20         WAIVER
OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

(Signature Pages Follow)

 

    34

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	ALLIANCE MMA, INC.	 	Address for Notice:
	 	 	 	 
	By:	/s/ John Price	 	Email: Jprice@alliancemma.com
	 	Name: John Price, President	 	 

 

With a copy to (which shall not constitute notice):

 

Company Counsel: Jnossiff@nossiff-law.com

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASERS FOLLOWS]

 

    35

     

    

 

PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE
AGREEMENT

 

IN WITNESS WHEREOF,
the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as
of the date first indicated above.

 

	Name of Purchaser:	 	 

 

	Signature of Authorized Signatory of Purchaser:	 
	 	 
	Name of Authorized Signatory:	 
	 	 
	Title of Authorized Signatory:	 
	 	 
	Email Address of Authorized Signatory:	 
	 	 
	Facsimile Number of Authorized Signatory:	 

 

	Address for Notice to Purchaser: 	 
	 	 
	 	 
	 	 
	 	 

 

The Purchaser Elects to purchase ______ Preferred Shares at
a purchase price of $___ per Preferred Share under the Securities Purchase Agreement at a total Purchase Price of $__________ ,
together with _____________ Warrants

 

Subscription Amount: ______________________

 

EIN Number: _______________________

 

    36

     

    

 

Annex A

 

CLOSING STATEMENT

 

Pursuant to the attached
Securities Purchase Agreement, dated as of October     , 2018, the Purchaser shall purchase $[            ]
of the Convertible Preferred Stock of and Warrants from Alliance MMA, Inc., a Delaware corporation (the “Company”),
for a total purchase price of $[               ].00.
All funds will be wired into an account maintained by the Company. All funds will be disbursed in accordance with this Closing
Statement.

 

Disbursement Date: October[   ],
2018

 

 

 

I.   PURCHASE PRICE

 

	Gross Proceeds to be Received	$

 

II. DISBURSEMENTS

 

Total Amount Disbursed: $

 

WIRE INSTRUCTIONS:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]